+ All Categories
Home > Documents > 1.1.16 master CV

1.1.16 master CV

Date post: 13-Apr-2017
Category:
Upload: kv-chalam
View: 131 times
Download: 13 times
Share this document with a friend
133
K.V. CHALAM, MD, PhD, MBA, FACS. Curriculum Vitae INDEX Page No. 1. Biodata 2 2. Current Position 2-3 3. Academic Qualifications 4 4. Membership 7 5. Honors & Awards 8-15 6. Bibliography 15- 80 1 06/13/22
Transcript
Page 1: 1.1.16 master CV

K.V. CHALAM, MD, PhD, MBA, FACS.Curriculum Vitae

INDEX Page No.

1. Biodata 2

2. Current Position 2-3

3. Academic Qualifications 4

4. Membership 7

5. Honors & Awards 8-15

6. Bibliography 15- 80

1 05/02/23

Page 2: 1.1.16 master CV

K.V. CHALAM, MD, PhD, MBA, FACSCurriculum Vitae

DATE OF BIRTH August 1, 1959MARITAL STATUS Married CITIZENSHIP United StatesBUSINESS ADDRESS Department of Ophthalmology

580 W 8th StreetJacksonville, FL 32209. Tel No. 904-403-2607 / 244-9361Fax No.904-244-9391

HOME ADDRESS 10053 Lakes End CourtJacksonville, FL 32256. Tel No. 904-403-2607 / 519-2949Fax No.904- [email protected] ; [email protected]

PRESENT ACADEMIC POSITION 1. Chairman and Tenured ProfessorDepartment of OphthalmologyUniversity of Florida College of MedicineJacksonville, Florida

2. Associate DeanVeterans Administration AffairsUniversity of Florida College of MedicineJacksonville, Florida

3. Program DirectorResidency EducationFellowship EducationDepartment of OphthalmologyUniversity of Florida College of MedicineJacksonville, Florida

4. Chief, Ophthalmology Service

2 05/02/23

Page 3: 1.1.16 master CV

UF Health Hospital University of Florida College of MedicineJacksonville, Florida

4. Director, Vitreoretinal ServiceNeuroophthalmology serviceElectrophysiology ServiceUveitis and Ocular Oncology ServiceDepartment of OphthalmologyUniversity of Florida College of Medicine, Jacksonville, Florida

PREVIOUS POSITION 1. Associate Chairman and Associate ProfessorDepartment of OphthalmologyUniversity of Florida College of MedicineJacksonville, Florida

2. ResidencyProgram DirectorResidency educationDepartment of OphthalmologyUSC School of MedicineColumbia, South Carolina

2. Associate ProfessorDepartment of OphthalmologyUSC School of MedicineColumbia, South Carolina

3. Attending ophthalmologistRichland Memorial HospitalDornJennings Veterans Administration HospitalHealthSouth HospitalProvidence HospitalColumbia, South Carolina

4. Director, Vitreoretinal ServiceNeuroophthalmology serviceElectrophysiology ServiceDepartment of Ophthalmology

3 05/02/23

Page 4: 1.1.16 master CV

USC School of Medicine, Columbia, South Carolina

ACADEMIC APPOINTMENTS / POSITIONS:

2006-Present Tenured Professor and ChairmanDepartment of OphthalmologyUniversity of Florida College of Medicine, Jacksonville, Florida

2004-Present Basic Science Research ProfessorDepartment of Microbiology and PathologyUSC School of Medicine, Columbia, South Carolina

2000-2005 Associate Professor and Associate ChairmanDepartment of OphthalmologyUniversity of Florida College of Medicine, Jacksonville, Florida

1998-99 Associate ProfessorDepartment of OphthalmologyUSC School of Medicine, Columbia, South Carolina

1994-98 Assistant ProfessorDepartment of OphthalmologyUSC School of Medicine. Columbia, South Carolina

1997-Present Visiting LecturerDepartment of OphthalmologyHarvard Medical School, Boston, Massachusetts

1993-94 InstructorDepartment of OphthalmologyUT Southwestern Medical School. Dallas, Texas

1992-93 Assistant InstructorDepartment of Ophthalmology

4 05/02/23

Page 5: 1.1.16 master CV

UT Southwestern Medical School. Dallas, Texas

POSTGRADUATE QUALIFICATIONS:

Earned

ABO Certification Diplomat, American Board of Ophthalmology

Nov.1993/2003/2013. Valid until 2024

Ph. D (Molecular Biology) University of South Carolina

Visual Science, Biomedical Sciences Graduate ProgramColumbia, South Carolina. May O4 / 3.63 / 4.00 GPA

M.B.A Webster University

St.Louis, Missouri. October 99 / 3.90 / 4.00 GPA

F.R.C.S.C (Ophthalmology) Fellow, Royal College of Physicians and Surgeons

CANADA. November 90

F.R.C. Ophth. Fellow, Royal College of Ophthalmologists

London, ENGLAND. November 90.

F.R.C.S (Ophthalmology) Fellow, Royal College of Surgeons of Edinburgh. Edinburgh,

ENGLAND. November 84.

D.O.R.C.S (Ophthalmology) Diplomat, Royal College of Surgeons

IRELAND. October 84.

M.S. (Ophthalmology) Post Graduate Institute of Medical Education and Research, Chandigarh,

INDIA. January 83.

Admitted

F.A.C.S Fellow, AmericanCollege of Surgeons

Ophthalmology, 1996

5 05/02/23

Page 6: 1.1.16 master CV

F.I.C.S Fellow, International College of Surgeons

USA Section, 1996

GRADUATE EDUCATION:

M.D. University of State of New York

Albany, New York. June 92

M.B.B.S GunturMedicalSchool

Guntur, INDIA. October 72- October 78

I.S. Andhra Loyola College

Vijayawada. India. July 70- June 72

POSTGRADUATE CLINICAL TRAINING:

FELLOWSHIP:

Vitreo-retinal Surgery UT Southwestern Medical School, DallasDepartment of OphthalmologyJuly 92 -June 94.Chairman: Dr. J. McCulley.Preceptor. Dr. R. Anand / Dr. C. Wilson.

Neuroophthalmology UT Medical School at HoustonDepartment of Ophthalmology July 87 - June 88.Chairman: Dr. R. Ruiz.Preceptor: Dr. R. Tang.

Ocular Oncology MD Anderson Cancer Center, HoustonDepartment of Ophthalmology / Head and Neck SurgeryJuly 87 - June 88.Chairman: Dr. H.Goepffert.Preceptor: Dr. R. Tang

6 05/02/23

Page 7: 1.1.16 master CV

RESIDENCY & INTERNSHIP:

Ophthalmology Catholic Medical Center

(Residency) Affiliate. Cornell University Medical SchoolNew York. July 89- June 92. Chairman: Dr. David Paton

General Surgery Catholic Medical Center

(Internship) Affiliate. Cornell University Medical SchoolNew York. July 88- June 89. Chairman: Dr. Walter Pizzi

Instructor Department of Ophthalmology

Ipswich Hospital, Ipswich, ENGLANDMay 85- June 87Chairman: Dr. M. J. Parkinson

Senior Resident Prince Charles Eye Unit.

Ophthalmology King Edward VII Hospital, Windsor. ENGLAND. March 84 - April 85Chairman: Dr. J.J. Kanski.

Teaching fellow Post Graduate Medical Institute

Ophthalmology Chandigarh, INDIA.January 80 - March 83

INTERNSHIP Guntur General Hospital. Guntur, India.Transitional October 78- December 79

LICENSURE:

South Carolina July 94/ 17105Florida Jan.97/ 72613New York Jan. 89/ 176948 Texas July.92 / J-1634

7 05/02/23

Page 8: 1.1.16 master CV

ECFMG Jan 79/ 307-821-9 USLME Sept. 83/ 307-821-9FLEX Dec. 86/ I.D. NO. 550801024

Eligible for licensure in all states United Kingdom April 84/ 121346

NATIONAL AND INTERNATIONAL SPECIALTY BOARD CERTIFICATION : Diplomat, American Board of Ophthalmology, November.1993. Recertified 2003, 2013

Royal college of Physicians and Surgeons of Canada, November.1990

Royal College of Ophthalmologists, United Kingdom, July.1990

RoyalCollege of Surgeons, Edinburgh, United Kingdom, November.1984

Royal college of Physicians and Surgeons, Ireland, August.1984

Certificate in specialist surgical training, Royal Academy of Medicine, London, January.1998

MEMBERSHIP, PROFESSIONAL SOCIETIES AND LEARNED SCIENTIFIC BODIES:Fellow / American College of Surgeons (FACS)

Fellow / American Academy of Ophthalmology

Fellow / Association for Research and Vision in Ophthalmology

Member, American Society of Retinal Specialists

Member, American Association for Advancement of Science

Member, Association of Biomedical Engineers

Member, International Society for Stem Cell Research

Member/ Association of University Professors in Ophthalmology

Member/ American Association of University Professors

Member, Medical Group Management Association

Member, American Medical Association, Southern Medical Association

Member/Canadian Ophthalmological Society

Fellow/American Society of Cataract and Refractive Surgeons

Fellow, RoyalCollege of Ophthalmologists, England

Fellow, RoyalCollege of Surgeons, Canada

Fellow, Royal College Surgeons, Edinburgh

Member, Florida Ophthalmological Society

Member, Florida Medical Association

Member, All India Ophthalmological society

8 05/02/23

Page 9: 1.1.16 master CV

Member, North American Neuro-ophthalmology Society

Member, Uveitis Society

Member, Ophthalmic Echographers Association

Member, Sigma XI Science Society

Member, American Medical Writers Association

Member, International Society for Ocular Pharmacology and Toxicology

HONORS & AWARDS:

“University of Florida Research Foundation Professor” awarded by University of Florida for outstanding research contributions 2015-2018

“Jackonville Health Care Hero” awarded by Jackonville Business Journal for outstanding contributions to community of Jacksonville 2015

“Senior Achievement Award” for outstanding program service to American Academy of Ophthalmology. 2010

“Outstanding Alumni Award for 2012” from University of South Carolina School of Medicine for outstanding research and scholarly contributions

“Deans Research / Scholar Award” for outstanding research and scholarly contributions during 2004-05 Academic Year

“Senior Honor Award” for outstanding program service to American Society of Retinal Specialists. 2005

“Director, Top Research Site award from National Institute of Health-Diabetic Retinopathy Clinical Research Network” for year 2008 (1/202 investigative sites)

“Director, Top Site award for R protocol Recruitment” from National Institute of Health-Diabetic Retinopathy Clinical Research Network” (1/202 investigative sites)

“Medical Director, O Protocol” National Institute of Health-Diabetic Retinopathy Clinical Research Network

“Member, Executive Committee” Diabetic retinopathy Clinical Research Network, National Eye Institute.

Chair, Basic and Clinical Science Course Volume 2, American Academy of Ophthalmology, Continuing Medical Education Division, 2005-2010

Secretary-Treasurer, International Society of Ocular Toxicology and Pharmacology, 2005-2013 “Best Teacher of the year” academic years 1995 and 1996, Department of Ophthalmology, USC

School of Medicine, Columbia, South Carolina.

“Achievement Honor Award” for outstanding program service to American Academy of Ophthalmology. 2000

“Honor Award” for outstanding program service to American Society of Retinal Specialists. 2004

9 05/02/23

Page 10: 1.1.16 master CV

“Member, Steering Committee” Diabetic retinopathy Clinical Research Network, National Eye Institute.

“Chancellor List” for outstanding graduate work at University of South Carolina, 2005

“Certificate of Appreciation” for outstanding program service to American Board of Ophthalmology. 1997 and 2007

“Certificate of Appreciation” for outstanding program service to National Eye Care Project of American academy of Ophthalmology. 2001

“Who is Who in World” Marquis Who’s Who Publication 2000-Present

“Who is Who in America” Marquis Who’s Who Publication 2000- Present

Associate Examiner, American Board of Ophthalmology, 1995 – Present

“Who is Who in Science and Engineering” Marquis Who’s Who Publication 2000- Present

“Who is Who in Finance and Industry” Marquis Who’s Who Publication 2000- Present

“Who is Who in America” Strathmore’s Who’s Who Publication 2000-2001

“Who is Who in Science and Engineering” Strathmore’s Who’s Who Publication 2000-2001

“Who is Who in Science and Engineering” Lexington’s Who’s Who Publication 2000-2001

Score of 99 in written qualifying examination of American Board of Ophthalmology, 1993.

“2000 Outstanding Scholars of 21st Century” International Biographic Institute Publication 2000-2001

OKAP Score of 99 for three consecutive years during residency training, 1989 - 92

Chief Resident, Catholic Medical Center, Department of Ophthalmology 1991 - 92

Annual Residents Day Research Award, Catholic Medical Center, 1990, 91 & 92

FIRST RANK in Master of Surgery (Ophthalmology) Examination, 1983, India

Honors and Distinction In ANATOMY 6/75

Honors and Distinction In PHYSIOLOGY 6/75

Honors and Distinction In BIOCHEMISTRY 6/75

Honors and Distinction In PHARMOCOLOGY 6/76

Honors and Distinction In PATHOLOGY 6/77

Honors and Distinction In MICROBIOLOGY 6/77

Honors and Distinction In PUBLIC HEALTH 12/77

Honors and Distinction In GENERAL MEDICINE 8/78

Honors and Distinction In GENERAL SURGERY 8/78

Class standing 2/152 in Medical School, 10/78

College Scholarships, Medical College, Guntur, 1972 - 78

National Science Talent Search Scholarship, National Council for Educational Research and Training, Govt. of India, 1970

National Scholarship, Ministry of Education and Youth Services, Government of India, 1970

10 05/02/23

Page 11: 1.1.16 master CV

Ranked first in the state Higher secondary examination, 1970

COMMITTEE APPOINTMENTS:

2004-2010 Chairman, Basic and Clinical Science Course Review Committee, Continuing Medical Education Division, American Academy of Ophthalmology

2000-present Member, Online Continuing Medical Education Committee, American Academy of Ophthalmology

2000-present Program Director, Residency and Fellowship Education, Department of Ophthalmology, Shands Jacksonville Hospital, Jacksonville, Florida

2000-present Chief, Department of Ophthalmology, Shands Jacksonville Hospital, Jacksonville, Florida

2000-present Chief Compliance Officer, Department of Ophthalmology, Shands Jacksonville Hospital, Jacksonville, Florida

2000-present Member, University of Florida Finance Committee, Jacksonville, Florida

2004-present Member, Institutional Review Board, University of Florida College of Medicine, Jacksonville Campus, Florida

2000-present Member, Board of Directors, University of Florida Jacksonville Health Sciences Incorporated, Jacksonville, Florida

2000-present Member, Medical Executive Committee, Shands Jacksonville Hospital, Jacksonville, Florida

2000-present Member, Gradual Medical Education Committee, Shands Jacksonville Hospital, Jacksonville, Florida

2001-present Member, Ethics Committee, Shands Jacksonville Hospital, Jacksonville, Florida

2000-present Member, Telephone Task Force, Shands Jacksonville Hospital, Jacksonville, Florida

1995-2002 Member, Basic and Clinical Science Course Review Committee, Continuing Medical Education Division, American Academy of Ophthalmology

1994-2000 Member, Operating Room Committee, Richland Memorial Hospital, Columbia, South Carolina

1994-2000 Chair, Resident Selection Committee, Department of Ophthalmology, University of South Carolina School of Medicine

1994-2000 Member, Graduate Medical Education Committee, Richland Memorial Hospital

1994-2000 Member, Education Trust Committee, University of South Carolina School of Medicine

1994-2000 Member, Student Advisory Committee, University of South Carolina School of Medicine

1995-2000 Member, Quality Assurance Committee, Department of Ophthalmology, University of South Carolina School of Medicine

11 05/02/23

Page 12: 1.1.16 master CV

1995 Member, Internal Review Committee, Department of Anesthesia, Richland Memorial Hospital

1995 Member, Internal Review Committee, Department of Emergency Medicine, Richland Memorial Hospital

1996 Member, Internal Review Committee, Graduate Medical Education, Richland Memorial Hospital

1997-2000 Member, Cooperative Staff of Center for Cancer Treatment and Research

1997-2000 Member, Curriculum Committee, University of South Carolina School of Medicine

PUBLIC SERVICE and CIVIC ACTIVITIES: Public media interview, WLTX TV, Columbia, "Floaters and their Implications" program (host Phyllis

Dean, WIS news) July 29, 1997

Public media interview, WSCQ TV, Columbia, "Prevention of Ocular trauma and Precautions On a July 4 weekend " program (host Mike Suber, WIS news) June 28, 1996

Public media interview, Carolinian Magazine, Columbia, "Treatment of AIDS patients with a new Intra ocular device" Reporter: Karen White, June 26, 1997

Associate Examiner to American Board of Ophthalmology, since July 1995.

Diabetic Retinopathy and Glaucoma Screening in conjunction with South Carolina Eye Institute, South Carolina Commission of the Blind and Lions Club, March 22-25, 1996

Diabetic Retinopathy and Glaucoma Screening in conjunction with South Carolina Eye Institute, at State Fair, August 27-29, 1996, Columbia, South Carolina

Diabetic Retinopathy and Glaucoma Screening in conjunction with South Carolina Eye Institute, at State Fair, September 2-6, 1995, Columbia, South Carolina

Consultant, Ophthalmology Service, Ryan White Free AIDS Clinic, Columbia, South Carolina, July 1995-December 2000. Provide free preventive screening for Indigent Patients.

Participant, Annual Diabetic Screening in Conjunction with Parkland Memorial Hospital Outreach program for Indigent Population, 1992-94

Participant, Weekly free clinic in Conjunction with Catholic Charities Church program, Jamaica, New York, August 88- June 92.

Volunteer Resident Member, Lions Eye Club, Queens, New York, Procured Donor eyes for corneal transplantation, 89-92.

Participated and performed over 1000 free cataract surgeries 1980-83, under the auspices of the Rotary Club in the provinces of Haryana and Punjab, India.

Mentor, Minority Students, Bedford-Stuyvesant section, Brooklyn, New York, 90-92 academic years.

Member, Richland Memorial Hospital Curriculum development committee on role of medical ethics in graduate medical education, 1995-97.

Participant, National Eye Care project sponsored by American Academy of Ophthalmology, 1994-present

12 05/02/23

Page 13: 1.1.16 master CV

Active participant, Operation sight saver (Sponsor: Commission for the Blind) to provide NO COST surgery with care to needy diabetics who otherwise could not afford care in an attempt to eliminate preventable blindness in South Carolina

Member, Board of Directors, AVASC Foundation, 1998-present, New York

Volunteer Surgeon, ORBIS international flying eye hospital, 2010-present, New York

ADMINISTRATIVE EXPERIENCE: Chairman, Department of Ophthalmology, University of Florida College of Medicine, Jacksonville,

Florida, 11/99-present

Residency and Fellowship Program Director, Department of Ophthalmology, University of Florida School of Medicine, Jacksonville, Florida, 11/99-present

Chief Administrative Officer, Department of Ophthalmology, University of Florida College of Medicine, Jacksonville, Florida, 11/99-present

Residency Program Director, Department of Ophthalmology at University of South Carolina School of Medicine since 6/94 – 11/99

Administrative Chief Resident in charge of organizing day to day residency activities at CMC Ophthalmology program, 07/91 - 06/92

President of House Staff body of 450 resident members at Catholic Medical Center during residency

Extensive RRC review experience: Collected data and prepared relevant documentation for RRC visit during chief residency year in 1992 as well as program director in 1997, 2007, and 2010. Full accreditation was awarded on all occasions.

CLINICAL EXPERIENCE: Director, Vitreoretinal service, University of Florida School of Medicine, Jacksonville, Florida, 1999-

Present

Director, Neuro-ophthalmology and Electrophysiology service, University of Florida School of Medicine, Jacksonville, Florida, 1999-Present

Director, Vitreoretinal service, University of South Carolina School of Medicine, 1994-1999

Director, Neuro ophthalmology and Electrophysiology service, University of South Carolina School of Medicine, 1994-99

Extensive experience in vitreo-retinal surgery including management of advanced PVR with modern molecular biological agents, severe diabetic traction retinal detachments, phakoemulsification combined with vitrectomy and severe ocular trauma. Performed over 20,000 procedures as primary surgeon

Specially trained in using Wide angle Vitrectomy system, Perfluorocarbon liquids and placement of telescopic implants and therapeutic intraocular implants

Fellowship trained in the management of Ocular tumors during Ocular oncology fellowship at MD Anderson Cancer Center, UT Houston, Texas

Organized Neuro-ophthalmology clinic and supervised Electrophysiology laboratory during Neuro-ophthalmology fellowship

13 05/02/23

Page 14: 1.1.16 master CV

TEACHING EXPERIENCE: Grand rounds coordinator, University of Florida / Shands Jacksonville Ophthalmology Residency

Program, Jacksonville, Florida, 2000-present

Grand rounds coordinator, Richland Memorial Hospital/University of South Carolina Ophthalmology Residency Program, Columbia, SC 1994-Present

Preceptor, University of South Carolina School of Medicine Students on surgery rotation and Family practice residents of Richland Memorial Hospital 1994-2000

Medical Student Advisor, University of South Carolina School of Medicine, 1994-2000

Organizer: Didactic and Microscopic surgery courses to new residents instructing phacoemulsification and basic surgical retinal skills.

Co-director, Clinical Ophthalmology section of Physical Diagnosis, Course # D603/4, M-II, The University of South Carolina School of Medicine, 1994 - 2000

Co-director, Clinical Ophthalmology section of Physical Diagnosis, Course # D620, M-IV, The University of South Carolina School of Medicine, 1994 - 2000

Co-director, Family Practice resident Ophthalmology rotation, Richland Memorial Hospital, 1994-2000.

Co-director, Internal Medicine resident Ophthalmology rotation, Richland Memorial Hospital, 1994-2000.

RESEARCH EXPERIENCE:Grants-in-Aid

1. Principal investigator of NIH Grant: “Phase III Trial-AREDS II- A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Fatty Acids in Age-Related Macular Degeneration.” Sponsor National Eye Institute N01-EY-5-0007($126,000)

2. Co- principal investigator ofNIH Grant: “Vascular Reparative Mechanism by ACE2/Ang-(1-7) in Diabetes.” Sponsor National Eye Institute 1R01HL110170 – 01 ($253,000)

3. Principal investigator of NIH Grant “Evaluation of Vitrectomy for Diabetic Macular Edema.” Sponsor Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14231 ($164,000)

4. Principle Investigator of NIH Grant “Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination with Laser Photocoagulation for Diabetic Macular Edema”. Sponsor. Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($522,000)

5. Principle Investigator of NIH Grant “A pilot study in individuals with center involved diabetic macular edema undergoing cataract surgery” Sponsor. Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($72,000)

6. Principle Investigator of NIH Grant “Observational study in individuals with diabetic retinopathy without center involved diabetic macular edema undergoing cataract surgery”. Sponsor. Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($114,000)

14 05/02/23

Page 15: 1.1.16 master CV

7. Principle Investigator of NIH Grant “An evaluation of intravitreal Ranizumab for Vitreous hemorrhage due to Proliferative Diabetic retinopathy”. Sponsor. Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($172,000)

8. Principle Investigatorof NIH Grant “Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy”. Sponsor. Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($522,000)

9. Principle Investigator of NIH Grant “Comparison of Time Domain OCT and Spectral Domain OCT Retinal ThicknessMeasurement in Diabetic Macular Edema”. Sponsor. Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($522,000)

10. Principle Investigator of NIH Grant “Effects of Diabetes education during Retinal ophthalmology visits on diabetic control”. Sponsor. Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($76,000)

11. Principal investigator of NIH grant: "Ischemic Optic Neuropathy Decompression Trial, Follow up study" 1997-2002. UIO EY09566-04 ($48,000)

12. Principal investigator of NIH grant: "Ischemic optic Neuropathy Decompression Trial" 1991-1996. UIO EY09566-03 ($134,000)

13. Consultant for NIH grant: “Collaborative Image Annotation in Ophthalmology UIO EY09566-03. 2003-04($98,000)

14. Principle Investigator of “A Double-Masked, Placebo-Controlled, Parallel-Group, Multi-center, Dose-Ranging Study to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Active Sight Threatening, Non-Infectious Anterior Uveitis”. Sponsor. Lux Biosciences, Inc.

15. Principal investigator of “A Prospective Continuation Multicenter Clinical Trial of the Implantable Miniature Telescope (IMT) In patients with Central Vision Impairment Associated with Age-Related Macular Degeneration.” Sponsor VISIONCARE Ophthalmic Technologies ($30,000)

16. Co-Investigator of “A Phase II/III Study of Encapsulated Human NTC-201 Cell ImplantsReleasing Ciliary Neurotrophic Factor (CNTF) for Participants with Retinitis Pigmentosa Using Visual Acuity as the Primary Outcome”. Sponsor. Neurotech USA, Inc. (160,000$)

17. Principal investigator of “A Phase 3 Multicenter, Randomized, Double-Masked, Controlled Study of Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated with Age-Related Macular Degeneration” Sponsor: Gaenera Corporation project no MSI-1256F-301. ($270,000)

18. Principal investigator of " A multi center randomized controlled study to evaluate the safety and efficacy of oral gancyclovir in comparison to intravitreal Gancyclovir implant in patients with newly diagnosed cytomegalovirus retinitis. Sponsor Syntex Project GANS. 2304 ($160,000)

19. Principal investigator of " A 12 Week, Multi-center, randomized, double-masked, three treatment parallel group comparison of fixed combination of latanoprost and timolol vs. latanoprost vs.timolol in glaucoma patients with optic nerve head abnormalities and visual field defects ” Sponsor Pharmacia Project Xalcom. 912-OPT-0076-022 ($47,000)

20. Principal investigator of " A multi center randomized, double masked, controlled study to evaluate the safety and efficacy of an intravitreal Flucinolone Acetonide (0.5 or 2 mg) Implant in Patients with Diabetic Macular Edema. Sponsor: Bausch & Lomb Incorporated Project BL 415-007 ($400,000)

15 05/02/23

Page 16: 1.1.16 master CV

21. Principal investigator of " A multi center randomized, double masked, controlled study to evaluate the safety and efficacy of an intravitreal Flucinolone Acetonide (0.5 or 2 mg) Implant in Patients with Noninfectious Uveitis Affecting the Posterior Segment of the Eye. Sponsor: Bausch & Lomb Incorporated Project BL 415-001 ($170,000)

22. Principal investigator of “A Safety and Efficacy Assessment of Chimeric Ribozyme to PCNA to Prevent Recurrence of Proliferative Vitreoretinopathy. Sponsor: Immusol Corp. Project IM-VIT 100 ($17,000)

23. Principal investigator of “Retinopathy of Prematurity screening in pre-term babies”. Sponsor. Childrens Miracle Network. 2000-2001 ($64,000).

24. Principal investigator of “Electrophysiology Diagnostic Service for children with Retinopathy of Prematurity in North East Florida”. Sponsor. Children’s Miracle Network. 2001-2002 ($35,000)

25. Co-investigator of “Glaucoma and Diabetic Retinopathy Screening and Awareness in South Carolina - A Blindness Prevention Project. Sponsor: South Carolina Commission for the Blind ($15,000)

26. Co-investigator of “Oxidation in micro vascular disease”. Sponsor South Carolina Consortium for Cardiovascular Disease and Stroke, 1997 - 98 ($17,000)

27. Co-Investigator of “Use of perfluorocarbon liquids in management of complex retinal detachments " a pilot study conducted at UT Southwestern Medical School. 1992- 94

28. Co-investigator of “Effects of vitreous on metalloproteinase activity in retinal pigment cells” Sponsor South Carolina Consortium for Cardiovascular Disease and Stroke, 1997 - 98 (20,000$).

29. Co-investigator of “Anti PDGF antibodies effectively inhibit RPE induced collagen contraction in Proliferative Vitreoretinopathy.” Sponsor. Palmetto Richland Health alliance, 1997-98 (5000$).

30. Co-investigator of “Apoptosis of the retinal pigment epithelial and photoreceptor cells in Age Related Retinal Degeneration” Sponsor. Palmetto Richland Health alliance, 1998-99 (5000$).

31. Co-investigator of “Acquisition of instrumentation for the development of novel environmentally conscious manufacturing processes employing water jet technologies” Sponsor. National Science Foundation. 1998-99 (840,240$).

32. Co-investigator of “A Randomized double blind, Phase III comparative trial of 2 doses of ZD1839 (TRESSA) in combination with paclitaxel and carboplatin versus placebo in combination with paclitaxel and carboplatin in chemotherapy-naïve patients with advanced (stage III or IV non-small cell lung cancer”. Sponsor. AstraZeneca Pharmaceuticals inc. 2000-2002 (350,000$)

33. Co-investigator of “A Study to evaluate the safety and Efficacy of TAK-37 versus Placebo in Subjects with Irritable Bowel Syndrome”. Sponsor. MDS Pharma Services. 2000-2002 (350,000$)

SCIENTIFIC REVIEWER : Ophthalmology

Experimental Eye Research

International Journal of Ocular Pharmacology

Archives of Ophthalmology

Current Eye Research

Focal Points in Ophthalmology

16 05/02/23

Page 17: 1.1.16 master CV

Investigative Ophthalmology and Visual Science

Retina

European Journal of Ophthalmology

British Journal of Ophthalmology

Journal of Medical Case Series

BMC Ophthalmology

Neuroscience Research

Indian Journal of Ophthalmology

Cutaneous and Ocular Toxicology

Clinical Ophthalmology

Acta Ophthalmologica

PloS One

Molecular Vision

Pediatrics

MAJOR INTERESTS:Clinical: Vitreo-retinal Diseases and Surgery; Uveitis and Ocular Oncology;

Neuro-Ophthalmology

Current Research: Optical lens designing for vitrectomy systems

Retinal Stem cell Isolation and transplantation

Design of synthetic biological and chemical agents that facilitate vitreolysis

Neuronal regeneration and retinal transplants using neural cell cultures

Glutamate metabolism in retinal ganglion cells and evaluation of gene therapy

BIBLIOGRAPHY:

Contributions to Books & Monographs :

1. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 1997-98, Section 2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American Academy of Ophthalmology, San Francisco. 1997, p381-450

2. Tripathi BJ, Tripathi RC, and Chalam KV: Eye Anatomy. In ENCYCLOPEDIA OF HUMAN BIOLOGY, ed. R. Dulbecco. 2nd edition. Academic Press, San Diego. 1997, p883-901

17 05/02/23

Page 18: 1.1.16 master CV

3. Tripathi BJ, Tripathi RC, Li J, Qian Y, Kosnosky W, and Chalam KV: Barotoxic effects on morphology and viability of trabecular cells: A preliminary report. In ADVANCES IN OCULAR TOXICOLOGY, ed. K. Green, H.F. Edelhauser, R.B. Hackett, D.S. Hull, D.E. Potter, and R.C. Tripathi. Plenum Press, New York. 1997, p55-61

4. Bryan C, Li J, Tripathi BJ, Chalam KV, Pakalnis VA, Tripathi RC: Topical fluorescein application can induce iritis and glaucoma: an unusual case report. In ADVANCES IN OCULAR TOXICOLOGY, ed. K. Green, H.F. Edelhauser, R B. Hackett, D.S. Hull, D.E. Potter, and R.C. Tripathi. Plenum Press, New York. 1997, p87-91

5. Weiss R, Chalam KV, Ellsworth R: Introduction to Imaging Techniques in Orbital and Ocular Tumors: Radiology of Orbit. Editors: B Haik and M Mafee, Permagon Press 1991, p207-263

6. Tang R, Chalam KV, Musgrove K: Exercise induced oscillopsia in Arnold-Chairi Malformation: NEURO-OPHTHALMOLOGY ENTERS NINETIES: ed: L. Smith. Dutton Press 1990, p199-207

7. Paton D, Craig J, and Chalam KV: Clinical Symposia: Management of cataracts: Vol 42 Number 4 1990 CIBA - GEIGY, p1-32

8. Tang R, Chalam KV: Ophthalmic manifestations in systemic disease: A Slide Script Manual. American Academy of Ophthalmology, San Francisco. 1990, p1-32

9. Chalam KV: HLA - Typing in recurrent herps simplex keratitis, Thesis accepted in partial fulfillment of Masters degree in Ophthalmology. Post Graduate Medical Institute, Chandigarh, PGI Press, India 1983, p1-132.

10. Chalam, KV ., Lawler, J. Management of Diabetic Retinopathy in the New Millennium . Jacksonville Medicine 51: 8, 2000

11. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 1998-99, Section 2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American Academy of Ophthalmology, San Francisco. 1998, p381-450

12. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 1999-00, Section 2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American Academy of Ophthalmology, San Francisco. 1999, p381-450

13. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 2000-01, Section 2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American Academy of Ophthalmology, San Francisco. 2000, p381-450

14. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 2001-02, Section 2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American Academy of Ophthalmology, San Francisco. 2001, p381-450

15. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 2002-03, Section 2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American Academy of Ophthalmology, San Francisco. 2002, p381-450

18 05/02/23

Page 19: 1.1.16 master CV

16. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 2003-04, Section 2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American Academy of Ophthalmology, San Francisco. 2003, p381-450

17. Chalam KV: An in vitro model to study the effect of hydrostatic pressure on retinal ganglion cells and its relevance to Glaucomatous eye disease. Thesis accepted in partial fulfillment of Doctor of Philosophy degree. University of South Carolina, Columbia. 2004, p1-212.

18. Chalam KV, Lin S. Management of Diabetic Retinopathy in 21st Century. Jacksonville Medicine 2009

Peer Reviewed Journals:

2016

1. Grover S, Chalam K. Reply to: Normative data for macular volume with high-definition spectral-domain optical coherence tomography (Spectralis). European Journal of Ophthalmology. 2015;25(12):546-51

2015

2. Khaja W A, Grover S, Kelmenson AT, Ferguson LR, Kumar Sambhav, Chalam KV. Comparison of central corneal thickness: ultrasound pachymetry versus slit-lamp optical coherence tomography, specular microscopy, and Orbscan. Clinical Ophthalmology. 2015:9 1065–1070

3. Abu-Amero K, Kondkar A A., Chalam KV. An Updated Review on the Genetics of Primary Open Angle Glaucoma. International Journal of Molecular Sciences. 2015;16(12):28886-911

4. Chalam KV, Murthy RK, Priluck JC, Khetpal V, Gupta SK. Concurrent removal of intravitreal lens fragments after phacoemulsification with pars plana vitrectomy prevents development of retinal detachment. International Journal of Ophthalmology. 2015 Feb 18;8(1):89-93

5. Sambhav K, Shakir O, Chalam KV. Bilateral isolated concurrent superior ophthalmic vein thrombosis in systemic lupus erythematosus. International Medical Case Reports Journal. 2015;8:181-3

6. Chalam KV, Li W, Koushan K, Grover S, Balaiya S. Effect of distance and duration of illumination on retinal ganglion cells exposed to varying concentrations of brilliant blue green. Journal of Clinical Medical Research. 2015 ;7(7):517-24

7. Li W, Chalam KV, Grover S. Bilateral Choroidal Detachment in Waldenström Macroglobulinemia. JAMA Ophthalmolology. 2015 Jun;133(6):715-6

19 05/02/23

Page 20: 1.1.16 master CV

8. Diabetic Retinopathy Clinical Research Network. Assessing the Effect of Personalized Diabetes Risk Assessments during Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. JAMA Ophthalmology. 2015; 133(8):888-96.

9. Diabetic Retinopathy Clinical Research Network. Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. JAMA Ophthalmology. 2015; 133 (5):589-97.

10. Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. New England Journal of Medicine. 2015; 372(13):1193-203

11. Diabetic Retinopathy Clinical Research Network. Topical nepafenec in eyes with noncentral diabetic macular edema. Retina. 2015;35(5):944-56

12. Murthy RK, Diaz M, Chalam KV, Grover S. Normative data for macular volume with high-definition spectral-domain optical coherence tomography (Spectralis). European Journal of Ophthalmology. 2015;25(6):546-51

13. Sambhav K, Grover S, Chalam KV. Evaluation of portable digital fundus video camera for fluorescein angiography. Retina. 2015 Dec 29

2014

14. Haji S, Sambhav K, Grover S, Chalam KV. Evaluation of the iPad as a low vision aid for improving reading ability. Clinical Ophthalmology. 9:17-20, 2014

15. Ferguson LR, Grover S, Dominguez JM, Balaiya S, Chalam KV. Retinal thickness measurement obtained with spectral domain optical coherence tomography assisted optical biopsy accurately correlates with ex vivo histology. PLoS One. 9:10-18, 2014

16. Balaiya S, Grant MB, Priluck J, Chalam KV. Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans. American Journal of Endocrinology and Metabolism. 307 (8): 695-702, 2014

17. Chalam KV, Sambhav K, Grover S, Balaiya S, Murthy RK. Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration. Journal of Ophthalmology. 502174, 2014

18. Chalam KV, Brar VS, Murthy RK. Human ciliary epithelium as a source of synthesis and secretion of vascular endothelial growth factor in neovascular glaucoma. JAMA Ophthalmology. 132 (11): 1350-54, 2014

19. Diabetic Retinopathy Clinical Research Network Writing Committee, Bressler SB, Edwards AR, Chalam KV, Bressler NM, Glassman AR, Jaffe GJ, Melia M, Saggau DD, Plous OZ . Reproducibility of

20 05/02/23

Page 21: 1.1.16 master CV

spectral domain optical coherence tomography retinal thickness measurements and conversion to equivalent time domain metrics in diabetic macular edema. JAMA Ophthalmology. 132(9):1113-22, 2014

20. Balaiya S, Koushan K, McLauchlan T, Chalam KV. Assessment of the effect of distance and duration of illumination on retinal pigment epithelial cells exposed to varying doses of Brilliant Blue Green. Journal of Ocular Pharmacology and Therapeutics. 30 (8): 625-33, 2014

21. Koushan K, Chalam KV. Miniaturized high-resolution wide-field contact lens for panretinal photocoagulation. Clinical Ophthalmology. 8:703-06, 2014

22. Diabetic Retinopathy Clinical Research Network. Pilot study of individuals with diabetic macular edema undergoing cataract surgery. JAMA Ophthalmology. 131(7):870-9, 2014

23. Diabetic Retinopathy Clinical Research Network. Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy . JAMA Ophthalmology. 132 (7):889-90, 2014

24. AREDS2 Research Group. Effect of long chain w-3 fatty acids and lutein+zeaxanthin supplements on cardiovascular outcoms; results of the age-retlated eye disease study 2 (AREDS2) randomized clinical trial. JAMA Ophthalmology. 132 (7):889-99, 2014

25. Murthy RK, Ravi K, Balaiya S, Brar VS, Chalam KV. Lutein protects retinal pigment epithelium from cytotoxic oxidative stress. Cutaneous Ocular Toxicology. 33 (2): 132-7, 2014

26. Balaiya S, Chalam KV. An in vitro assay to quantify nitrosative component of oxidative stress. Journal of Molecular Genetics and Medicine. 8 (3): 625-33, 2014

2013

27. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.JAMA Ophthalmology. 1 (3):283-93, 2013

28. Rusovici R, Patel CJ, Chalam KV. Bevacizumab inhibits proliferation of choroidal endothelia cells by regulation of cell cycle. Clinical ophthalmology 7:321-7, 2013

29. Koushan K, Ferguson LR, Rusovici R, Chalam KV. The role of lutein in eye-related disease. Nutrients 5(9):1823-39, 2013

30. Luo L, Uehara H, Zhang X, Das SK, Olsen T, Holt D, Simonis JM, Jackman K, Singh N, Miya TR, Huang W, Ahmed F, Bastos-Carvalho A, Le YZ, Mamalis C, Chiodo VA, Hauswirth WW, Baffi J, Lacal j PM, Orecchia A, Ferrara N, Gao G, Young-Hee K, Fu Y, Owen L, Albuquerque R, Baehr W, Thomas K, Li DY, Chalam KV, Shibuya M, Grisanti S, Wilson DJ, Ambati J, Ambati BK. Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.ELife 18(2) e00324-35, 2013

31. Balaiya S, Murthy RK, Chalam KV. Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells. Molecular Vision 19.2385-92, 2013

21 05/02/23

Page 22: 1.1.16 master CV

32. Birch DG, Weleber RG, Duncan JL, Jaffe GJ, Tao W, Ciliary neurotrophic factor retinitis pigmentosa study groups. Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. American Journal of Ophthalmology 156(2): 283-292, 2013

33. Murthy RK, Balaiya S, Brar V, Chalam KV. Lutein protects retinal pigment epithelium from cytotoxic oxidative stress. Cutaneous and Ocular Toxicology 31(1): 4-9, 2013

34. Ferguson LR, Balaiya S, Grover S, Chalam KV. Retinal Thickness Normative Data in Wild-Type Mice Using Customized Miniature SD-OCT. PLos One 8(6) e67265-34, 2013

35. Balaiya S, Murthy RK, Mylyapa RS, Grover S, Chalam KV. Differential sensitivity of choroidal endothelial, retinal ganglion, and retinal pigment epithelial cells in vitro to proton radiation. American Journal of Ophthalmology 156(3): 444-453, 2013

36. Murthy RK, Perez L, Priluck JC, Grover S, Chalam KV. Acute bilateral concurrent central retinal artery occlusion in sickle cell disease after use of tadalafil (Cialis) JAMA Ophthalmology 131(11): 1471-13, 2013

37. Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG, Diabetic Retinopathy Clinical Research Network. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial . JAMA Ophthalmology 131(8): 1033-40, 2013

38. Bressler SB, Almukhtar T, Aiello LP, Bressler NM, Ferris FL, Greven CM. Green or yellow laser treatment for diabetic macular edema exploratory assessment within the diabetic retinopathy clinical research network. Retina. 33(10):870-9, 2013

39. Diabetic Retinopathy Clinical Research Network. Macular edema after cataract surgery in eyes without pre-operative central-involved diabetic macular edema.JAMA Ophthalmology. 131(7):870-9, 2013

40. Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group.Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). Investigative Ophthalmology and Visual Science. 54(7):4548-54, 2013

41. The age related eye disese study 2 (AREDS2) research Group Chew EY, Clemons TE, SanGiovanni JP, Danis RP, Ferris FL 3rd; Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalapally A, Friberg, T, Wong WT, Rosenfeld PJ, Agron E, Toth CA, Bernstein PS, Sperduto RD. Secondary analysis of the effects of lutein/zetaxanthin on Age related macular degeneration progression: AREDS2 report no.3. JAMA Ophthalmology. 54(9):5989-94, 2013

42. Domalpally A, Danis RP, , Chew EY, Clemons TE, Reed S, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group. Evaluation of optimized digital fundus reflex photographs for lens opacities in the age related eye disease study 2. AREDS2 report 7.Investigative Ophthalmology and Visual Science. 54(9):5989-94, 2013

43. Age related Eye Disease Study2 Research Group. Lutein + zeataxanthin and omega-3 fatty acids for age related macular degeneration: the age related eye disease study 2 (AREDS2) randomized clinical trial. Journal of American Medical Association. 309(19):2005-15, 2013

22 05/02/23

Page 23: 1.1.16 master CV

2012

44. Balaiya S, Ferguson LR, Chalam KV. Evaluation of sirtuin role in neuroprotection of retinal ganglion cells in hypoxia. Investigative ophthalmology and Visual Science. 53(7):4315-22. 2012

45. Chalam KV, Khetpal VJ, McLauchlan T, Murthy RK. New miniaturized contact lens for wide-angle fundus fluorescein angiography: wide angle fluorescein angiography lens. Retina 32(3):640-2,2012

46. Chalam KV, Murthy RK, Brar V,Radhakrishnan R, Khetpal VJ, Grover S. Evaluation of a novel noncontact, automated Focal Laser with Integrated (NAVILAS) Fluorescein angiography for Diabetic Macular Edema. Middle East African Journal of Ophthalmology19(1):158-62, 2012

47. Glassman AR, Stockdale CR, Beck RW, Baker C, Bressler NM for Diabetic Retinopathy Clinical Research Network. Evaluation of masking study participants to intravitreal injections in a randomized clinical trial.Archives of Ophthalmology. 130(2):190-194. 2012

48. Chalam KV, Khetpal VJ, Patel CJ. Spectral domain optical coherence tomography documented rapid resolution of psuedophakic cystoids macular edema with topical difluprednate.Clinical Ophthalmology 6: 155-8, 2012

49. Balaiya S, Khetpal VJ, Chalam KV. Hypoxia initiates sirtuin1 mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor 2α. Molecular Vision18:114-20, 2012

50. Grover S, Kelmenson AT, Chalam KV, Edward DP. Webcasts for resident education. Ophthalmology118(1):199-200, 2012

51. Sun JK, Qin H, Aiello LP, Melia M, Beck RW, Chalam KV. (Diabetic Retinopathy Clinical Research Network). Evaluation of visual acuity measurements after autorefraction vs manual refraction in eyes with and without diabetic macular edema. Archives of Ophthalmology. 130(4):470-9. 2012

52. Chalam KV, Peck CC, Grover S, Radhakrishnan R. Lenticular meridional astigmatism secondary to iris mesectodermal leiomyoma. Cataract and Refractive Surgery38(1):170-73, 2012

53. Balaiya S, Mylyapa RS, Hsi W, Murthy RK, Chalam KV. Evaluation of proton beam radiation sensitivity of proliferating choroidal endothelial and retinal ganglion cell proliferation with clonogenic assay. Cutaneous and Ocular Toxicology31(1): 4-9, 2012

54. ARED2 Research group, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Danis R. Age related eye disease study 2 ( AREDS2) : Study Design and baseline characteristics ( AREDS2 Report Number 1). Ophthalmology. 119(11):2282-9, 2012

55. Chalam KV, Bressler SB, Edwards AR, Berger BB, Grover S, Gupta SK, Neilsen JS. Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. Investigative Ophthalmology and Visual Science.13;53(13):8154-61, 2012

56. Chalam KV, Murthy RK,Gupta SK, Khetpal VJ. Prophylactic circumferential intraoperative laser retinopexy decreases the risk of retinal detachment after macular hole surgery.European Journal of Ophthalmology 18(2):255-62, 2012

57. Bressler NM, Miller KM, Beck RW, Bressler SB, Glasman AR, Kitchens JW,Melia M, Schlossmann DK. Observational study of subclinical diabetic macular edema. Eye. 26(6):833-40, 2012

23 05/02/23

Page 24: 1.1.16 master CV

58. Chalam KV, Patel CJ, Edwards J, Murthy RK. T-cell leukemia. Ophthalmology. 119(8):1713-1714.2012

59. Bressler SB, Qin H, Beck RW, Chalam KV, Kim JE, Melia M, Wells JA. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Archives of Ophthalmology. 1:130(9):1153-61. 2012

60. Priluck JC, Chalam KV, Grover S. Spectral-domain optical coherence tomography of Roth spots in multiple myeloma. Eye 26(12):1588-9. 2012

61. Ferguson LR, Balaiya S, Grover S, Chalam KV. Modified protocol for in vivo imaging of wild-type mouse retina with customized miniature spectral domain optical coherence tomography (SD-OCT) device. Biological Procedures Online. 14(1):9. 2012

62. Priluck JC, Grover S, Chalam K. Meridional lenticular astigmatism associated with bilateral concurrent uveal metastases in renal cell carcinoma. Clinical Ophthalmology.;6:1839-41.2012

63. Diabetic Retinopathy Clinical Research Network, Elmana MJ, Qin H, Aiello LP, Beck RW, Bressler NM, Ferris FL III, Glassman AR, Maturi RK, Melia M. Intravitreal ranibizumab for diabetic macular edema and prompt vs deferred laser treatment: 3-year randomized trial results.Ophthalmology. 119(7):2312-18, 2012

64. Bhavsar AR, Stockdate CR, Ferris FL III, Brucker AJ, Bressler NM, Glassman AR for Diabetic Retinopathy Clinical Research Network. Update on risk of endophthalmitis after Intravitreal drug injections and potential impact of elimination of topical antibiotics.Archives of Ophthalmology. 1:130(6):809-10. 2012

2011

65. Rusovici R, Sakhalkar M, Chalam KV. Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells. Molecular Vision17:3339-46, 2011

66. Chalam KV, Balaiya S, Mylyappa RS, Hsi W, Brar VS,Murthy RK. Evaluation of choroidal endothelial cell proliferation after exposure to varying doses of proton beam radiation.Retina 31(1): 169-76, 2011

67. Chalam KV, Gupta SK, Brar VS, Murthy RK. Spectral domain OCT features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab. Indian Journal of Ophthalmology. 59(1): 47-8

68. Balaiya S, Grover S, Chalam KV. Freezing adversely effects measurement of vascular endothelial growth factor levels in human aqueous samples. Clinical Ophthalmology 5: 1-5, 2011

69. Murthy RK, Grover S, Chalam KV. Temporal macular thinning on Spectral-domain Optical Coherence Tomography in proliferative sickle cell retinopathy. Archives of Ophthalmology 129(2): 247-9, 2011

70. Chalam KV, Balaiya S, Mylyappa RS, His W, Brar VS,Murthy RK: Comparative in vitro safety analysis of dyes for chemovitrectomy- Indocyanin Green, Brilliant Blue Green, Bromophenol Blue, and infracyanine Green.. Retina 31(6):1128-36, 2011

24 05/02/23

Page 25: 1.1.16 master CV

71. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Gangaputra S, Almukhthar T, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD . Comparision of film and digitalfundus photographs in eyes of individuals with diabetes mellitus. InvestigativeOphthalmology & Visual Science.52(9):6168-6173, 2011

72. Balaiya S, Edwards J, Tillis T,Khetpal V, Chalam KV. Tumor necrosis factor –alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma.Clinical Ophthalmology.5: 553-6, 2011

73. Chalam KV, Khetpal V, Rusovici R, Balaiya S. A review: Role of ultraviolet radiation in age related macular degeneration. Eye and Contact Lens.37:225-232, 2011

74. Chalam KV, Lin S, Gupta SK, Brar VS, Murthy RK, Radhakrishnan R. Evaluation of modified retinopathy of prematurity screening guidelines using birth weight as the sole inclusion criterion.Middle East African Journal of Ophthalmology18(3):214-19, 2011

75. Grover S, Brar VS, Murthy RK, Chalam KV. Infrared imaging and spectral-domain optical coherence tomography findings correlate with microperimetry in acute macular neuroretinopathy: a case report. Journal of Medical Case Reports5:536-39, 2011

76. Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis MD, Ferris F, Glassmann AR, Maturi RK, Stockdale CR, Topping FOR THE DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK.,Rationale for diabetic retinopathy clinical research network treatment protocol for center involved diabetic macular edema. Ophthalmology. 118:e5-14, 2011

77. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.Ophthalmology. 118 (6):609-14, 2011

78. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK. Randomized trial evaluating short term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina. 31:1009-27, 2011

79. Chalam KV, Brar VS. Proteomics in practice: Potential consequences of long term anti-VEGF therapy. Retinal Physician6:26-9, 2011

2010

80. Sharma RK, Rogojina AT, Chalam KV.Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF. Molecular Vision16: 2175-84,2010

81. Sharma RK, Balaiya S, Chalam KV. Bevacizumab suppression of establishment of micrometastasis in experimental ocular melanoma InvestigativeOphthalmology & Visual Science.51(12):6, 2010

25 05/02/23

Page 26: 1.1.16 master CV

82. Brar VS, Sharma RK, Murthy RK, Chalam KV. Bevacizumab neutralizes the protective effect of Vascular Endothelial Growth Factor on Retinal ganglion cells. Molecular Vision 16: 2175-84,2010

83. Murthy RK, Brar VS, Chalam KV. Evaluation of ultra wide angle ‘ora-ora’ high refractive index self-stabilizing contact lens for vitreous surgery. Retina 30(9):1551-3,2010

84. Ambatipudi, S, Goyal J, Shah GY, Pathangey A, Das T,Chalam KV. Novel dyes in intraocular surgery. American Journal of Ophthalmology 150(3):442-3, 2010

85. Murthy RK, Storm L, Grover S, Chalam KV. In-vivo high resolution imaging of Optic Nerve Head Drusen using Spectral- domain Optical Coherence Tomography. BMC Medical Imaging10:11, 2010

86. Murthy RK, Grover S, Chalam KV. Sequential spectral domain OCT documentation of retinal changes after branch retinal artery occlusion. Clinical Ophthalmology 2010; 4:327-9

87. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.Ophthalmology. 117 (6):1064-77, 2010

88. Murthy RK, Chalam KV. Assistant Independent OptiFlex system for contact as well as non contact wide angle viewing in vitreo-retinal surgery. Archives of Ophthalmology 128(4):490-2, 2010

89. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK,Writing committee, Haller JA, Qin H, Apte RS, Beck RW, Bressler NM, Browning DJ, Danis RP, Glassman AR, Googe JM, Kollman C, Lauer AK, Peters MA, Stockman ME. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.Ophthalmology. 117 (6):1087-93, 2010

90. Chalam KV, MurthyRK, Gupta SK, Brar VS. Spectral-domain OCT guided photodynamic therapy for choroidal hemangioma. Cases Journal. 2: 8778, 2010

91. Balaiya S, Murthy RK, Brar VS, Chalam KV. Evaluation of Ultraviolet light toxicity on cultured Retinal Pigment Epithelial and Retinal Ganglion cells. Clinical Ophthalmology 4:33-9, 2010

92. Chalam KV, Gupta SK, Brar VS, Murthy RK, Grover S. Foveal structure delineated by Spectral-domain Optical Coherence Tomography correlates with visual function after Macular Hole surgery. European Journal of Ophthalmology 2010; 20(3):572-7

93. Chalam KV Balaiya S, Murthy RK. Accurate estimation of Vascular Endothelial Growth Factor levels in micro samples with a low cost bead based assay. Retina2010; 30(5):815-9

94. Grover S, Murthy RK, Brar VS, Chalam KV. Comparison of retinal thickness in normal eyes using Stratus and Spectralis Optical Coherence Tomography. InvestigativeOphthalmology & Visual Science.2010; 51(5):2644-7

95. Kelmenson, AT, Brar VS, Chalam KV. Fundus autoflourescene and microperimetry detect Plaquenil toxicity before changes in visual acuity.European Journal of Ophthalmology20(3):572-7, 2010

96. Chalam KV, Murthy RK. Spectral domain OCT documented resolution of pseudophakic cystoid macular edema after intravitreal Triamcinolone. Ophthalmology and Eye diseases2010;2:1-4

26 05/02/23

Page 27: 1.1.16 master CV

2009

97. Chalam KV, Murthy RK. Spectral domain OCT features of hypotonous maculopathy after successful retinal detachment surgery. Retinal Cases and Brief Reports

98. Chalam KV , Shah VA. Modified portable digital camera for screening of diabetic retinopathy. Ophthalmic Research 28;42(1):60-62,2009

99. Chalam KV, Agarwal S, Brar VS, Murthy RK, Sharma RK .Evaluation of cytotoxic effects of bevacizumab on human corneal cells. Cornea 28(3):328-33,2009

100. Browning DJ, Apte RS, Bressler SB, Chalam KV, Danis RP, Davis MD, Kollman C, Qin H, Sadda S, Scott IU; FOR THE DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK .,Association of the the extent of Diabetic macular edema as assessed by Optical Coherence Tomography with visual acuity and retinal outcome variables - Retina. 23 (6):815-820, 2009

101. Grover S, Sharma R, Chalam KV. Intracameral Bevacizumab Effectively Reduces Aqueous VEGF in Neovascular Glaucoma British Journal of Ophthalmology93(2):273-4,2009

102. Gupta S, Syed F, Murthy RK, Brar VS, Chalam KV. Sinonasal lymphoma masquerading as persistent blepharoconjunctivitis. Orbit,28(1):34-6,2009

103. Grover S, Murthy RK, Brar VS, Chalam KV. Normative Data for Macular Thickness by High-Definition Spectral-Domain Optical Coherence Tomography (Spectralis).American Journal of Ophthalmology148(2): 266-71,2009

104. Sharma RK, Chalam KV,. In vitro evaluation of bevacizumab toxicity on retinal ganglion cell line, Acta Ophthalmologica, 87(6):618-22,2009

105. Sharma RS, Chalam KV,. Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor , Molecular Vision, 15:60-9 . 2009

106. Parappuam S, Chang B, Li L, Hartung R, Chalam, KV., Hunt DM., Hunt, RC.,Differential effects of TGF Beta and Vitreous on thetransformation of Human Pigment Epithelial Cells. Investigative Ophthalmolology and Visual Science 50(12)5965-74, 2009

107. Chalam KV, MurthyRK, AgarwalS, GuptaS, GroverS. Comparative Efficacy of Topical Tetravisc vs. Lidocaine Gel in Cataract Surgery. BMC Ophthalmology9:7,2009

108. Brar VS, Sharma RK, Murthy RK, Chalam KV. Evaluation of differential toxicity of varying doses of Bevacizumab on retinal ganglion cells, retinal pigment epithelial cells and vascular endothelial growth factor enriched choroidal endothelial cells. Journal of Ocular Pharmacology and Therapeutics.25(6):507-11, 2009

109. Balaiya S, Murthy RK, Brar VS, Chalam KV. Effects of Indocyanine Green on Cultured Retinal Ganglion Cells In-Vitro. BMC research notes 2: 236, 2009

27 05/02/23

Page 28: 1.1.16 master CV

110. Brar VS, Murthy RK, Chalam KV.Functional microperimetry and SD-OCT confirm consecutive retinal atrophy from optic nerve pit.Clinical Ophthalmology.3:625-8, 2009

111. Shah VA, Chalam KV. Values for Macular Perimetry Using MP-1 microperimeter in Normal Subjects. Ophthalmic Research. 41(1):9-13, 2009

2008

112. Chalam KV, Gupta SK, Brar V. Inverse Argyll Robertson Pupil in Burkitt’s lymphoma. Clinical Ophthalmology 2(1):1-4, 2008

113. Chalam KV, Brar VS, Agarwal S.Direct Image Creating Aspheric Lens for Indirect Ophthalmoscopy. Ophthalmic Research.2007.40(2):94-7, 2008

114. Chalam KV, Gaurav Y Shah, Swati Agarwal, Shailesh Gupta. Illuminated Curved 25 Gauge Levels Vitrectomy Probe for removal of Subsclerotomy Vitreous in Vitreoretinal Surgery. Indian Journal of Ophthalmology. 56(4):331-4, 2008.

115. Gupta S, Brar VS, Murthy RK, Chalam KV., Aplastic anemia induced disc edema and visual loss in pregnancy: a case report.Cases Journal. 2008;1(1):322- 4

116. Chalam KV, Shailesh Gupta, Sandeep Grover, Swati Agarwal. Intracameral Avastin Dramatically Resolves Iris Neovascularization and Reverses Neovascular Glaucoma. European Journal of Ophthalmology 18(2):255-62, 2008

117. Chalam KV, Tina Tillis, Syed F, Agarwal S. Acute Bilateral Simultaneous Angle Closure Glaucoma after Topiramate Administration: a case report. J Med Case Reports 8;2:1, 2008

118. Chalam KV, Sharma Rk, Murthy RK. Limitations and difficulties in assessing nerve growth factor levels in aqueous humor samples from human eyes. BMC Research Reports 1:22,2008

119. Chalam KV, RK Murthy, Brar VS. Spectral domain Optical Coherence Tomography documented resolution of recalcitrant macular edema after intravitreal Bevacizumab in Branch Retinal Vein Occlusion. European Journal of Ophthalmology. 2008 18 (5): 831-3

120. Chalam KV , Murthy RK. Reusable sutureless silicone ring for housing contract lens during vitreoretinal surgery. Retina28 (10):1550-1, 2008

121. Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H; Diabetic Retinopathy Clinical Research Network: Diabetic retinopathy research Network team: Optical Coherence Tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. (University of Florida, Chalam, K.V, P.l.) Ophthalmology. 115 (8):1366-71, 2008

122. Callanan DG, Jaffe GJ,, Martin DF, Pearson PA, Comstock TL, and Fluocinolone Acetonide Uveitis Study Group: Treatment ofPosterior Uveitis with a Fluocinolone Acetonide Implant (Retisert) : Three year clinical results (University of Florida, Chalam, K.V, P.l.). Archives of Ophthalmology 126(9): 1191-201, 2008.

28 05/02/23

Page 29: 1.1.16 master CV

2007

123. Chalam KV , Gupta SK, Swati Agarwal. Rituximab Effectively Reverses Papilledema Associated with Cerebral Venous Sinus Thrombosis in Anti Phospholipid Antibody Syndrome. European journal of Ophthalmology. 5:867-70, 2007

124. Chalam KV , Amit Chokshi, Swati Agarwal, Deepak Edward. Complications of Alphacor tm

Keratoprosthesis- A Clinicopathologic Report. Cornea26(10):1258-60,2007

125. Chalam KV , Swati Agarwal, Gupta SK. Light Weight Autoclavable Wide-Angle Contact Lens for Vitreous Surgery. Ophthalmic Surg Lasers Imaging.38(6):523-4,2007

126. Chalam KV,Swati Agarwal, Gupta SK Recovery of Retinal sensitivity after branch retinal artery occlusion.Ophthalmic Surg Lasers Imaging.38(4):328-9, 2007

127. Chalam KV, Vinay Shah. 20G Illuminated Curved Vitrectomy Probe for Vitreoretinal Surgery Ophthalmic Surg Lasers Imaging. 2007. 38(4):525-6, 2007

128. Scherer RW, Feldon SE, Levin L, Langenberg P, Katz J, Keyl PM, Wilson D,. Kelman SE, Dickersin K, and Ischemic Optic Neuropathy Decompression Trial Research Group: Visual Fields at Follow-up in the Ischemic Optic Neuropathy Decompression Trial(South Carolina Eye Institute, Chalam, K.V, P.l.): Evaluation of Change in Pattern Defect and Severity Over Time Ophthalmology. 125:1161-1167, 2007

129. William M. Schiff, MD; John C. Hwang, MD; Michael D. Ober, MD; Jeffrey L. Olson, MD; Elona Dhrami-Gavazi, MD; Gaetano R. Barile, MD; Stanley Chang, MD; Naresh Mandava, MD: Safety and Efficacy Assessment of Chimeric Ribozyme to Proliferating Cell Nuclear Antigen to Prevent Recurrence of Proliferative Vitreoretinopathy (University of Florida, Chalam, K.V, P.l.) Archives of Ophthalmology. 125:1161-1167, 2007

130. Hartung R, Ganti R, Parappuam S, Chalam, KV., Hunt DM., Hunt, RC.,Vitreous induces heme oxygenase-1 expression mediated by transforming growth factor-β and reactive oxygen species generation in human retinal pigment epithelial cells. Molecular Vision. 13:66-78, 2007

131. Sharma RS, Chalam KV,. Letter. Scratch Technique and evaluation of cytotoxicity of Bevacizumab. British Journal of Ophthalmology. 2007

132. Sharma RS, Chalam KV,. Letter. Experimental conditions and RPE cytotoxicity. Investigative Ophthalmology and Visual Science.2007

133. Sharma RS, Chalam KV,. Letter. In appropriate choice of animal age for investigating retinal progenitor cells. Investigative Ophthalmology and Visual Science.2007

2006

134. Chalam KV , Shah V. Resolution of macular scotoma after radial optic neurotomy in central retinal vein occlusion. Ophthalmic Surgery, Lasers and Imaging. 37(1):72-5,2006

135. Chalam KV , Gupta SK, Shah GY, Agarwal S. Successful management of melanocytoma associated CNV with Photodynamic Therapy. European Journal of Ophthalmology. 16(5): 776-8

29 05/02/23

Page 30: 1.1.16 master CV

136. Chalam KV , Shah GY, Rappaport k, Shah VA. Choroidal neovascularization associated with ocular melanocytoma of the optic disc. Retina26(6):703-4,2006

137. Chalam KV , Shah GY, Shah VA. Evaluation of web based Annotation of ophthalmic Images for multi-center clinical trials. Indian Joural of Ophthalmology 54(2):126-9, 2006

138. Chalam, KV, IONDT Research Group: Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression (South Carolina Eye Institute, Chalam, K.V, P.l.). BMC Ophthalmology 6: 34-42, 2006.

139. Glenn J. Jaffe MD, Daniel Martin MD, David Callanan MD, P. Andrew Pearson MD, Brian Levy OD, MS, Timothy Comstock OD, MS and Fluocinolone Acetonide Uveitis Study Group : Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis ,Thirty-Four–Week Results of a Multicenter Randomized Clinical Study (University of Florida, Chalam, K.V, P.l.). Ophthalmology 113: 1020-27, 2006.

140. Shah VA, Shah GY, Chalam KV, Letter Endophthalmitis following 25-guage vitrectomy Eye. 20(6):735-36, 2006

141. Shah V. Chalam KV. Letter regarding correlation of retinal sensitivity measured with fundus related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular oedema. Eye. 20 (11) 1307-08, 2006

2005

142. Chalam KV , Shah GY. Letter. Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. American Journal of Ophthalmology139 (6):1146, 2005

143. Chalam KV , Shah VA. Two piece Dual Purpose Comprehensive Contact Lens system for Vitreous surgery. Ophthalmic Research 37(4):175-178, 2005

144. Chalam KV , Gupta SK, Agarwal S, Shah V. Sutureless Limited Vitrectomy for Positive Vitreous Pressure in Cataract Surgery. Ophthalmic Surgery, Lasers and Imaging 36:518- 522, 2005

145. Chalam KV , Shah VA. Severe Bilateral Posterior Ischemic Optic Neuropathy as a Complication of Spinal Surgery. Eye 19(3):367-8, 2005

146. Shah VA,Chalam KV. Intraocular Central Retinal Vein. Ophthalmic surgery, lasers and Imaging 36(2):174-6, 2005)

2004

147. Chalam KV , Shah VA. Successful Management of Cataract Surgery Associated Vitreous Loss with Sutureless Small Gauge Pars Plana Vitrectomy. American Journal of Ophthalmology 138(1): 79-84, 2004

148. Chalam KV , Shah VA, Tripathi RC. A curved vitrectomy probe. Ophthalmic surgery, lasers and Imaging 35(3):259-260, 2004

149. Chalam KV , Shah VA. Macular Infarction a presentation of Sickle Cell Crisis. Eye 18(12): 1277-8, 2004

30 05/02/23

Page 31: 1.1.16 master CV

150. Chalam KV , Shah VA. Self-Illuminated Contact Lens for Peripheral Vitreous Surgery. Ophthalmic Surgery Laser and Imaging35(1): 76-77, 2004

151. Chalam KV , Pakalnis VA, Shah VA, Tripathi RC, Tripathi BJ, Yee D. Cataract in Kniest Dysplasia: Clinicopathological Correlation. Archives of Ophthalmology 122(6): 913-915, 2004

152. Chalam KV , Shah VA. A newly designed guarded radial neurotomy knife. Retina24(5) 817-8, 2004

153. Chalam KV,Shah VA. Suction Assisted Self-Retaining two piece non-cased wide-angle Contact Lens for Vitrectomy. Ophthalmic surgery, lasers and Imaging 35(4):345-6 2004

154. Chalam KV , Shah VA. Optics of wide-angle panoramic viewing system assisted vitreous surgery. Survey of Ophthalmology 49(4): 437-445, 2004

155. Chalam KV , Shah VA. Self-Retaining Contact Lens system for Vitreous Surgery. Indian Journal of Ophthalmology. 52(1): 67-71, 2004

156. Chalam KV , Shah VA. Small Contact surface minified wide angle contact lens for pediatric vitreous surgery. Journal ofPediatric Ophthalmology & Strabismus 41(2): 109-111, 2004

157. Chalam KV , Vinjamaram S, Shah VA. Slitlamp Biomicroscopy adapter for simultaneous photodocumentation during clinical assessment. Journal of Cataract and Refractive Surgery. 34(8):1808-9, 2004

158. Chalam, KV , Shah VA. Liquid crystal display microperimetry in eyes with macular pathology .Indian Journal of Ophthalmology52(4): 293-6, 2004

159. Chalam KV , Shah VA. Author’s reply. Successful Management of Cataract Surgery Associated Vitreous Loss with Sutureless Small Gauge Pars Plana Vitrectomy. American Journal of Ophthalmology 138(6): 1091, 2004

160. Chalam KV . Author’s reply. Small Gauge Sutureless pars plana Vitrectomy to manage Vitreous Loss during Phakoemulsiification. Journal of Cataract and Refractive Surgery30(11):2253, 2004

161. Shah VA, Gupta, SK, Shah VK, Vinjamaram S, Chalam KV: TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD Ophthalmic Epidemiology. 11(1):43-51, 2004

162. Shah VA,Chalam KV. Congenital Retinal Macrovessel Causes reduced Retinal sensitivity at the Macula. European Journal of Ophthalmology 14(4):341-44, 2004

163. Shah VA, Chalam KV.Autoclavable two-piece non cased wide-angle contact lens system for vitrectomy. Ophthalmic Research36(2):94-97, 2004

164. Shah VA, Chalam KV. Liquid Crystal Display Microperimetry in Idiopathic Subretinal Fibrosis. Ophthalmic Surgery and Lasers 35(4): 321-4, 2004

165. Shah VA, Chalam KV. Autoclavable Wide-Angle Contact Lens for Vitreous Surgery. American Journal of Ophthalmology 137(2): 359-60, 2004

2003

166. Chalam KV , Patel CC, Shah VA. Newly Designed Self-Retaining Contact Lens for Vitreous Surgery. American Journal of Ophthalmology 135(4): 544-546, 2003

167. Chalam, K.V , Gupta SK, Vinjamaram S, Shah VA. Congenital Anomalous Retinal Artery associated with a Leaking Macroaneurysm- A Case Report. Archives of Ophthalmology. 121: 409-410, 2003

31 05/02/23

Page 32: 1.1.16 master CV

168. Chalam KV , Roche Gancyclovir Study Group. Endophthalmitis after gancyclovir implant in patients with AIDS and cytomegalovirus treated retinitis. (South Carolina Eye Institute, Chalam, K.V, P.l.) American Journal of Ophthalmology 136(4): 649-654, 2003

169. Chalam KV , Shah VA, Gupta SK, Tripathi RC. Evaluation of Lens and Peripheral Retinal Relationships with the Use of Newly Designed Curved Endolaser and Vitrectomy Probes. Retina23 (6):815-820, 2003

170. Chalam KV , Gupta SK, Vinjamaram S, Shah VA. Small Gauge Sutureless pars plana Vitrectomy to manage Vitreous Loss during Phakoemulsiification. Journal of Cataract and Refractive Surgery29:1482-1486, 2003

171. Chalam KV , Malkani S, Shah VA. Intravitreal Dexamethasone Effectively Reduces Postoperative Inflammation After Vitreoretinal Surgery. Ophthalmic Surgery and Lasers. 34 (3): 188-192; 2003

172. Chalam, KV, IONDT Research Group: Comparison of Information Obtained by Operative Note Abstraction to That Recorded on a Standardized Data Collection Form. (South Carolina Eye Institute, Chalam, K.V, P.l.) Surgery. 133: 324-330.2003.

173. Chalam, KV, IONDT Research Group: Surgical Quality Assurance in the Ischemic Optic Neuropathy Decompression Trial. (South Carolina Eye Institute, Chalam, K.V, P.l.) Controlled Clinical Trials. 24(3):294-305.2003

174. Shah VA, Chalam KV. Self-Stabilizing Wide-Angle Contact Lens for Vitreous Surgery. Retina23:667-669, 2003

175. Shah VA, Chalam KV. Newly Designed Self-Retaining Prism Contact Lens for Vitreous Surgery. Retina 23:721-722, 2003

176. Shah VA, Chalam KV.Suction Assisted one piece Self-Retaining Wide-angle Contact Lens for Vitrectomy. Ophthalmic Research 35(3):170-172, 2003

177. Shah VA, Gupta SK, Chalam KV. Management of vitreous loss during cataract surgery under topical anesthesis with transconjunctival vitrectomy system. European Journal of Ophthalmology 13 (8): 693-6, 2003

2002

178. Chalam KV , Gupta SK, Tripathi, R.C., Gandham, S. Parsplana Modified Baerveldt Implant versus ND:Yag Cyclophotocoagulation in the Management of Neovascular Glaucoma. Ophthalmic Surgery and Lasers. 33: 383-393, 2002

179. Chalam, K.V , Panthagani, P., Tripathi, R.C.: Metastatic Aspergillus Terreus Endophthalmitis secondary to Bone Infection in Immunocompromised Host. Annals of Ophthalmology. 34(2): 153-156, 2002

180. Chalam, KV, IONDT Research Group: The Fellow Eye in NAION: Report from the Ischemic Optic Neuropathy Decompression Trial Follow-up Study. (South Carolina Eye Institute, Chalam, K.V, P.l.) American Journal of Ophthalmology. 134: 317-328, 2002

2001

32 05/02/23

Page 33: 1.1.16 master CV

181. Das, T., Sharma, S., Singh, J., Rao, D.V., Chalam, KV.: Evaluation of Glutaraldehyde and Providone Iodine for sterilization of Wide Field Contact Vitrectomy Lenses . Ophthalmic Surgery and Lasers. 32(4): 300-304, 2001

2000

182. Chalam, KV , Li, J., Tripathi, R.C.: Occurrence of Atypical Acute Bilateral Multifocal Choroidal Neovascularization in Membranoproliferative Glomerulonephritis Type II. Annals of Ophthalmology 32(4):320-24, 2000

183. Chalam, KV, IONDT Research Group: The ischemic optic neuropathy decompression trial (IONDT): Twenty Four month update. (South Carolina Eye Institute, Chalam, K.V, P.l.) Archives of Ophthalmology. 118: 793-798, 2000

184. Malkani, S, Chalam, K.V., Tripathi, R.C. Funduscopic Changes in Ophthalmomyasis Interna, Digital Journal of Ophthalmology. 6(1):2000 [http://www.djo.Harvard.edu/GR/Malkani/Malkani0600.htm]

1999

185. Chalam, KV, Roche Gancyclovir Study Group. Oral gancyclovir in patients with cytomegalovirus treated with a gancyclovir implant: A randomized clinical trial. (South Carolina Eye Institute, Chalam, K.V, P.l.) New England Journal of Medicine. 340: 1063-1070, 1999

186. Tripathi, RC, Parapuram SK, Tripathi, BJ, Zhong Y, Chalam KV.Corticosteroids and Glaucoma Risk. Drugs and Aging 15(6):439-50,1999

187. Tsao K, Chalam, K.V., Pakalnis V.A, Tripathi, R.C. Occupational history is clue to unilateral Photic retinopathy, Journal of Cutaneous and Ocular toxicology. 18(1): 57-63, 1999

1998

188. Chalam, KV, IONDT Research Group: The ischemic optic neuropathy decompression trial (IONDT): Design and Methods. (South Carolina Eye Institute, Chalam, K.V, P.l.) Controlled Clinical Trials. 19: 276-298.1998

189. Tripathi, RC., Li, J., Tripathi, BJ., and Chalam, KV., Adamis, AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology.105:232-237,1998

1997

190. Chalam, K.V . and Tripathi, R.C. Recurrent choroidal neovascular membrane from Toxoplasmic chorioretinal scar. Annals of Ophthalmology. 29: 306-308,1997

191. Chalam, KV, IONDT Research Group: Participation in the Ischemic Optic Neuropathy Decompression trial: Sex, race, and age. (South Carolina Eye Institute, Chalam, K.V, P.l.) Ophthalmic Epidemiology. 4:157-173.1997

33 05/02/23

Page 34: 1.1.16 master CV

192. Ambati J, Chalam KV, Chawla D, D'Angio CT, Guilet, EG, Rose SJ, Vanderlinde RE, Ambati BK. Elevated GABA, glutamate, and vascular endothelial factor levels in the vitreous of patients with proliferative diabetic retinopathy. Archives of Ophthalmology. 115: 1161-66. 1997

1996

193. Chalam, KV, IONDT Research Group: Characteristics of patients with nonarteritic ischemic neuropathy eligible for the ischemic optic neuropathy decompression trial. (South Carolina Eye Institute, Chalam, K.V, P.l.) Archives of Ophthalmology. 114: 1366-1374.1996

194. Tripathi, RC, Li J, Chalam KV, and Tripathi BJ. Expression of growth factor mRNAs by human Tenon's capsule fibroblasts. Experimental Eye Research. 63: 339-346, 1996.

195. Li J, Tripathi BJ, Chalam KV, Tripathi RC. Transforming growth factor beta 1 and 2 positively regulate TGF-1 beta mRNA expression in trabecular cells. Investigative Ophthalmolology and Visual Science. 37: 2778-2782, 1996

1995

196. Chalam, KV, IONDT Research Group: Optic nerve decompression surgery for Nonarteritic Anterior Ischemic optic neuropathy (NAION) is not effective and may be harmful. (South Carolina Eye Institute, Chalam, K.V, P.l.). Journal of American Medical Association 273: 625-632 .1995.

1985

197. Dhir S.P, Munjal VP, Chalam KV, Jain IS. : A retrospective study of lacrimal gland tumors, Indian Journal of Ophthalmology, 33(1): 47-49, 1985.

Papers Submitted to Peer Reviewed Journals:

198. Chalam KV, Shah VA. Flexcell Pressure Chamber: An In vitro system to study the effect of pressure on growth and morphology of retinal ganglion cells. Submitted to the Ophthalmic Research

199. Chalam, K.V, Malkani, S, Tripathi, R.C.: Intravitreal Triamcinolone effectively reduces postoperative inflammation after vitreoretinal surgery.Submitted to Retina

Peer Reviewed Abstract Publications:

34 05/02/23

Page 35: 1.1.16 master CV

1. Chalam KV, Sandeep Grover, Kumar Sambhav.Deep capillary macular perfusion index obtained with SSADA-assisted OCT-angiography strongly correlates with degree of non-proliferative diabetic retinopathy. American Academy of Ophthalmology, Las Vegas, 2015. P0475

2. S. Grover, K. Sambhav, O. Shakir, Chalam KV.. Decrease in Choroidal Thickness in Patients with Retinitis Pigmentosa Out of Proportion to the Retinal Thickness by Swept Source OCT. American Academy of Ophthalmology, Las Vegas, 2015. P0475

3. K Sambhav, Sandeep Grover, Chalam KV. Choroid Thickness Measured With Swept Source OCT Strongly Correlates With Degree of Sickle Cell Disease. . American Academy of Ophthalmology, Las Vegas, 2015. P0475

4. K.V. Chalam, MD, PhD, S. Gupta, MD. Intraviteral VEGF levels in proliferative vascular retinopathies strongly correlate with the extent of capillary nonperfusion noted on wide angle angiography. American Academy of Ophthalmology, Las Vegas, 2015. P0475

5. K Sambhav, S Grover, Chalam KV. Three Dimensional Swept Source OCT Accurately Measures Optic Disc Volume in Primary Open Angle Glaucoma and Correlates with Severity of Visual Field Loss Association for Research in Vision and Ophthalmology, Denver, Colorado. 2015: 1034/B0172

6. S. Grover, K. Sambhav, O. Shakir, Chalam KV.. Decrease in Choroidal Thickness in Patients with Retinitis Pigmentosa Out of Proportion to the Retinal Thickness by Swept Source OCT. Association for Research in Vision and Ophthalmology, Denver, Colorado. 2015: 1034/B0172

7. Sankarathi Balaiya, Maria B. Grant, Chalam KV. Characterization of Vitreous proteome from Human Proliferative Diabetic Retinopathy Subjects. Association for Research in Vision and Ophthalmology, Denver, Colorado. 2015: 1034/B0172

8. Chalam KV, Sankarathi Balaiya, William B. Cook. Evaluation of the effect of varying concentration and osmolality characteristics of Brilliant Blue Green on Retinal Pigment Epithelial cells exposed to surgical endoilluminator used in vitreous surgery. Association for Research in Vision and Ophthalmology, Denver, Colorado. 2015: 1034/B0172

9. Chalam KV, K Sambhav. Choroid Thickness Measured With Swept Source Optical Coherance Tomography in Posterior Staphyloma Strongly Correlates With Axial Length and visual acuity of Eye Proceedings of 33nd Annual Meeting of American Society of Retina Specialists, Vienna, 2015. p.328

10. Chalam KV, K Sambhav. SSADA assisted Angio- OCT confirms attenuation of deep capillary macular vascular flow index in non proliferative diabetic retinopathy Proceedings of 33nd Annual Meeting of American Society of Retina Specialists, Vienna, 2015. p.328

11. Wenhua Li, Sankarathi Balaiya, Maria B Grant, Chalam, KV. Aqueous Growth Factors in Proliferative Diabetic Retinopathy Inhibit Migration of Endothelial Progenitor Cells (CD34+). Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014: 1034/B0172

12. Chalam, KV, Sankarathi Balaiya, William Scott, Lee R. Ferguson. Spontaneously Differentiated Human Embryonic Stem Cell derived Retinal Pigment Epithelium Cells express RPE-65 and ZO-1 proteins. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014: 1362/A0118

35 05/02/23

Page 36: 1.1.16 master CV

13. Lee R. Ferguson, Chalam, KV. Fluorescence Microscopy Identification of Retinal Pigment Epithelium-65 and Zonular Occludens-1 Expression in Spontaneously Differentiated Human Embryonic Stem Cell derived Retinal Pigment Epithelium Cells. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 1849/A0405

14. Keyvan Koushan, Raluca Rusovici and Chalam, KV. Proliferating Retinal Vascular Endothelial Cells are More Sensitive to Bevacizumab than Choroidal Vascular Endothelial Cells. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 1944/B0209

15. Sankarathi Balaiya, Maria Grant and Chalam KV. Growth Factors/Cytokines Present In Diabetic Vitreous Inhibit CD34+ Bone Marrow Derived Stem Cell Function. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 1354/A0072

16. Sandeep Grover, Omar Shakir, Chad Hummel. Assessment of Macular Thickness and Volume by Spectraldomain Optical Coherence Tomography in Patients With Retinitis Pigmentosa. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 1406/A0263

17. Chad Kaplan, Chalam KV, Sandeep Grover. Intraocular Pressure Reduction After Tarsal Strip Procedure. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 151/A0211

18. Ashley Cowart, Lee R. Ferguson, Sankarathi Balaiya, Ghulam Hamdani, Sandeep Grover, Chalam KV. In Vivo Optical Biopsy Derived Retinal Thickness Accurately Correlate with In Vitro Histology Measurement in Wild-Type Mice. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 2084/D0059

19. Omar Shakir, S. Grover. Spectral Domain Optical Coherence Tomography in Lipemia Retinalis. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 5880/C0066

20. Chad Hummel, Sandeep Grover. Spectral Domain Optical Coherence Tomography and Fundus Autofluorescence in Patients with Rubella Retinopathy. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 3385/C0078

21. Wassia Khaja, Chalam KV, Sandeep Grover. Normative data for intraocular pressure and central corneal thickness in preterm infants. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 5913/C0099

22. Ravi Keshavamurthy, Sandeep Grover, Chalam KV. Correlation between foveal ischemia and spectral-domain optical coherence tomography findings in retinal vein occlusion. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 3892/C0194

23. Shamim A. Haji, Sandeep Grover, Balaiya Sankarathi, Chalam KV. Aqueous VEGF levels in Retinal Vascular Occlusion (RVO) before and after Intravitreal injection of Bevacizumab Correlate with Visual Acuity and Macular Thickness. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 3917/C0219

24. Kevin Cronin, Sandeep Grover. Spectral-Domain Optical Coherence Tomography (Spectralis) and Fundus Autofluorescence Findings in Foveal Hypoplasia. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 5935/C0121

36 05/02/23

Page 37: 1.1.16 master CV

25. Sankarathi Balaiya , William B. Cook, K.V. Chalam. Effect of Solvent and Xenon light on Retinal Pigment Epithelial toxicity. Proceedings of 32nd Annual Meeting of American Society of Retina Specialists, San Diego, 2014. p.328

26. K V Chalam, Wenhua Li, Sandeep Grover. Evaluation of second generation, portable, non-mydriatic, digital fundus camera (Pictor Plus) for teleretinal screening of retinal disorders. Proceedings of 32nd Annual Meeting of American Society of Retina Specialists, San Diego, 2014. p.329

27. K V Chalam, Wenhua Li, Kumar Sambhav, Sandeep Grover. Swept source optical coherance tomography is superior to SD-OCT in estimation of choroidal thickness in humans. Proceedings of 32nd Annual Meeting of American Society of Retina Specialists, San Diego, 2014.

28. Kumar Sambhav, Keyvan Koushan , Sandeep Grover, K. V. Chalam. Disposable inexpensive single use Light-Weight High Resolution Wide Field Contact Lens for Vitreo-retinal Surgery. Proceedings of 32nd Annual Meeting of American Society of Retina Specialists, San Diego, 2014. p.335

29. Sandeep Grover, Shamim A. Haji, Wassia Khaja, K.V. Chalam. Merrill Stass-Isern. Measurement of Corneal Thickness and IOP in Preterm Babies. American Academy of Ophthalmology, Chicago, 2014. P0475

30. K V Chalam, Shailesh K Gupta, Kumar Sambhav, Sandeep Grover. Three dimensional Swept Source OCT Accurately Measures Optic Disc Volume In Primary Open Angle Glaucoma. American Academy of Ophthalmology, Chicago, 2014. P0380

31. K V Chalam, Kumar Sambhav, Sandeep Grover. Modified Portable Digital Camera (Pictor Plus) is as Effective As Traditional Nonmydriatic Fundus Camera For Teleretinal Screening of Diabetic Retinopathy. American Academy of Ophthalmology, Chicago, 2014. P0370

32. Shailesh K Gupta, K V Chalam. Intravitreal VEGF Levels in Proliferative Sickle Cell Retinopathy Strongly Correlates With the Extent of Capillary Nonperfusion Noted on Wide Angle Angiography. American Academy of Ophthalmology, Chicago, 2014. P0558

33. K V Chalam, Kumar Sambhav, Sandeep Grover. Swept Source OCT is Superior to Spectralis in Accuracy as Well as Reproducibility of Choroid Thickness and Volume Measurements. American Academy of Ophthalmology, Chicago, 2014. P0571

34. A Cowart, S Balaiya, G Hamdani, S Grover, KV Chalam. In vitro optical biopsy derived retinal thickness accurately correlate with in vitro histology measurement in wild type mice. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

35. S Haji S, Balaiya, S Grover, KV Chalam. Aqueous VEGF levels in retinal vascular occlusion before and after intravitreal injection of bevacizumab correlate with visual acuity and macular thickness. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

36. K.Koushan, R Rusovici, K.V. Chalam. Proliferating retinal vascular endothelial cells are more sensitive to bevacizumab than choroidal vascular endothelial cells. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

37. KV Chalam, S Balaiya, Scott W,. Spontaneously differentiated human embryonic stem cell derived retinal pigment epithelium cells express RPE-65 and ZO-1 proteins. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

37 05/02/23

Page 38: 1.1.16 master CV

38. LR Ferguson, KV Chalam. Fluorescence microscopy identification of retinal pigment epithelium -65 and Zonualar occludence -1 expression in spontaneously differentiated human embryonic stem cell derived retinal pigment epithelium cells. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

39. R Keshavamurthy, S Grover, KV Chalam. Correlation between foveal ischemia and spectral domain optical coherence tomography findings in retinal vein occlusion. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

40. W Li, S Balaiya, Grant MB, KV Chalam. Aqueous growth factors in proliferative diabetic retinopathy inhibit migration of endothelial progenitor cells (CD 34+). Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

41. S Balaiya, Grant MB, KV Chalam. Growth factors/cytokines present in diabetic vitreous inhibit CD 34+ bone marrow derived Stem cell function. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

42. K.V. Chalam, MD, PhD, S. Gupta, MD. Intraviteral VEGF levels in proliferative vascular retinopathies strongly correlate with the extent of capillary nonperfusion noted on wide angle angiography. American Academy of Ophthalmology, New orleans, p.232, 2013

43. S. Gupta, MD, K.V. Chalam, MD, PhD, S. Grover, MD , K.Koushan, MD,. Modified retinopathy of prematurity screeing guidelines using birth weight as the only criterion. American Academy of Ophthalmology, New orleans, p.232, 2013

44. S. Gupta, MD, R Keshavamurthy, MD, J Priluck, MD, K.V. Chalam, MD, PhD, Change in macular volume (Spectral domain OCT) is superior to macular thickness in predicting functional recovery in diabetic macular edema after anti VEGF therapy. American Academy of Ophthalmology, New orleans, p.232, 2013

45. K.V. Chalam, MD, PhD, S. Gupta, MD, S. Grover,. Spectalis obtained SD-OCT is superior to Cirrus in accuracy as well as reproducibility of retinal thickness and volume measurements. American Academy of Ophthalmology, New orleans, p.232, 2013

46. K.V. Chalam, MD, PhD, S. Gupta, MD, S. Grover,. Electronic tablet (I-Pad) improves reading ability as well as quality of life of patients with poor vision secondary to macular degeneration. American Academy of Ophthalmology, New orleans, p.232, 2013

47. K.Koushan, R Rusovici, K.V. Chalam. Proliferating retinal vascular endothelial cells are more sensitive to bevacizumab than choroidal endothelial cells. Proceedings of 31st Annual Meeting of American Society of Retina Specialists, 2013, Toronto

48. K.V. Chalam, K.Koushan, W Li, S Balaiya. Effect of distance and duration of illumination from a surgical endoilluminator on retinal cells exposed to varying doses of brilliant blue green. Proceedings of 31st Annual Meeting of American Society of Retina Specialists, 2013, Toronto

49. K.Koushan, K.V. Chalam. Miniaturized high resolution (HR) wide field contact lens for panretinal photocoagulation. Proceedings of 31st Annual Meeting of American Society of Retina Specialists, 2013, Toronto

38 05/02/23

Page 39: 1.1.16 master CV

50. S Balaiya, Grant MB, KV Chalam. Influence of diabetic retinopathy aqueous in causing defective CD34 cells. Association for Research in Vision and Ophthalmology, Seattle, Washington. 2013:274/ D223

51. R Bouhenni, DP Edward, S Grover, KV Chalam, AL Sewell, K Abu-amero. The aqueous humor proteome in patients with diabetic retinopathy. Association for Research in Vision and Ophthalmology, Seattle, Washington. 2013:1155/ D53

52. L Ferguson, S Grover, KV Chalam. Evaluation of spontaneous differentiation of hESCs into RPEs in the absence of BFGF.Influence of diabetic retinopathy aqueous in causing defective CD34 cells. Association for Research in Vision and Ophthalmology, Seattle, Washington. 2013:2211/A80

53. R Keshavamurthy, J Koh, S Chen, KV Chalam. Quantitative proteomics of vitreous humor to identify potential markers in the induction of posterior vitreous detachment. Association for Research in Vision and Ophthalmology, Seattle, Washington. 2013:3306/ B194

54. KV Chalam, W Li, S Balaiya. Evaluation of Brilliant blue green (BBG) toxicity on retinal ganglion cells exposed to varying levels of illumination with surgical metal halide endoilluminator. Association for Research in Vision and Ophthalmology, Seattle, Washington. 2013:5773/ D23

55. K.V. Chalam. Safety and efficacy of anti=VGF drug therapy. International Society of Ocular Pharmacology and Theraupeutics, 2013, Paris, France, P.53

56. Chalam KV. Biology of VEGF and implications in clinical practice. Proceedings of Asia Pacific Ophthalmic Society, Hyderabad, India, 2013, p422

57. Chalam KV. Lenticular meridional astigmatism secondary to renal metastasis: a challenging case. Proceedings of Asia Pacific Ophthalmic Society, Hyderabad, India, 2013, p812

58. Chalam KV. Rationale of DRCR.net intravitreal Anti-VEGF treatment and follow up of center involved DME. Proceedings of Asia Pacific Ophthalmic Society, Hyderabad, India, 2013, p812

59. S. Grover, MD , M. Diaz, MD, L. Ferguson, MD, K.V. Chalam, MD, PhD . Retinal function by microperimetry correlates with macular volume by spectral domain OCT. American Academy of Ophthalmology, Chicago, p.232, 2012

60. S. Gupta, MD , S Balaiya, PhD, K.V. Chalam, MD, PhD . Aqueous interleukin-6 is superior to VEGF as biomarker in monitoring therapeutic response in wet macular degeneration. American Academy of Ophthalmology, Chicago, p.235, 2012

61. K.V. Chalam, MD, PhD, D. Davis, MD, S. Grover, MD. Modified portable digital camera (Pictor) is as effective as traditional nonmydriatic fundus camera for teleretinal screening of retinal disorders. American Academy of Ophthalmology, Chicago, p.235, 2012

62. S. Gupta, MD , S. Grover, MD, K.V. Chalam, MD, PhD . Photoreceptor outer segment length on ultra high resolution spectral domain OCT accurately predicts visual acuity recovery after macular surgery. American Academy of Ophthalmology, Chicago, p.235, 2012

63. K.V. Chalam, MD, PhD , R.K. Murthy, S. Gupta, MD ,. Change in macular volume (Spectral Domain OCT) is superior to macular thickness in predicting functional recovery in diabetic macular edema in

39 05/02/23

Page 40: 1.1.16 master CV

diabetic macular edema after anti VEGP therapy.. American Academy of Ophthalmology, Chicago, p.236, 2012

64. Raluca Rusovici, Chirag Patel, K.V. Chalam. Effect of Bevacizumab on Cell Cycle of VEGF- Enriched Proliferating Choroidal Endothelial Cells. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:788/A665

65. Joshua C. Priluck, K V. Chalam, Sandeep Grover. Macular Volume Change By Sectral-domain Optical Coherence Tomography After Treatment With Bevacizumab in Exudative Macular Degeneration. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:801/D739

66. Shailesh K. Gupta, Ivana Obradovic, Rena Cappelli, Natalie McKee, Joshua Priluck, K V. Chalam, Sandeep Grover.Evaluation of Fundus Images Using the New Hand-held 'Pictor' Camera.. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:3107/D1236

67. Michelle Diaz, Ravi Kevashamurthy, K V. Chalam, Sandeep Grover. Normative Data for Macular Volume by Spectral-Domain Optical Coherence Tomography (Spectralis). Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:4075/D1163

68. Kavitha Ravi, Ravi Keshavamurthy, S Balaiya, K V. Chalam. Dose Response Study Of Cytoprotective Effect By Lutein And Zeaxanthin On Retinal Pigment Epithelium From Oxidative Stress Induced Cytotoxicity. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 20122:4755/A430

69. Lee R. Ferguson, KV. Chalam. Evaluation of Retinal Thickness with Customized Spectral Domain Optical Coherence Tomography (SD-OCT) in Normal Mice. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:5000/D1011

70. Chirag J. Patel, K.V. Chalam, Sandeep Grover, Ravi Keshavamurthy, Joshua C. Priluck. Aqueous Interleukin-6 (IL-6) Levels Are Superior To Vascular Endothelial Growth Factor (VEGF) Levels In Predicting Therapeutic Response To Bevacizumab In Age-Related Macular Degeneration (AMD). Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:5175/D1228

71. Carolee M. Cutler Peck, Raluca Rusovici, Sandeep Grover, K V. Chalam. Evaluation Of Cytotoxicity Of Bevacizumab On VEGF-enriched Corneal Endothelial Cells. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:6002/D823

72. Ivana V. OBRADOVIC, Rena Cappelli, Joshua C. Priluck, K V. Chalam, Sandeep Grover. Comparison of Color Vision Testing By Standard Ishihara Color Plates Versus iPad Version. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:6394/A84

73. Wassia A. Khaja, Amy Kelmenson, K V. Chalam, Sandeep GroverComparison of Central Corneal Thickness: Slit Lamp-OCT versus Ultrasound Pachymetry, Specular Microscopy, and Orbscan. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:108/A251

74. V. Khetpal, S. Balaiya, KV Chalam. Inhibitory role of Resveratrolin the proliferation of choroidal endothelial cells under hypoxic stress.Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:442/D1119

40 05/02/23

Page 41: 1.1.16 master CV

75. KV Chalam,S. Balaiya, R Malyapa. Differential sensitivity of cultured mature retinal cells (staurosphorine differentiated retinal ganglion cells and retinal pigment epithelial cells) against proliferating choroidal endothelial cells to proton radiation.Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:5564/D1191

76. Don K Davis, S.Balaiya, KV Chalam, Sandeep Grover. Neuroprotective role of sirtuin (SIRT1) against hypoxia in Retinal ganglion cells. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:1958/A651

77. R.K. Murthy, S Balaiya, Tatiana McLauchlan, KV Chalam. In vitro cytotoxic effects of Brilliant Blue Green (BBG) on retinal pigment epithelial cells after metal halide illumination.Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:3791/A257

78. S. Balaiya, K.V. Chalam. Regulation of hypoxia mediated toxicity by a post-transcriptional regulator, SIRT1 in choroidal neovascularization. International Society of Ocular Toxicology, 2011; Portland, Oregon

79. S. Balaiya, K.V. Chalam. Protective role of sirtuin against hypoxia induced neurotoxicity. . International Society of Ocular Toxicology, 2011; Portland, Oregon

80. KV Chalam, S. Balaiya, RS Malyapa. Proton beam radiation selectively destroys proliferating chorodial endothelial cells and preserves non-proliferating retinal pigment epithelial cells: a model for choroidal neovascular membrane.International Society of Ocular Toxicology. 2011; Portland, Oregon

81. Tatiana McLauchlan, S Balaiya, KV Chalam. In vitro cytotoxic effects of Brilliant Blue Green (BBG) on retinal pigment epithelial cells after metal halide illumination. International Society of Ocular Toxicology. 2011; Portland, Oregon

82. K.V. Chalam, MD, PhD, V.Khetpal, MD, S. Gupta, MD, S. Grover, MD, . Navigated laser vs traditional argon green modified grid photocoagulation for diffuse diabetic macular edema American Academy of Ophthalmology, Orlando, p.222, 2011

83. K.V. Chalam, MD, PhD,S. Gupta, MD, S. Grover, MD, Evaluation of the impact of Ipad (as a low visual aid) on reading ability and quality of life of low vision patients. American Academy of Ophthalmology, Orlando, p.228, 2011

84. S. Balaiya, V.Khetpal, K.V. Chalam. Hypoxia induces a post-transcriptional regulator, SIRT1 (Histone deactylase; HDAC) mediated VEGF activation in choroidal retinal neovascularisation.Proceedings of 29th Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.84

85. K.V. Chalam,V.Khetpal,S. Balaiya,. Resveretrol inhibits proliferation od choroidal endothelial cells in hypoxia: a model for neovascular AMD.Proceedings of 29th Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.86

86. K.V. Chalam, V.Khetpal, R.Radhakrishnan. Newly designed miniaturized light weight wide angle contact lens for digital fluorescien angiographic evaluation of retinal ischemia.Proceedings of 29th

Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.139

87. V.Khetpal, R.Radhakrishnan, R.K. Murthy,K.V. Chalam. Evaluation of a novel contact automated focal laser with integrated (NAVILAS) fluorescien angiography for diabetic macular

41 05/02/23

Page 42: 1.1.16 master CV

edema.Proceedings of 29th Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.141

88. V.Khetpal, R.Radhakrishnan, K.V. Chalam. Ultra wide angle fluoroscien angiography revealed peripheral retinal ischemia correlates with retinal thinning in asymptomatic sickle cell patients.Proceedings of 29th Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.156

89. R.Radhakrishnan, J.Edwards, V.Khetpal, K.V. Chalam. SD-OCT and infrared imaging of leukemic infiltration of the choroid.Proceedings of 29th Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.175

90. R. Radhakrishnan, K.V. Chalam, V.S. Brar, S. Gupta, V. Khetpal, R. Keshavamurthy, S. Grover. Evaluation of the Use of Navigated Laser (NAVILAS) in the Treatment of Diabetic Macular Edema. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011,52: E-594

91. R Keshavamurthy, VS Brar, KV Chalam. Lutein And Zeaxanthin Protect Retinal Pigment Epithelium From Oxidative Stress Induced Cytotoxicity. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011, 52: E-4433

92. Rena Cappelli, Ravi Radhakrishnan, KV Chalam, Sandeep Grover. Spectral Domain Optical Coherence Tomography Features of Retinal Astrocytoma.Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011, 52: E-3697

93. S.Balaiya, Vijay Khetpal, KV Chalam. Sirt-1 Induces Vascular Endothelial Growth Factor through the activation of HIF-2α in hypoxia. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011,52: E-2322

94. V. Khetpal, S. Balaiya,KV Chalam. Resveratrol inhibits proliferation in hypoxia treated choroidal endothelial cells. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011,52: E-4853

95. Jr. Don,S. Balaiya,KV Chalam. Protective action of a transcription regulator Sirt1against oxidative stress in choroidal endothelial cells: a model for age related macular degeneration. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011,52: E-2313

96. KV. Chalam, S.Balaiya, R. Malyapa. Proton Beam Radiation destroys VEGF induced Choroidal endothelial cell Proliferation in association with age related macular degeneration. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011, 52: E-1780

97. Vikram S. Brar, Monali Sakhalkar, S. Balaiya, KV. Chalam. Intracameral Bevacizumab reduces deep stromal neovascularisation and improves corneal graft clarity. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011,52: E-2006

98. R Keshavamurthy,MD, VS Brar, MD, K.V. Chalam, MD, PhD. Foveal Microstructure Delineated by Spectral-Domain OCT Correlates With Functional Outcome Mapped With Macular Microperimetry, after Macular Hole SurgeryAmerican Academy of Ophthalmology, 2010

99. V.S. Brar, MD, S. Gupta, MD, S. Grover, MD, K.V. Chalam, MD, PhD . Reduction of Human Aqueous VEGF Levels Accurately Predicts Resolution of Diabetic Macular Edema After Bevacizumab AdministrationAmerican Academy of Ophthalmology, 2010

42 05/02/23

Page 43: 1.1.16 master CV

100. KV Chalam,MD,PhD, R Keshavamurthy,MD, R Radhakrishnan,MD, VS Brar,MD, S Grover,MD. Evaluation of modified retinopathy of prematurity screening guidelines using birth-weight as sole inclusion criterionAmerican Academy of Ophthalmology, 2010

101. KV Chalam,MD,PhD R Keshavamurthy,MD, V Brar MD. Ultrastructural anatomical changes noted on high- resolution specitral domain oct accurately predicts visual acuity recovery after vitrectomy for epiretinal membranesAmerican Academy of Ophthalmology, 2010

102. R Keshavamurthy,MD, KV Chalam,MD,PhD, S Gupta, MD. Circumfrencial intraoperative laser retinopexy eliminates the risk of retinal detachment after macuar hole surgeryAmerican Academy of Ophthalmology, 2010

103. R. Radhakrishnan, S. Balaiya, V.S. Brar, R.K. Murthy, K.V. Chalam. Aqueous VEGF Levels in Patients Treated With Bevacizumab for Central Serous Chorioretinopathy Proceedings of American Society of Retina Specialists, 2010

104. R. Radhakrishnan, R. Keshavamurthy, S. Gupta, KV Chalam. Comparative (Contact Vs Noncontact) Evaluation of Utility of Optiflex in Wide-Angle Vitreoretinal Surgery Proceedings of American Society of Retina Specialists, 2010

105. K.V.Chalam, MD, PhD, R.K. Murthy MD ,S. Balaiya Ph.D, R. Malyapa MD, PhD . Evaluation of Differential Sensitivity of Retinal Ganglion Cells and Choroidal Endothelial Cells to Proton Beam Radiation: A Model for the study of AMD Proceedings of American Society of Retina Specialists, 2010

106. R Keshavamurthy MD, KV Chalam MD, S Grover MD . Asymptomatic temporal inner retinal thinning on Spectral-domain Optical Coherence Tomography: An indicator of peripheral ischemia in proliferative sickle cell retinopathy Proceedings of American Society of Retina Specialists, 2010

107. R Keshavamurthy MD, KV Chalam MD, S Grover MD . Foveal structural and functional changes in Patients with pattern dystrophy. Proceedings of American Society of Retina Specialists, 2010

108. S. Balaiya, R. Malyapa, K.V. Chalam. Proton Beam Radiation Selectively Destroys Proliferating Chorodial Endothelial Cells and preserves Non-proliferating Retinal Pigment Epithelial Cells: A Model for Choroidal Neovascular Membrane. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-2775

109. K. V. Chalam, S. Balaiya, R. Keshavamurthy, Brar VS. Comparative in vitro Safety Analysis of Vital Dyes for Chromovitrectomy-Indocyanine Green, Infracyanine Green, Brilliant Blue Green and Bromophenol Blue. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-3597

110. J.D. Edwards, S. Balaiya, K.V. Chalam. Estimation of TNF-α Concentration In Aqueous Humor Samples of Normal Human Subjects With Bead Based Immuno Assay. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-711

111. S. Grover, S. Balaiya, V.S. Brar, K.V. Chalam. Measurement of Aqueous VEGF levels in Patients with Retinal Diseases is Superior and Accurate in Fresh Than Stored Samples. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-3343

43 05/02/23

Page 44: 1.1.16 master CV

112. R. Radhakrishnan, S. Balaiya, V.S. Brar, R.K. Murthy, S. Grover, K.V. Chalam. Aqueous VEGF levels after Intravitreal Ranibizumab for Diabetic Macular Edema. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-5042

113. D.W. Hwang, S. Balaiya, R. Malyapa, K.V. Chalam. Effect of Proton Beam Radiation on The Survival of Two Different Ocular Cell-colonies: Fine Tuning Treatment of Choroidal Neovascularization with Radiation. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-3120

114. V.S. Brar, R. Keshavamurthy, S. Balaiya, K.V. Chalam. Aqueous Vascular Endothelial Growth Factor Levels in Exudative Age Related Macular Degeneration after Combination Treatment with Bevacizumab and Photodynamic Therapy. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-2787

115. C.M. Cutler Peck, S. Grover Functional Changes Correlate with Structural Changes in North Carolina Macular Dystrophy Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-4066

116. R. Cappelli, K.V. Chalam, S. Grover. Spectral-Domain Optical Coherence Tomography and Fundus Autofluorescence Findings in Patients with Pattern Dystrophy Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-4381

117. R. Keshavamurthy, V.S. Brar, S.K. Gupta, S. Grover, K.V. Chalam. Foveal Microstructure As Delineated By Spectral-domain OCT Accurately Predicts Functional Outcome On Microperimetry After Macular Hole Surgery Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-1335

118. Rajesh K Sharma, Anna T Rogojina, K.V. Chalam. Anti-VEGF therapy normalizes pathological intraocular environment in neovascular conditions Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-5905

119. A.T. Kelmenson, R.K. Murthy, S. Grover. Functional Changes Correlate With Structural Changes in Patients with Stargardt's Disease Using SDOCT, Autofluorescence, and Micro-perimetry Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-1389

120. B. Chang, K.V.Chalam, Hunt,R. C. Hunt. Role of TGFβ and IL1β in Vitreous Transformation of Human Retinal Pigment Epithelial Cells. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51:1668

121. Shailesh K Gupta, Ravi Keshavamurthy, Sandeep Grover, K V Chalam. Concurrent Pars Plana Vitrectomy Performed to Remove Intravitreal Lens Fragment After Phacoemulsification Eliminates the Risk of Retinal Detachment.American Academy of Ophthalmology, 2009.

122. Sandeep Grover, Deepak Paul Edward, Erica P Dixon, K V Chalam. Live webcast lectures: an innovative tool in ophthalmology resident education American Academy of Ophthalmology, 2009

123. VS Brar, S Balaiya, RK Murthy, KV Chalam “An in vitro effect of UV-induced phototoxicity on retinal cells” ASIA Association of Research in vision and ophthalmology, Hyderabad, India, 2009

124. S. Balaiya, R. Malyapa, N. Mendenhall, KV Chalam. “An effect of proton radiotherapy on cultured retinal cells” ASIA Association of Research in vision and ophthalmology, Hyderabad, India, 2009

44 05/02/23

Page 45: 1.1.16 master CV

125. R Keshavamurthy, S Grover, KV Chalam. “Difference In Macular Thickness As Measured By Time-domain OCT (Stratus) And Spectral-domain OCT (Spectralis)” ASIA Association of Research in vision and ophthalmology, Hyderabad, India, 2009

126. Keshavamurthy R, Balaiya S, Chalam KV. Comparative Effect of Indocyanine and Infracyanine Green on Cultured Retinal Ganglion Cells. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-137

127. Sharma RK, Roberts ML, Chalam KV. Protective Effect of Preconditioning on Oxidative Stress Induced Cell Death in RGC Cells. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-140

128. Patel MC, Balaiya Mehanathan S, Chalam KV. Ultraviolet Induced Oxidative Stress on Retinal Ganglion and Pigment Epithelial Cells. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-142

129. Brar VS, Sharma RK, Keshavamurthy R, Chalam KV. Vascular Endothelial Growth Factor Protects Against Oxidative Stress in Differentiated Retinal Ganglion Cells. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-379

130. Kelmenson AT, Keshavamurthy R, Brar VS, Hwang DW, Chalam KV, Grover S. Comparative Difference in Macular Thickness as Measured Between Spectral-Domain OCT (Spectralis) and Time-Domain OCT (Stratus). Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-1072

131. Hwang DW, Keshavamurthy R, Brar VS, Chalam KV, Grover S. Establishment of Macular Thickness in Normal Eyes With Spectral-Domain Spectralis Optical Coherence Tomography. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-1084

132. Roberts ML, Sharma RK, Gupta SK, Chalam KV. Proliferating Retinal Cells Produce Growth Factors that Create Pro-Proliferation Environment. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-1311

133. Cappelli R, Keshavamurthy R, Brar VS, Chalam KV, Grover S. Evaluation of Thickness of Individual Layers of the Retina With Spectral-domain OCT for Establishment of Normal Clinical Values. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-3788

134. Storm L, Keshavamurthy R, Brar V, Chalam KV, Grover S. Evaluation of Optic Nerve Head Drusen Using Spectral-domain OCT (Spectralis). Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida,50: E-4022

135. Chalam KV, Balaiya Mehanathan S, Keshavamurthy R. Evaluation of Differential Sensitivity of Retinal and Choroidal Cells to Proton Beam Radiation: A Model for Age Related Macular Degeneration. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-4945

136. Balaiya Mehanathan S, Malyapa R, Mendenhall N, Chalam KV. Proton Radiation Predominantly Destroys Choroidal Endothelial Cells While Preserving Retinal Ganglion Cells. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.50: E-6221

137. RK Murthy, S Balaiya, VS Brar, KV Chalam. “Effects of Indocyanine green on cultured retinal ganglion cells: An in vitro study” International society of ocular toxicology , Philadelphia, PA, 2008

45 05/02/23

Page 46: 1.1.16 master CV

138. ML Roberts, RK Sharma,VS Brar, KV Chalam. “Effect of bevacizumab on viability of human corneal cell lines” International society of ocular toxicology, Philadelphia, PA, 2008

139. S.Balaiya, R Malyapa, KV Chalam. “In vitro study of proton beam radiation toxicity on retinal cells” International society of ocular toxicology, Philadelphia, PA, 2008

140. VS Brar, S Balaiya, RK Murthy, KV Chalam, “An in vitro effect of UV-induced phototoxicity on retinal cells” International society of ocular toxicology, Philadelphia, PA, 2008

141. Chalam KV, Gupta SK, Brar VS, Murthy RK. Evaluation of Ultra wide angle ‘ora-ora’ high refractive index self-stabilizing Wide-angle Contact lens for Vitreous Surgery. American Society of Retina Specialists October 11–15, 2008 Maui, Hawaii.

142. Grover S, Keshavamurthy R, Brar VS, Chalam KV. Normative data for macular thickness by spectral-domain OCT (Spectralis). American Society of Retina Specialists October 11–15, 2008 Maui, Hawaii.

143. Brar VS, Sharma RK, Chalam KV. In vitro toxicity of bevacizumab (Avastin®) in retinal ganglion and choroidal endothelial cell. American Society of Retina Specialists October 11–15, 2008 Maui, Hawaii.

144. Gupta SK, Brar VS, Keshavamurthy R, Sharma RK, Chalam KV. Evaluation of aqueous VEGF levels after intravitreal bevacizumab for retinal vein occlusion. American Society of Retina Specialists October 11–15, 2008 Maui, Hawaii.

145. Murthy RK, Chalam KV. “Quality of Life Measured by the 25-Item NEI Visual Function Questionnaire Correlates Accurately With Severity of Diabetic Macular Edema” American Academy of Ophthalmology, Atlanta, 2008.

146. Chalam KV, Murthy RK, Gupta SK. “ Inner Segment/Outer Segment Changes on Ultrahigh-Resolution Spectral OCT Accurately Predict Visual Acuity Recovery After macular hole repair” American Academy of Ophthalmology, Atlanta, 2008.

147. Grover S, Murthy RK, Brar S, Chalam KV.Macular thickness in normal subjects by spectral-domain OCT (Spectralis)”. American Academy of Ophthalmology, Atlanta, 2008.

148. Chalam KV, Gupta SK. Aqueous Vascular Endothelial Growth Factor Levels Accurately Correlate With Regression of Neovascularization After Avastin Administration in Exudative Macular Degeneration. American Academy of Ophthalmology, Atlanta, 2008.

149. V.S. Brar, R.K. Sharma, K.V. Chalam, “Assessment of Cytotoxicity of Bevacizumab on Choroidal Endothelial, Retinal Ganglion, and Retinal Pigment Epithelial Cells” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.

150. R.K. Sharma, A. Rogojina, K.V. Chalam, “Use of Multiplex Technology for Analyzing Human Aqueous Samples for a Battery of Analytes” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.

151. M.C. Patel, V. Brar, S. Gupta, K.V. Chalam, Evaluation of Second Generation Modified Portable Digital Camera for Documentation of Retinal Pathology”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.

46 05/02/23

Page 47: 1.1.16 master CV

152. M.G. Roberts, R.K. Sharma, C.N. Nagineni, A. Grover, K.V. Chalam, “Evaluation of Bevacizumab Cytotoxicity on Human Corneal Cell Lines” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.

153. S. Grover, W. Phillips, J. Sifrit, A. Dominik, A. Shtjefni, K. Chalam“Perifoveal Retinal Function in Patients With Macular Drusen” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.

154. C.N. Nagineni, V.K. Kommineni, K.V. Chalam, B. Detrick, J.J. Hooks, “Interleukin-11 Expression by Human Retinal and Corneal Cells: Regulation by IL-1, TNF-α, IFN-γ and TGF-β”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008

155. K.V. Chalam, S. Grover, S. Gupta, V.S. Brar, R.K. Sharma,“Evaluation of Vascular Endotheilal Growth Factor Levels After Intravitreal Bevacizumab in Retinal Disorders” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008

156. S.N. Syed, S. Gupta, V.S. Brar, S. Grover, K.V. Chalam”Improvement of Visual Acuity and Resolution of Macular Edema Associated With Chronic Disciform Scars After Intravitreal Bevacizumab”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008

157. S.K. Gupta, V.S. Brar, K. Chalam, “Comparative (Contact vs. Noncontact) Evaluation of Utility of Optiflex Assistant System in Wide Angle Panoramic Vitreoretinal Surgery”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008

158. K.V. Chalam, Shailesh K Gupta, Sandeep Grover. “Portable Digital Camera is as effective as traditional nonmydriatic fundus camera in screening for AMD”, American Academy of Ophthalmology, New Orleans, 2008.

159. K.V. Chalam, Shailesh K Gupta, Sandeep Grover, Sadiq N Syed, “Birth weight alone is the most predictable and reliable criteria in screening for ROP” American Academy of Ophthalmology, New Orleans, 2008.

160. K.V. Chalam, Shailesh K Gupta, Swati Agarwal, Sandeep Grover, “Human Aqueous Vascular Endothelial Growth Factor levels accurately predict regression of Iris neovascularization after Avastin administration in neovascular glaucoma” American Academy of Ophthalmology, New Orleans,2008.

161. K.V.Chalam, Shailesh K Gupta, “Comparative analysis of optical coherence tomography and retinal angiography in eyes treated with intravitreal bevacizumab for neovascular AMD” Proceedings of American Society of Retina Specialists,2008

162. Shailesh K Gupta, K.V. Chalam, “Microperimetry findings in patients treated with intraviteal avastin for exudative age-related macular degeneration” Proceedings of American Society of Retina Specialists,2008

163. K.V. Chalam,Shailesh K Gupta,“Evaluation of touch sensitive optiflex system as surgical assistant in vitreoretinal surgery” Proceedings of American Society of Retina Specialists,2008

164. Shailesh K Gupta, K. V. Chalam, “Evaluation of simultaneous placement of a foldable IOL (FIOL) in vitreoretinal surgery combined with phakoemulsification surgery” Proceedings of American Society of Retina Specialists, 2008

47 05/02/23

Page 48: 1.1.16 master CV

165. K. V. Chalam, Farhana Syed, Jason Sifrit, Sadiq Syed, Sandeep Grover, Shailesh Gupta “Evaluation of Modified Portable Digital Camera as a Screening Tool in Retinal Disorders” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Page 129

166. Swati Agarwal, Rajesh Sharma, K V Chalam, Tina Tillis, “Evaluation of Nerve growth factor levels (NGF) in Aqueous of Primary Open Angle Glaucoma” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Page 212

167. Sandeep Grover, Swati Agarwal, Shailesh Gupta, K.V. Chalam, “Role of Intracameral Avastin in Neovascularization of Iris Secondary to Retinal Diseases” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Page 246

168. C.N. Nagineni, V.K. Kommineni, K.V. Chalam, R.Raju, B.Detrick, J.J. Hooks “TGF-β Upregulates Extracellular Matrix Protein Anosmin (KAL-1) Expression in Human Retinal Pigment Epithelial Cells” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Page 126

169. Manish Patel, Swati Agarwal, Shailesh Gupta, K.V. Chalam “Evaluation of OptiFlex as Surgical Assistant in Wide-angle contact lens assisted Vitreoretinal Surgery” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Page 110

170. William Phillips, Farhana Syed, Shailesh Gupta, Sandeep Grover, K.V. Chalam “Evaluation of Modified Retinopathy of Prematurity (ROP) Using Birth-Weight (BW) as Sole Inclusion Criterion” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Page 198

171. Lorene F. Ward, Rajesh K. Sharma and K.V. Chalam “Induction of Stem Cell Markers in Non-Stem Cell Lines With Growth Factor Stimulation” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007 Page 199

172. Farhana Syed, K.V. Chalam, R.C. Tripathi, Brenda J. Tripathi “Ciliary Epithelium is an Extraretinal Source of Vascular Endothelial Growth Factor (VEGF) in Neovascular Glaucoma” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007 Page 284

173. S. Gupta, S.Grover, W. Phillips, K.V. Chalam “Microperimetry vs. Humphrey Visual Field in the Evaluation of Toxic Maculopathy” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007 Page 201

174. S.N. Syed, K.V. Chalam, S.K. Gupta, S. Grover, F. Syed, W. Phillips “Intravitreal Bevacizumab for the Treatment of Central Retinal Vein Occlusion” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Page 16

175. Chalam KV, Grover S, Beaver H, Tsai J. Emerging Biological and Pharmacological Therapies for Ocular Diseases: Highlights of BCSC 2. American Academy of Ophthalmology, Las Vegas, 2006

176. Chalam KV, Gupta S, Grover S, Agarwal S. Intracameral Avastin dramatically resolves Iris Neovascularization and Reverses Neovascular glaucoma. American Academy of Ophthalmology, Las Vegas, 2006

177. Chalam KV, Gupta S, Grover S, Agarwal S. Modified Portable Digital Camera as effective as Traditional Nonmydriatic Fundus Camera in screening of Diabetic Retinopathy. American Academy of Ophthalmology, Las Vegas, 2006

48 05/02/23

Page 49: 1.1.16 master CV

178. Chalam KV, Gupta S, Grover S, Agarwal S. Evaluation of comparative Efficacy of Topical Tetravisc vs.Lidocaine Jelly in cataract surgery. American Academy of Ophthalmology, Las Vegas, 2006

179. Chalam KV, Agarwal S, Gupta SK . Evaluation of portable digital camera for screening of Diabetic retinopathy in primary care and satellite clinics. Proceedings of American Society of Retina Specialists, 2006. p140

180. Chalam KV, Gupta S, Grover S, Agarwal S. Evaluation of Relationship between VEGF levels and Age Related Macular Degeneration. Proceedings of American Society of Retina Specialists, 2006. p140

181. Agarwal S,Grover S, Chalam KV, Gupta S. Effect of Intracameral Bevacizumab on Neovascularization of the Iris. Proceedings of American Society of Retina Specialists, 2006. p140

182. Agarwal S,Gupta S, Grover S,Chalam KV. Correlation of Optical Coherance Tomography and Retinal angiography in Patients treated with Bevacizumab for Choroidal Neovascular Membrane. Proceedings of American Society of Retina Specialists, 2006. p140

183. K. V. Chalam, William.W.Phillips, Swati Agarwal, Sandeep Grover, Shailesh Gupta “Evaluation of toxic effects of Ultra-violetB induced Apoptosis in Retinal Ganglion Cells.” International Society of Ocular Toxicology, Germany, 2006

184. William.W.Phillips, Kakarla. V. Chalam, Swati Agarwal, Sandeep Grover, Shailesh Gupta “Effects of Indocyanine Green on Cultured Rat Retinal Ganglion Cells in Vitro.” International Society of Ocular Toxicology, Germany, 2006

185. Patel M, Sifrit JA, Agarwal S, Gupta SK, Chalam KV. “Autoclavable Wide-Angle Multi-lens Contact Lens for Vitreoretinal evaluation”. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006. 2006;46:ARVO E-Abstract 3641

186. Sifrit JA, Patel M, Agarwal S, Gupta SK, Chalam KV. “ Evaluation of Fixation Patterns in Macular Diseases with Liquid Crystal Display Fundus Microperimetry”. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006. 2006;46:ARVO E-Abstract 3625

187. Chalam KV, Ward L, Agarwal S, Tripathi B, Tripathi R. “Evaluation and Comparison of Vitreal Nerve Growth Levels in various Retinal diseases”. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006. 2006;46:ARVO E-Abstract 2775

188. Ward L, Chalam KV “Evaluation of Growth Factors in Human Neural Stem and Retinal Progenitor Cell Conditioned media”.Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006. 2006;46:ARVO E-Abstract 3687

189. Agarwal S, Agarwal N, Tripathi B, Tripathi R, Chalam KV. “Influence of Ciliary Neurotrophic factor (CNTF) on Apoptotic Retinal Ganglion Cell Death Induced by Glutamate Excitoxicity”.Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006. 2006;46:ARVO E-Abstract 3266

190. Chalam KV. Anti VEGF therapy for AMD. Proceedings of All India Ophthalmic Society, Bhopal, India, 2006, p62

191. Chalam KV.MP-1 microperimetry in Retinal disorders. Proceedings of All India Ophthalmic Society, Bhopal, India, 2006, p67

49 05/02/23

Page 50: 1.1.16 master CV

192. Chalam KV.“Screening with birth weight < 1250 (g) identifies all high risk retinopathy of prematurity for early treatment and avoids unnecessary examinations” Proceedings of All India Ophthalmic Society, Bhopal, India, 2006, p352

193. Shah GY, Chalam KV. Inmnovative surgical approach to anterior vitreoretinal pathology – instrumentation and its uses. Proceedings of American Society of Retina Specialists, 2005. p140

194. Chalam KV, Shah GY. A novel reuseable instrument system for creating 25-gauge sclerotomies in suturelss pars plana vitrectomies. Proceedings of American Society of Retina Specialists, 2005.p139

195. Gupta SK, Chalam KV. Quality of life in diabetic retinopathy as measured by the 23-item NEI and TTO utility values. Proceedings of American Society of Retina Specialists, 2005.p141

196. Lin SJ, Chalam KV. Comparative evaluation of toxic effects of indocyanine green and tryphan blue on survival or retinal ganglion cells. Proceedings of American Society of Retina Specialists, 2005. p145

197. Chalam KV. Determination of patterns of foveal fixation in age related macular degeneration with fundus microperimetry (LCDMP-1). Proceedings of American Society of Retina Specialists, 2005.p149

198. Shah GY, Chalam KV. Evaluation of web based annotation of ophthalmic images for multi-center clinical trials. Proceedings of American Society of Retina Specialists, 2005.p158

199. Lin SJ, Chalam KV. Birthweight 1250 grams(g) identifies all high risk Retinopathy of Prematurity (ROP) for early treatment. Proceedings of American Society of Retina Specialists, 2005. p160

200. Gupta SK, Chalam KV. Evaluation of simultaneous placement of foldable IOLs in vitreoretinal surgery combined with bimanual microincisional phacoemulsification surgery. Proceedings of American Society of Retina Specialists, 2005.p163

201. Shah GY, Chalam KV. Successful management of optic disc melanocytoma associated choroidal neovascularization with photodynamic therapy (PDT). Proceedings of American Society of Retina Specialists, 2005.p169

202. Lin DT, Pakalnis VA, Tripathi RC, Yee SB, Chalam KV. Spontaneous medial wall fracture caused by nose blowing and persisting as proptosis.Evaluation of Screening Criteria for Retinopathy of Prematurity. American Journal of Ophthalmology 139(3): S24, 2005

203. Gupta SK, Chalam KV.“Screening with birth weight < 1250 (g) identifies all high risk retinopathy of prematurity for early treatment and avoids unnecessary examinations” American Academy of Ophthalmology, Chicago, 2005

204. Chalam KV, Shah GY, Agarwal S, Gupta SK. “25 g vs. 20 g: Ultrasound Biomicroscopic Evaluation of Vitreous Incarceration in Sclerotomies after Pars Plana Vitrectomy ” American Academy of Ophthalmology, Chicago, 2005

205. Gupta SK, Agarwal S,Chalam KV. “Evaluation of Concurrent Sutureless 25g Vitreoretinal Surgery & Bimanual Microincisional Phakoemulsification with Placement of Foldable IOLs” American Academy of Ophthalmology, Chicago, 2005

50 05/02/23

Page 51: 1.1.16 master CV

206. Shah GY, Gupat SK, Agarwal S, Chalam KV “Evaluation of Web-based Annotation of Ophthalmic Images for Multi-center Clinical Trials”. American Academy of Ophthalmology, Chicago, 2005

207. Chalam KV, Gupta P, Shah V. “Quality of Life measured by the 25-Item NEI Correlates accurately with severity of macular scotoma in age related macular generation.” American Academy of Ophthalmology, Chicago, 2005

208. Lin SJ, Shah VA, Gupta SK, Chalam KV. Evaluation of Screening Criteria for Retinopathy of Prematurity. Proceedings of American Society of Retina Specialists, 2004. Page 86

209. Gupta SK, Shah VA, Chalam KV. Evaluation of Concurrent Placement of Foldable IOLs in Vitreoretinal Surgery Combined with Phacoemulsification. Proceedings of American Society of Retina Specialists, 2004. Page 104

210. Chalam KV, Lin SJ, Phillips W, Shah VA. Evaluation of various retinal pathologies with Liquid Crystal Display Microperimeter. Proceedings of American Society of Retina Specialists, 2004. Page 142

211. Shah VA, Lin SJ, Phillips W, Chalam KV. Normal Values for Fundus Perimetry Using Liquid Crystal Display Microperimeter. Proceedings of American Society of Retina Specialists, 2004. Page 146

212. Chalam KV, Shah VA. Direct Image Creating Aspheric Lens for Indirect Ophthalmoscopy. Proceedings of American Society of Retina Specialists, 2004. Page 180

213. S.K. Gupta, G.Y. Shah, V.A. Shah, K.V. Chalam. Evaluation of Light Weight Autoclavable Self-Stabilizing Wide-Angle Contact Lens for Vitreous Surgery. Invest. Ophthalmol. Vis. Sci. 2005;45:ARVO E-Abstract 690

214. L.F. Ward, D.Edward, K.V. Chalam.Localization of Retinal Stem cells in Normal Human Eye. Invest. Ophthalmol. Vis. Sci. 2005; 45:ARVO E-Abstract 3146

215. K.V.Chalam, G.Shah, L.F. Ward. Immunolocalization of Retinal Stem Cells With Multiple Markers in Human Proliferative Vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 2005;45:ARVO E-Abstract 3230

216. V.A. Shah, S.J. Lin, G.Y. Shah, K.V. Chalam. Normal Values for Fundus Perimetry Using Liquid Crystal Display Microperimeter. Invest. Ophthalmol. Vis. Sci. 2005; 45:ARVO E-Abstract 4316

217. S.J. Lin, V.A. Shah, G.Y. Shah, P.Wludyka, K.V. Chalam. Evaluation of Modified Retinopathy of Prematurity(ROP) Screening Guidelines Using Birth-Weight(BW) as Sole Inclusion Criteria. Invest. Ophthalmol. Vis. Sci. 2005;45:ARVO E-Abstract 4100

218. R.C. Tripathi, S.Lin, W.Philips, B.J. Tripathi, K.V. Chalam. Effects of Trypan Blue on Cell Viability and Gene Expression of Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2005;45:ARVO E-Abstract 5419

219. G.Y. Shah, V.A. Shah, S.K. Gupta, K.V. Chalam. Management of Vitreous Incarcerated in Sclerotomies in Phakic Eyes With a 25 Gauge Illuminated Curved Vitrector. Invest. Ophthalmol. Vis. Sci. 2005;45:ARVO E-Abstract 5456

51 05/02/23

Page 52: 1.1.16 master CV

220. B.J. Tripathi, W.Philips, R.C. Tripathi, K.V. Chalam. Sub-Solar Ultraviolet Radiation Decreases Cell Viability and Alters Gene Expression of Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2005;45:ARVO E-Abstract 5252

221. K.V. Chalam, B.J. Tripathi and R.C. Tripathi. The effect of pH on survival of retinal ganglion cells in vitro. Proceedings of International Society of Ocular Toxicology, 8th Congress. 2004

222. R.C. Tripathi, B.J. Tripathi and K.V. Chalam. Ciliary Epithelium is an extraretinal source of Vascular Endothelial growth factor (VEGF) Proceedings of International Society of Ocular Toxicology, 8th

Congress. 2004

223. K.V. Chalam, B.J. Tripathi and R.C. Tripathi. High hydrostatic pressure decreases survival of retinal ganglion cells in vitro. Proceedings of International Society of Ocular Toxicology, 8th Congress. 2004

224. B.J. Tripathi, K.V. Chalam, and R.C. Tripathi. Indocyanine Green induces apoptosis in retinal ganglion cells. Proceedings of International Society of Ocular Toxicology, 8th Congress. 2004

225. Phillips WW, Shah VA, Tripath B, .Tripath R, Chalam KV. An In Vitro Study of the effect of varying pH on survival of Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2004;45:ARVO E-Abstract 875

226. Chalam KV, Phillips WW, Shah V, Tripath R, Tripathi B. The Effect of Increased Pressure on In Vitro Survival of Transfected Rat Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2004;45:ARVO E-Abstract 887

227. Gupta SK, Shah VA, Phillips WW, Chalam KV. Evaluation of Newly Designed Aspheric Panoramic Wide-Field Lens for Gonioscopy. Invest. Ophthalmol. Vis. Sci. 2004;45:ARVO E-Abstract 2406

228. Shah VA, Chalam KV. Evaluation of a Direct Image Fundus Lens for Indirect Ophthalmoloscopy. Invest. Ophthalmol. Vis. Sci. 2004;45:ARVO E-Abstract 2806

229. Tripathi BJ, Chalam KV, Phillips WW, Shah VA, Tripathi RC. Indocyanine Green induces apoptosis in Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2004;45:ARVO E-Abstract 3269

230. Lin SJ, Shah VA, Phillips WW, Chalam KV. Correlation of Retinal Sensitivity to Visual Acuity Using Liquid Crystal Display Microperimetry. Invest. Ophthalmol. Vis. Sci. 2004;45:ARVO E-Abstract 5452

231. Li J, Tripathi BJ, Tripathi RC, Chalam KV,. Trabecular cell Expression of Fibronectin and MMP-3 is modulated by Aqueous Humor Growth Factors. Invest. Ophthalmol. Vis. Sci. 2004;45:ARVO E-Abstract 4421

232. Tripathi RC, Tripathi BJ, Chalam KV, Li J, Edward DP. Evidence for ciliary epithelium as a source of Vascular Endothelial Growth factor. Invest. Ophthalmol. Vis. Sci. 2004;45:ARVO E-Abstract 4414

233. Chalam KV, Gupta SK, Shah VA. Macular infarction in a young male with sickle cell disease. Proceedings of American Society of Retina Specialists, 2003. Page 186

52 05/02/23

Page 53: 1.1.16 master CV

234. Chalam KV, Shah VA. The Use of Liquid Crystal Display Microperimetry to Detect Visual Impairment Following Photocoagulation in patients with Diabetic Macular Edema. Proceedings of American Society of Retina Specialists, 2003. Page 172

235. Shah VA, Chalam KV. Autoclavable wide-angle two-piece lens for vitreous surgery. Proceedings of American Society of Retina Specialists, 2003. Page 164

236. Shah VA, Vinjamaram S, Chalam KV. Slitlamp Biomicroscopy Adapter for Simultaneous Photodocumentation during Clinical Assessment of the Fundus. Proceedings of American Society of Retina Specialists, 2003. Page 164

237. Chalam KV, Gupta SK, Patel CC, Vinjamaram S, Shah VA. Quality of Life in Diabetic Retinopathy as measured by the 25-Item NEI and TTO Utility Values. American Academy of Ophthalmology 2003. Page 262

238. Shah VA, Gupta SK, Chalam KV. Successful Management of Cataract Surgery Associated Vitreous Loss with Sutureless Small Gauge Pars Plana Vitrectomy. American Academy of Ophthalmology 2003. Page 129

239. Phillips WW, Shah VA, Lin S, Chalam KV. The Effect of Elevated Atmospheric Pressure on the In Vitro Survival of Retinal Ganglion Cells. Molecular Biology of the Cell Supplement 2003; Nov 14

240. Shah VA, Phillips WW, Lin S, Chalam KV. Effect of Elevated Pressure on Retinal Pigment Epithelial Cell Viability: An In Vitro Study. Molecular Biology of the Cell Supplement 2003; Nov 14

241. Chalam KV, Gupta SK, Vinjamaram S,Shah VA. The Evaluation of a Self-Retaining Modified Levicky Infusion Cannula in Pars Plana Vitrectomy. Proceeding of Vitreous Society meeting, San Francisco, 2002

242. Shah VA, Vinjamaram S, Chalam KV, Gupta S. The Effect Of Pressure On The Survival Of Retinal Ganglion Cells: Using a Unique Pressure Chamber System. Presented at the 61 st ‘All India Ophthalmological Society’ New Delhi, India. 2003; 184.

243. Shah VA, Chalam KV, Vinjamaram S, Gupta S. Levels of a5ß3 and a5ß5 Integrin on Proliferating Endothelial Cells of CNV. Presented at the 61st ‘All India Ophthalmological Society’, India. 2003;180.

244. Shah VA, Chalam KV, Vinjamaram S, Gupta SK, Jain P. Introduction & Evaluation of SVG Based Ophthalmic Image Annotation in Internet Based Multi-Center Clinical Trials. Presented at the 61 st ‘All India Ophthalmological Society’ New Delhi, India. 2003;150.

245. K.V. Chalam, S.Vinjamaram, V.A. Shah, B.Tripathi, R.Tripathi. An In Vitro System for Studying the Effect of Ambient Hydrostatic Pressure on Growth, Morphology, and Biochemical Aspects of Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

246. R.Sharma, S.Vinjamaram, V.A. Shah, S.K. Gupta, K.V. Chalam. The Effect of Elevated Atmospheric Pressure on the Survival of Retinal Ganglion Cells Using Flexcell Biopress System. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

53 05/02/23

Page 54: 1.1.16 master CV

247. B.J. Tripathi, J.Chen, J.Li, K.V. Chalam, S.Gotsis, V.A. Pakalnis. Growth Factors in Secondary Aqueous Humor Modulate Trabecular Cell Expression of MMP-3. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

248. V.A. Shah, S.Vinjamaram, R.Sharma, S.K. Gupta, K.V. Shah, K.V. Chalam. Alpha-V beta-3 and Alpha V Beta-5 Integrin identification on Endothelial Cells of Human Eyes with Choroidal Neovascular Membranes. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

249. S.Vinjamaram, K.V. Chalam, V.A. Shah. The Effect of Increased Hydrostatic Pressure on the Survival of Retinal Pigment Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

250. V.A. Pakalnis, R.C. Tripathi, J.Bullajian, K.V. Chalam. Ocular Toxicity of Fireworks. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

251. M.C. Patel, S.K. Gupta, S.Vinjamaram, K.V. Chalam, V.A. Shah. Newly Designed Dual Purpose Autoclavable Lens for Vitreous Surgery. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

252. S.K. Gupta, B.Raisler, V.A. Shah, S.Vinjamaram, K.V. Shah, K.V. Chalam. Intravitreal Concentration of Pigment-Epithelium Derived Growth Factor (PEDF) in Eyes with Proliferative Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

253. B.J. Tripathi, R.C. Tripathi, Y.Y. Xing, K.V. Chalam, J.Li. Optic Nerve Astrocytes Under Pressure Decrease Synthesis and Secretion of Transforming Growth Factor-ß1. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO 2003.

254. Chalam KV, Gupta SK, Shah VA, Vinjamaram S. No Patch Clear Shield Dressing vs. Conventional Eye Patch and Shield in Uncomplicated Vitreous Surgery. Proceeding of Vitreous Society meeting, San Francisco, 2002

255. Vinjamaram S, Chalam KV, Gupta SK,Shah V. Apoptotic Cell Death of Retinal Ganglion Cells in Glaucoma. Molecular Biology of the Cell S2002; Nov 13 308a.

256. Chalam KV, Gupta SK,Shah VA, Vinjamaram S. The Role of Integrin V3 in Ocular Neovascular Disease. Molecular Biology of the Cell S2002; Nov 13:288a.

257. Shah VA, Gupta SK, Vinjamaram S, Chalam KV. Vitreous Nerve Growth Factor Levels in Vitreoretinal Pathologies. Molecular Biology of the Cell S2002; Nov 13:483a

258. V.A.Pakalnis, R.C.Tripathi, D.Yee, K.V. Chalam. Histopathologic and Ultrastructural Characterization of Anterior and Posterior Capsule in Kneist Dysplasia. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2002.

259. K.V. Chalam, N.Agarwal, R.Agarwal, R.Wordinger, S.Vinjamaram,. Evaluation and Comparison of Vireal NGF levels in Human Proliferative Diabetic Retinopathy and Proliferative Vitreoretinopathy . Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2002.

260. S.Gupta, K.V. Chalam, S.Vinjamaram, V.A.Pakalnis. Levels of Alpha-V beta-3 Integrin on Proliferating Endothelial Cells of CNV.Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2002.

261. P.Jain, K.V. Chalam, S.Gupta,. SVG Based Ophthalmic Image Annotation in Internet Based Multi-center Clinical Trials. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2002.

54 05/02/23

Page 55: 1.1.16 master CV

262. S.Vinjamaram, K.V. Chalam, S.Gupta, R.C.Tripathi. Anti PDGF Antibody Effectively Prevents Mesenchymal Transformation of RPE in Human PVR. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2002.

263. B.J.Tripathi., Y.Y.Xing., Tripathi. R.C., V.A.Pakalnis, Chalam, K.V. Expression of Gamma Interferon mRNA by Astrocytes. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2002.

264. S K Gupta . S Vinjamaram, K V Chalam. Quality of Life in Age-Related Macular Degeneration as Measured by the 25-Item NEI VFQ and the TTO Method Ophthalmology 2001 Vol.107:11A . p283

265. K V Chalam, S M Malkani, VA Pakalnis,S K Gupta Evaluation of Concurrent Placement of Foldable IOLs in Vitreoretinal Surgery Combined with Phacoemulsification Ophthalmology 2001 Vol.107:11A . p283

266. S.M. Malkani, P. Panthagani , K.V. Chalam. A Comparative Analysis of Corneal Thickness by Optical Coherence Tomography and Pachymetry. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2001.

267. P.B. Panthagani , R. Korrapati , K.V. Chalam.Evaluation of Suction Assisted Self-retaining Contact Wide-angle Lens for Vitreoretinal Microsurgery. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2001

268. S.K. Gupta , P. Panthagani , K.V. Chalam. Intravitreal Triamcinolone use in the control of Inflammation After Vitreoretinal Surgery .Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2001

269. B.J. Tripathi, D. Ehrich, R.C. Tripathi, K.V. Chalam, G.I.W. Duncker Influence of Increased Hydrostatic Pressure on Expression of Matrix Metalloproteases by Trabecular Cells.Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2001

270. K.V. Chalam, S.M. Malkani, P. Panthagani, R.C. Tripathi.Amplification of Platelet-derived Growth Factor genes occurs in Retinal Pigment Epithelium in Human Proliferative Vitreoretinopathy . Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2001.

271. Chalam, K.V., Malkani, S., Tripathi, R.C., Ambati, J.: Neovascular Glaucoma:Parsplana Baerveldt Implant vs. ND:Yag Cyclophotocoagulation vs. Yag Endocyclophotocoagulation. Ophthalmology 2001 Vol.107: 11A. P168

272. Chalam, K.V., Malkani, S., Gulani, A . Intravitreal Dexamethasone as well as Intravitreal Triamcinolone Reduces Postoperative Inflammation in Vireoretinal Surgery. Ophthalmology 2001 Vol.107: 11A. P182

273. Malkani, S., Panthagani, P., Gulani, A., Chalam, K.V. Optical Coherance Tomography Versus Pachymetry Measurements of Corneal Thickness in LASIK Candidates. Ophthalmology 2001 Vol.107: 11A. P256

274. Malkani, S., Panthagani, P., Chalam, K.V. Evaluation of Risk Factors Associated with Cataract Formation After Vitreoretinal Surgery. Ophthalmology 2001 Vol.107: 11A. P291

55 05/02/23

Page 56: 1.1.16 master CV

275. Shane, T., Martin, D.,Endophthalmitis Gancyclovir Implant TeamEndophthalmitis Following Gancyclovir Implant. (Chalam, K.V. P.I University of South Carolina).Ophthalmology 2001 Vol.107: 11A. P283

276. Chalam, K.V., Gupta, S., Malkani, S.: Evaluation of Suction Assisted Self Retaining Low Weight One Piece Wide Angle Contact Lens for Vitreoretinal Surgery. Proceedings of Vitreous Society meeting, p 174, Peurto Rico, 2001

277. Chalam, K.V., Gupta, S., Malkani, S.: HRQL in Patients with Diabetic Retinopathy as Measured by the 25-Item NEI VFQ and Time Trade off Method. Proceedings of Vitreous Society Meeting, p 190, Peurto Rico, 2001

278. K.V.Chalam, S.Malkani, A.C.Gulani, R.C.Tripathi. Evaluation of Intravitreal Dexamethasone Treatment for Intraocular inflammation After Vitreoretinal Surgery . Proceedings of International Society of Ocular Toxicology, 7th Congress. P 53.

279. K.V.Chalam, R.C.Tripathi. Evaluation of Glutaraldehyde and Providine Iodine for Sterilization of Wide Field Contact lenses. Proceedings of International Society of Ocular Toxicology, 7 th Congress. P 52.

280. A.C.Gulani, K.V.Chalam, A.Neumann, W.Kopelowitz,. Comparative Study of Ten Different Refractive Strategies for Hyperopia. Proceedings of International Society of Ocular Toxicology, 7 th Congress .P 54

281. A.C.Gulani, K.V.Chalam, W.Kopelowitz.Epithelial Ingrowth Following LASIK: Avoidance and Management Proceedings of International Society of Ocular Toxicology, 7 th Congress. P 52.

282. A.C.Gulani, K.V.Chalam, W.Kopelowitz, M.Edelstein. Corneal Arcus and Blood Lipid Levels: Risk Factors for Cardiovascular Disease. Proceedings of International Society of Ocular Toxicology, 7 th

Congress. P 55

283. K.V.Chalam, R.C.Tripathi. Intraocular Delivery of Therapeutic Agents with Sustained Release Surgical Implants in the New Millennium. Proceedings of International Society of Ocular Toxicology, 7 th

Congress. P 36.

284. S.M.Malkani, K.V.Chalam, V.A.Pakalinis, R.C.Tripathi. Retinal Toxicity in Internal Ophthalmomyasis . Proceedings of International Society of Ocular Toxicology, 7 th Congress. P 48.

285. A.C.Gulani, K.V.Chalam. Anterior and Posterior Chamber Phakic Implants for High Myopia . Proceedings of International Society of Ocular Toxicology, 7 th Congress. P 36.

286. Chalam, K.V., N.Lin., Tripathi, R.C. Apoptosis of Retinal Pigment Epithelial Cells in Age Related macular Degeneration. Invest. Ophthalmol. Vis. Sci. 41(4): S400, ARVO abstract, 2000.

287. Malkani, S, Chalam, K.V., Tripathi, R.C. Intravitreal corticosteroid use in the control of inflammation after Vitreoretinal surgery Invest. Ophthalmol. Vis. Sci. 41(4): S361, ARVO abstract, 2000

288. N.Lin., Chalam, K.V., Tripathi, R.C. Insulin like growth factor-1 and its receptors are present in pterygia. Invest. Ophthalmol. Vis. Sci. 41(4): S451, ARVO abstract, 2000

289. N.Lin., Chalam, K.V., Tripathi, R.C., Chen.B., Sheedlo, H.J., Turner, J.E. Apoptosis of Photoreceptor cells in Fischer 344. Invest. Ophthalmol. Vis. Sci. 40(4): S228, ARVO abstract, 1999.

56 05/02/23

Page 57: 1.1.16 master CV

290. Tripathi, R.C., S.K.Parapuram.,Tripathi, B.J., Chalam, K.V. Growth factors present in Secondary Aqueous Humor increase expression of fibronectin in the trabecular meshwork system. Invest. Ophthalmol. Vis. Sci. 40(4): S667, ARVO abstract, 1999.

291. Li.J., Tripathi, B.J., Chalam, K.V., Pakalnis, V.A., Tripathi, R.C. TGF-Beta-2 modulates the mRNA expression protein production and secretion of fibronectin by trabecular cells. Invest. Ophthalmol. Vis. Sci. 40(4): S668, ARVO abstract, 1999.

292. S.K.Parapuram.,Tripathi, R.C., Tripathi, B.J., Chalam, K.V. Stromelysin expression in the trabecular meshwork of anterior segments perfused with growth factors present in secondary aqueous humor. Invest. Ophthalmol. Vis. Sci. 40(4): S670, ARVO abstract, 1999.

293. Chalam, K.V.,Tsao, K., Pakalnis, V.A., Tripathi, R.C., Basic fibroblast growth factor and antiplatelet growth factor derived antibody synergistically inhibit retinal pigment epithelial cell induced collagen contraction Invest. Ophthalmol. Vis. Sci. 40(4): S784, ARVO abstract, 1999.

294. Whiteside, B., Malkani, S., Chalam, K.V., Tripathi, R.C. A comparision of snellen acuity estimates by visual evoked potentials by LKC Technology .Vs. Actual Snellen Acuity measurements. Invest. Ophthalmol. Vis. Sci. 40(4): S820, ARVO abstract, 1999.

295. Sadat,T., Chalam, K.V., Hackett, S., Tripathi, R.C. Enhanced visualization and access of peripheral retina in trans pars plana vitrectomy surgery with usage of a dual function curved light and laser probe. Invest. Ophthalmol. Vis. Sci. 40(4): S946, ARVO abstract, 1999.

296. Das, T.P., Singh, J., Liu, F., Sharma, S., Chalam, K.V. Rapid sterilization of wide field contact lens used in vitreoretinal surgery. Invest. Ophthalmol. Vis. Sci. 40(4): S946, ARVO abstract, 1999.

297. Tsao, K., Chalam, K.V., Hunt, R.C., Pakalnis, V.A., Tripathi, R.C. Anti insulin like growth factor antibody I and II have no inhibitory effect on retinal pigment epithelial cell induced collagen contraction. Invest. Ophthalmol. Vis. Sci. 40(4): S461, ARVO abstract, 1999.

298. Chalam, K.V., Lin, N., Tripathi, R.C., Gandham, S. ND:Yag Cyclophotocoagulation versus Parsplana Modified Baerveldt Implant in the Management of Neovascular Glaucoma. Ophthalmology 1999 Vol.105: 11A. P189

299. Chalam, K.V, Malkani, S, Tripathi, R.C.: Intravitreal Dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery. Ophthalmology 1999 Vol.105: 11A. P189

300. Tsao, K., Chalam, K.V., Hunt, R.C., Pakalnis, V.A., Tripathi, R.C., Comparision of retinal pigment epithelial cell contraction when incubated in vitreous aspirates from patients with proliferative vs. nonproliferative forms of retinopathies. Invest. Ophthalmol. Vis. Sci. 39(3): S732, ARVO abstract, 1998.

301. Malkani, S., Chalam, K.V., Tripathi, R.C. Evaluation of self retaining wide angle true field contact lens for vitreoretinal microsurgery. Invest. Ophthalmol. Vis. Sci. 39(3): S375, ARVO abstract, 1998.

302. Lin, N., Chen, B., Sheedlo., Chalam, K.V., Tripathi, R.C., Turner, J.E. Effect of basic fibroblast growth factor on age related retinal degeneration in Fisher 344 rats: An ultrastructural study. Invest. Ophthalmol. Vis. Sci. 39(3): S572, ARVO abstract, 1998.

57 05/02/23

Page 58: 1.1.16 master CV

303. Zhong, Y., Tripathi, R.C., Tripathi, B.J., Frankel,.R.A., Chalam, K.V., Tripathi, P.C., Li, J. Fibronectin mRNA and protein expression by trabecular cells in anterior segments perfused with transforming growth factor -bb2. Invest. Ophthalmol. Vis. Sci. 39(3): S437, ARVO abstract, 1998.

304. Chalam, K.V., Tsao, K., Hunt, R.C., Ambati, J., Tripathi, R.C. Anti-platelet derived growth factor antibody inhibits retinal pigment epithelial cell induced collagen contraction. Invest. Ophthalmol. Vis. Sci. 39(3): S864, ARVO abstract, 1998.

305. Tripathi, R.C., Li, J., Tripathi, B.J., Edward, D.P., Chalam, K.V., Li, T., Lin, N., Adamis, A. Detection of vascular endothelial growth factor mRNA and protein in the ciliary epithelium. Invest. Ophthalmol. Vis. Sci. 39(3): S372, ARVO abstract, 1998.

306. Chalam, K.V., Tsao, K., Tripathi, R.C., Ambati, J.: Anti-PDGF antibody inhibits RPE cell induced collagen contraction in Proliferative Vitreoretinopathy. Ophthalmology 1998 Vol.105: 11A. P189

307. Ambati, J.,Thomas, M., Ambati, B.K., Chalam, K.V., Watkins, R., Maniscalo, W.M.: VEGF mRNA Expression in Surgical Choroidal Neovascular Membranes Not Secondary to Age Related Macular Degeneration. Ophthalmology 1998 Vol.105: 11A. P165

308. Tsao, K., Chalam, K.V., Tripathi, R.C. Phototoxic retinal lesion caused by occupational exposure to an old style movie projector. Proc. 6th Cong. ISOT 1998. In press.

309. Chalam, K.V., Malkani, S., Tripathi, R.C. Cisplatin causes neuroretinal toxicity. Proc. 6th Cong. ISOT 1998. In press.Tripathi, R.C., Li, J., Edward, D.P., Tripathi, B.J., and Chalam, K.V. Aqueous humor in neovascular glaucoma patients contains a significantly increased level of vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 38(4): S473, ARVO abstract, 1997.

310. Chalam, K.V., Pakalnis, Tsao, K., Li, J., and Tripathi, R.C. Correlation between levels of intravitreal vascular endothelial growth factor (VEGF) and various types of retinopathy . Invest. Ophthalmol. Vis. Sci. 38(4): S358, ARVO abstract, 1997.

311. Li, J., Tripathi, R.C., Kemeny, G., Chalam, K.V., and Tripathi, B.J. Expression of TGF beta 3 mRNA and detection of the cytokine in human Tenon's capsule fibroblasts.. Invest. Ophthalmol. Vis. Sci. 38(4): S266, ARVO abstract, 1997.

312. Qian, Y., Tripathi, R.C. Li, J., Chalam, K.V., and Tripathi, B.J. Barotoxic effects on morphology and viability of trabecular cells. Invest. Ophthalmol. Vis. Sci. 38(4): S562, ARVO abstract, 1997.

313. Oakman, J.H., Chalam, K.V., and Tripathi, R.C. A comparative analysis of glutaraldehyde disinfection for sterilization of wide-angle lens systems for microvitreoretinal surgery. Invest. Ophthalmol. Vis. Sci. 38(4): S661, ARVO abstract, 1997.

314. Wisdom, J., Oakman, J., Tripathi, R.C., and Chalam, K.V. Enhanced visualization of anterior retina in bans pars plane vitrectomy surgery using a curved light probe. Invest. Ophthalmol. Vis. Sci. 38(4): S87, ARVO abstract, 1997.

315. Herrell, P.K., Tripathi, R.C., Whiteside, B.C., Smith, D.L., Pakalnis, V.A., Chalam, K.V., and Pophal, M.D., The use of contact transscleral Nd:Yag cyclophotocoagulation in neovascular glaucoma. Invest. Ophthalmol. Vis. Sci. 38(4): S171, ARVO abstract, 1997.

58 05/02/23

Page 59: 1.1.16 master CV

316. Lopasic, N.W., Chalam, K.V., Tsao, K., Tripathi, R.C., Pakalnis, V.A., and Pophal, M.D. Interobserver variations in optic nerve cupping quantitation using cup to disc ratios vs. measurement with a gridded lens system. Invest. Ophthalmol. Vis. Sci. 38(4): S831, ARVO abstract, 1997.

317. Ambati, J., Chalam, K.V., Chawla, D.K., Guillet, E.G., Rose, S.J., Vanderline, R.E.: Evidence for excitotoxicity in patients with Proliferative Retinopathy. Ophthalmology 1997 Vol.104: 10A. P184

318. Tripathi, B.J., Li, T., Li, J., Henderson, A., Chalam, K.V., and Tripathi. R.C. Expression of mRNAs for gamma-interferon and transforming groath factor beta 1 in the retina and optic nerve of glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 38(4): S162, ARVO abstract, 1997.

319. Chalam, K.V., Pakalnis, V.A., Tsao.K., Tripathi, R.C: Correlation between levels of intravitreal vascular endothelial growth factor (VEGF) in proliferative and non proliferative types of retinopathies. Proceedings of Vitreous Society meeting, p 52, New orleans, August, 1997

320. Roche Gancyclovir Study group:Combined oral gancyclovir(GCV) and intravitreal GCV implant for treatment of patients with Cytomegalovirus (CMV) retinitis : A randomized controlled (South Carolina Eye Institute, K.V. Chalam, P.l.) Proceedings ofInterscience Conference on Antimicrobial Agents and Chemotherapy 1997; 4:15

321. Bryan, C.,Chalam, K.V., Pakalnis, Al., Dutta, B.K., Whiteside, B., Tripathi, R.C.: The efficacy of contact ND. Yag laser cyclophoto coagulation in the treatment of neovascular glaucoma. Invest.Ophthalmol.Vis.Sci. Vol.37/(3.): S261, ARVO abstract, 1996.

322. Pakalnis, V.A, Kosnosky, W., Tripathi, R.C.,Chalam, K.V.,: A single prismatic reinverting lens system for vitreoretinal microsurgery. Invest.Ophthalmol.Vis.Sci. Vol.37/(4.): S.401, ARVO abstract, 1996.

323. Chalam, K.V., Lopasic, N., Tripathi, R.C.: Evaluation of lens and peripheral retinal relationships during vitreous surgery with the use of a newly designed curved vitrectomy probe . Invest.Ophthalmol.Vis.Sci. Vol.37/(4.): S.401, ARVO abstract, 1996.

324. Oakman, J.,Chalam, K.V., Wisdom, J., Tripathi, R. C.: Improved access to ora serrata using a curved endolaser probe. Invest.Ophthalmol.Vis.Sci. Vol.37/(4.): S.403, ARVO abstract, 1996.

325. Lopasic, N.,Chalam, K.V., Tripathi, R. C.: An indirect lens system providing true field erect images for retinal laser procedures. Invest.Ophthalmol.Vis.Sci. Vol.37/(4.): S.404, ARVO abstract, 1996.

326. Tripathi, B. J., Li, J., Chalam, K.V., Tripathi, R.C. Upregulated expression of gama interferon and transforming growth factor in the optic nerve of glaucomatous eyes . Invest Ophthalmol.Vis.Sci. Vol.37/(4.): S.411, ARVO abstract, 1996.

327. Kosnosky, W., Tripathi, B.J., Chalam, K.V., Pakalnis, V.A., Tripathi, R.C. Pressure dependent changes in trabecular meshwork cell morphology. Invest.Ophthalmol.Vis.Sci. Vol.37/(4.): S.823, ARVO abstract, 1996.

328. Li, J., Tripathi, R.C., Chalam, K.V., Tripathi, B.J. Expression of PDGF A and PDGF B mRNAS by trabecular cells and lack of detectable level of PDGF BB in aqueous humor.Invest.Ophthalmol.Vis.Sci. Vol.37/(4.): S.823, ARVO abstract, 1996.

59 05/02/23

Page 60: 1.1.16 master CV

329. Tripathi, R.C., Li, J.,Chalam, K.V., Tripathi, B.J. Differential expression of TGF isoforms by trabecular cells and tenon's fibroblasts: Implications in glaucoma filtration surgery. Invest.Ophthalmol.Vis.Sci. Vol.37/(4.): S.1118, ARVO abstract, 1996.

330. Tripathi, R.C., Li, J., Chalam, K.V. and Tripathi, B.J. Effects of bFGF and TGF-ß1 on c-fos expression and TGF-ß1 induction in trabecular cells. Invest.Ophthalmol.Vis.Sci. Vol.36/(4.): S.727, ARVO abstract, 1995.

331. Pakalnis, V.A., Kosnosky, W., Chalam, K.V. and Tripathi, R.C. A comparative study of IL-1 beta induced membranes in rabbit and human PVR membranes. Invest.Ophthalmol.Vis.Sci.Vol.36/(4.): S.102, ARVO abstract, 1995.

332. Chalam, K.V., Volk, D., Kosnosky, W. and Tripathi, R.C. Wide-angle true field lens system for vitreoretinal microsurgery.Invest.Ophthalmol.Vis.Sci. Vol.36/(4.): S.742, ARVO abstract, 1995

333. Li, J., Tripathi, B.J., Li, T., Chalam, K.V. and Tripathi, R.C. Effects of TGF-ß2 on mRNA Alternative splicing and protein synthesis of fibronectin in trabecular cells of the eye. Invest.Ophthalmol.Vis.Sci. Vol.36/(4.): S.727, ARVO abstract, 1995.

334. Wisdom, J., Chalam, K.V., Pakalnis, V.A., Tripathi, B.J. and Tripathi R.C. Increased tissue plasminogen activity in activated retinal pigmented epithelium and rationale for use in management of submacular hemorrhage. Invest.Ophthalmol.Vis.Sci. Vol.36/(4.): S.1002, ARVO abstract, 1995

335. Choudhury, A., Chalam, K.V., Pakalnis, V.A. and Bowers, W.E. Processing and presentation of S-antigen by rat choroidal dendritic cells. Invest.Ophthalmol.Vis.Sci. Vol.36/(4.): S.543, ARVO abstract, 1995

336. Chalam , K.V., Wilson C.A, Bruce Berkowitz,: Assessment of blood retinal barrier integrity in alloxan diabetic rats using contrast enhanced MRI. Invest.Ophthalmol.Vis.Sci.. Vol.35 (4.): S.1588, ARVO abstract, 1994

337. Chalam K.V., Anand, R. : Unusual clinical manifestations in Epstein-Barr Viral Retinitis : Proc. International Society of Ophthalmology, p31-32, Toronto, January, 1994

338. Metrikin, D.C., Srebro, R., Chalam, K.V., Anand, R.: Screening for Hydroxychloroquine Toxicity. Ophthalmology 1994 Vol.9A. P140

339. Chalam K. V., Wilson C.A, Bruce Berkowitz : Effect of blood retinal Barrier on contrast enhanced MRI Measurement in rabbit eyes. Invest.Ophthalmol.Vis.Sci. .Vol.34 (4.): S.674, ARVO abstract, 1993.

RECENT LECTURES AND PRESENTATIONS:

2012

60 05/02/23

Page 61: 1.1.16 master CV

Tiffany D. Tucker, Sandeep Grover.Optic Nerve and Macular Dimensions in Normals Using Spectral-Domain OCT (Spectralis). Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Sandeep Grover, Jayson Edwards. Macular Findings in Retinitis PigmentosaBy Spectral-Domain OCT (Spectralis). Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Raluca Rusovici, Chirag Patel, Kakarla V. Chalam. Effect of Bevacizumab on Cell Cycle of VEGF- Enriched Proliferating Choroidal Endothelial Cells. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Joshua C. Priluck, K V. Chalam, Sandeep Grover. Macular Volume Change By Spectral-domain Optical Coherence Tomography After Treatment WithBevacizumab in Exudative Macular Degeneration. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Shailesh K. Gupta, IvanaObradovic, Rena Cappelli, Natalie McKee, Joshua Priluck, K V. Chalam, Sandeep Grover.Evaluation of Fundus Images Using the New Hand-held 'Pictor' Camera. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Michelle Diaz, Ravi Kevashamurthy, K V. Chalam, Sandeep Grover.Normative Data for Macular Volume by Spectral-Domain Optical Coherence Tomography (Spectralis). Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Kavitha Ravi, Ravi Keshavamurthy, S Balaiya, K V. Chalam.Dose Response Study Of Cytoprotective Effect By Lutein And Zeaxanthin On Retinal Pigment Epithelium From Oxidative Stress Induced Cytotoxicity. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Lee R. Ferguson, Kakarla V. Chalam.Evaluation of Retinal Thickness with Customized Spectral Domain Optical Coherence Tomography (SD-OCT) in Normal Mice. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Chirag J. Patel, K.V. Chalam, Sandeep Grover, Ravi Keshavamurthy, Joshua C. Priluck.Aqueous Interleukin-6 (IL-6) Levels Are Superior To Vascular Endothelial Growth Factor (VEGF) Levels In Predicting Therapeutic Response To Bevacizumab In Age-Related Macular Degeneration (AMD). Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Carolee M. Cutler Peck, Raluca Rusovici, Sandeep Grover, K V. Chalam. Evaluation Of Cytotoxicity Of Bevacizumab On VEGF-enriched Corneal Endothelial Cells. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

61 05/02/23

Page 62: 1.1.16 master CV

Ivana V. OBRADOVIC, Rena Cappelli, Joshua C. Priluck, K V. Chalam, Sandeep Grover.Comparison of Color Vision Testing By Standard Ishihara Color Plates Versus iPad Version. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Wassia A. Khaja, Amy Kelmenson, K V. Chalam, Sandeep GroverComparison of Central Corneal Thickness: Slit Lamp-OCT versus Ultrasound Pachymetry, Specular Microscopy, and Orbscan. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

V. Khetpal, S. Balaiya,KV Chalam. Inhibitory role of Resveratrolin the proliferation of choroidal endothelial cells under hypoxic stress. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

KV Chalam,S. Balaiya, R Malyapa. Differential sensitivity of cultured mature retinal cells (staurosphorine differentiated retinal ganglion cells and retinal pigment epithelial cells) against proliferating choroidal endothelial cells to proton radiation. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

Don K Davis, S.Balaiya, KV Chalam, Sandeep Grover. Neuroprotective role of sirtuin (SIRT1) against hypoxia in Retinal ganglion cells. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

R.K. Murthy, S Balaiya,Tatiana McLauchlan, KV Chalam. In vitro cytotoxic effects of Brilliant Blue Green (BBG) on retinal pigment epithelial cells after metal halide illumination.Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Florida, 2012

2011

S. Balaiya, K.V. Chalam. Regulation of hypoxia mediated toxicity by a post-transcriptional regulator, SIRT1 in choroidal neovascularization. 12th Congress of the International Society of Ocular Toxicology, 2011; Portland, Oregon

S. Balaiya, K.V. Chalam. Protective role of sirtuin against hypoxia induced neurotoxicity. 12th Congress of the International Society of Ocular Toxicology, 2011; Portland, Oregon

KV Chalam, S. Balaiya, RS Malyapa. Proton beam radiation selectively destroys proliferating chorodial endothelial cells and preserves non-proliferating retinal pigment epithelial cells: a model for choroidal neovascular membrane. 12th Congress of the International Society of Ocular Toxicology, 2011; Portland, Oregon

Tatiana McLauchlan, S Balaiya, KV Chalam. In vitro cytotoxic effects of Brilliant Blue Green (BBG) on retinal pigment epithelial cells after metal halide illumination. 12th Congress of the International Society of Ocular Toxicology, 2011; Portland, Oregon

62 05/02/23

Page 63: 1.1.16 master CV

K.V. Chalam, MD, PhD, V.Khetpal, MD, S. Gupta, MD, S. Grover, MD, . Navigated laser vs traditional argon green modified grid photocoagulation for diffuse diabetic macular edema American Academy of Ophthalmology, Orlando, 2011

K.V. Chalam, MD, PhD,S. Gupta, MD, S. Grover, MD, Evaluation of the impact of Ipad (as a low visual aid) on reading ability and quality of life of low vision patients. American Academy of Ophthalmology, Orlando, 2011

S. Balaiya, V.Khetpal, K.V. Chalam. Hypoxia induces a post-transcriptional regulator, SIRT1 (Histone deactylase; HDAC) mediated VEGF activation in choroidal retinal neovascularisation. Proceedings of 29th Annual Meeting of American Society of Retina Specialists , 2011, Boston

K.V. Chalam, V.Khetpal, S. Balaiya,. Resveretrol inhibits proliferation od choroidal endothelial cells in hypoxia: a model for neovascular AMD. Proceedings of 29th Annual Meeting of American Society of Retina Specialists , 2011, Boston

K.V. Chalam, V.Khetpal, R.Radhakrishnan. Newly designed miniaturized light weight wide angle contact lens for digital fluorescien angiographic evaluation of retinal ischemia.Proceedings of 29th Annual Meeting of American Society of Retina Specialists , 2011, Boston

V.Khetpal, R.Radhakrishnan, R.K. Murthy, K.V. Chalam. Evaluation of a novel contact automated focal laser with integrated (NAVILAS) fluorescien angiography for diabetic macular edema.Proceedings of 29th Annual Meeting of American Society of Retina Specialists , 2011, Boston

V.Khetpal, R.Radhakrishnan, K.V. Chalam. Ultra wide angle fluoroscien angiography revealed peripheral retinal ischemia correlates with retinal thinning in asymptomatic sickle cell patients.Proceedings of 29th Annual Meeting of American Society of Retina Specialists , 2011, Boston

R.Radhakrishnan, J.Edwards, V.Khetpal, K.V. Chalam. SD-OCT and infrared imaging of leukemic infiltration of the choroid.Proceedings of 29th Annual Meeting of American Society of Retina Specialists , 2011, Boston

R. Radhakrishnan, K.V. Chalam, V.S. Brar, S. Gupta, V. Khetpal, R. Keshavamurthy, S. Grover. Evaluation of the Use of Navigated Laser (NAVILAS) in the Treatment of Diabetic Macular Edema. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011.

R Keshavamurthy, VS Brar, KV Chalam. Lutein And Zeaxanthin Protect Retinal Pigment Epithelium From Oxidative Stress Induced Cytotoxicity. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011

Rena Cappelli, Ravi Radhakrishnan, KV Chalam, Sandeep Grover. Spectral Domain Optical Coherence Tomography Features of Retinal Astrocytoma.Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011

S.Balaiya, Vijay Khetpal, KV Chalam. Sirt-1 Induces Vascular Endothelial Growth Factor through the activation of HIF-2α in hypoxia. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011

63 05/02/23

Page 64: 1.1.16 master CV

V. Khetpal, S. Balaiya,KV Chalam. Resveratrol inhibits proliferation in hypoxia treated choroidal endothelial cells. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011

Jr. Don,S. Balaiya,KV Chalam. Protective action of a transcription regulator Sirt1against oxidative stress in choroidal endothelial cells: a model for age related macular degeneration. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011.

KV. Chalam, S.Balaiya, R. Malyapa. Proton Beam Radiation destroys VEGF induced Choroidal endothelial cell Proliferation in association with age related macular degeneration. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011

Vikram S. Brar, Monali Sakhalkar, S. Balaiya, KV. Chalam. Intracameral Bevacizumab reduces deep stromal neovascularisation and improves corneal graft clarity. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011

2010

R Keshavamurthy,MD, VS Brar, MD, K.V. Chalam, MD, PhD. Foveal Microstructure Delineated by Spectral-Domain OCT Correlates With Functional Outcome Mapped With Macular Microperimetry, after Macular Hole SurgeryAmerican Academy of Ophthalmology, San Francisco, 2010

V.S. Brar, MD, S. Gupta, MD, S. Grover, MD, K.V. Chalam, MD, PhD . Reduction of Human Aqueous VEGF Levels Accurately Predicts Resolution of Diabetic Macular Edema After Bevacizumab AdministrationAmerican Academy of Ophthalmology, San Francisco, 2010

KV Chalam,MD,PhD, R Keshavamurthy,MD, R Radhakrishnan,MD, VS Brar,MD, S Grover,MD. Evaluation of modified retinopathy of prematurity screening guidelines using birth-weight as sole inclusion criterionAmerican Academy of Ophthalmology, San Francisco, 2010

KV Chalam,MD,PhD R Keshavamurthy,MD, V Brar MD. Ultrastructural anatomical changes noted on high- resolution specitral domain oct accurately predicts visual acuity recovery after vitrectomy for epiretinal membranesAmerican Academy of Ophthalmology, San Francisco, 2010

R Keshavamurthy,MD, KV Chalam,MD,PhD, S Gupta, MD. Circumfrencial intraoperative laser retinopexy eliminates the risk of retinal detachment after macuar hole surgeryAmerican Academy of Ophthalmology,San Francisco, 2010

R. Radhakrishnan, S. Balaiya, V.S. Brar, R.K. Murthy, K.V. Chalam. Aqueous VEGF Levels in Patients Treated With Bevacizumab for Central Serous Chorioretinopathy Proceedings of American Society of Retina Specialists, Vancouver, BC, 2010

R. Radhakrishnan, R. Keshavamurthy, S. Gupta, KV Chalam. Comparative (Contact Vs Noncontact) Evaluation of Utility of Optiflex in Wide-Angle Vitreoretinal Surgery Proceedings of American Society of Retina Specialists,Vancouver, BC, 2010

64 05/02/23

Page 65: 1.1.16 master CV

K.V.Chalam, MD, PhD, R.K. Murthy MD ,S. Balaiya Ph.D, R. Malyapa MD, PhD . Evaluation of Differential Sensitivity of Retinal Ganglion Cells and Choroidal Endothelial Cells to Proton Beam Radiation: A Model for the study of AMD Proceedings of American Society of Retina Specialists, Vancouver, BC,2010

R Keshavamurthy MD, KV Chalam MD, S Grover MD . Asymptomatic temporal inner retinal thinning on Spectral-domain Optical Coherence Tomography: An indicator of peripheral ischemia in proliferative sickle cell retinopathy Proceedings of American Society of Retina Specialists, Vancouver, BC,2010

R Keshavamurthy MD, KV Chalam MD, S Grover MD . Foveal structural and functional changes in Patients with pattern dystrophy. Proceedings of American Society of Retina Specialists, Vancouver, BC,2010

S. Balaiya, R. Malyapa, K.V. Chalam. Proton Beam Radiation Selectively Destroys Proliferating Chorodial Endothelial Cells and preserves Non-proliferating Retinal Pigment Epithelial Cells: A Model for Choroidal Neovascular Membrane. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-2775

K. V. Chalam, S. Balaiya, R. Keshavamurthy, Brar VS. Comparative in vitro Safety Analysis of Vital Dyes for Chromovitrectomy-Indocyanine Green, Infracyanine Green, Brilliant Blue Green and Bromophenol Blue. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-3597

J.D. Edwards, S. Balaiya, K.V. Chalam. Estimation of TNF-α Concentration In Aqueous Humor Samples of Normal Human Subjects With Bead Based Immuno Assay. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-711

S. Grover, S. Balaiya, V.S. Brar, K.V. Chalam. Measurement of Aqueous VEGF levels in Patients with Retinal Diseases is Superior and Accurate in Fresh Than Stored Samples. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-3343

R. Radhakrishnan, S. Balaiya, V.S. Brar, R.K. Murthy, S. Grover, K.V. Chalam. Aqueous VEGF levels after Intravitreal Ranibizumab for Diabetic Macular Edema. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-5042

D.W. Hwang, S. Balaiya, R. Malyapa, K.V. Chalam. Effect of Proton Beam Radiation on The Survival of Two Different Ocular Cell-colonies: Fine Tuning Treatment of Choroidal Neovascularization with Radiation. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-3120

V.S. Brar, R. Keshavamurthy, S. Balaiya, K.V. Chalam. Aqueous Vascular Endothelial Growth Factor Levels in Exudative Age Related Macular Degeneration after Combination Treatment with Bevacizumab and Photodynamic Therapy. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-2787

65 05/02/23

Page 66: 1.1.16 master CV

C.M. Cutler Peck, S. Grover Functional Changes Correlate with Structural Changes in North Carolina Macular Dystrophy Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-4066

R. Cappelli, K.V. Chalam, S. Grover. Spectral-Domain Optical Coherence Tomography and Fundus Autofluorescence Findings in Patients with Pattern Dystrophy Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-4381

R. Keshavamurthy, V.S. Brar, S.K. Gupta, S. Grover, K.V. Chalam. Foveal Microstructure As Delineated By Spectral-domain OCT Accurately Predicts Functional Outcome On Microperimetry After Macular Hole Surgery Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-1335

Rajesh K Sharma, Anna T Rogojina, K.V. Chalam. Anti-VEGF therapy normalizes pathological intraocular environment in neovascular conditions Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-5905

A.T. Kelmenson, R.K. Murthy, S. Grover. Functional Changes Correlate With Structural Changes in Patients with Stargardt's Disease Using SDOCT, Autofluorescence, and Micro-perimetry Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51: E-1389

B. Chang, K.V.Chalam, Hunt,R. C. Hunt. Role of TGFβ and IL1β in Vitreous Transformation of Human Retinal Pigment Epithelial Cells. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2010, 51:1668

2009

“An in vitro effect of UV-induced phototoxicity on retinal cells” ASIA Association for Research in vision and ophthalmology, Hyderabad, India, 2009

“An effect of proton radiotherapy on cultured retinal cells” ASIA Association for Research in vision and ophthalmology, Hyderabad, India, 2009

“Difference In Macular Thickness As Measured By Time-domain OCT (Stratus) And Spectral-domain OCT (Spectralis)” ASIA Association for Research in vision and ophthalmology, Hyderabad, India, 2009

“Comparative Effect of Indocyanine and Infracyanine Green on Cultured Retinal Ganglion Cells.”Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

66 05/02/23

Page 67: 1.1.16 master CV

:”Protective Effect of Preconditioning on Oxidative Stress Induced Cell Death in RGC Cells”. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

“Ultraviolet Induced Oxidative Stress on Retinal Ganglion and Pigment Epithelial Cells”. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

“Vascular Endothelial Growth Factor Protects Against Oxidative Stress in Differentiated Retinal Ganglion Cells”. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

“Comparative Difference in Macular Thickness as Measured Between Spectral-Domain OCT (Spectralis) and Time-Domain OCT (Stratus)”. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

“Establishment of Macular Thickness in Normal Eyes With Spectral-Domain Spectralis Optical Coherence Tomography”. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

“Proliferating Retinal Cells Produce Growth Factors that Create Pro-Proliferation Environment” . Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

“Evaluation of Thickness of Individual Layers of the Retina With Spectral-domain OCT for Establishment of Normal Clinical Values”. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

“Evaluation of Optic Nerve Head Drusen Using Spectral-domain OCT (Spectralis)”. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida

“Evaluation of Differential Sensitivity of Retinal and Choroidal Cells to Proton Beam Radiation: A Model for Age Related Macular Degeneration. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida.

“Proton Radiation Predominantly Destroys Choroidal Endothelial Cells While Preserving Retinal Ganglion Cells”. Association for Research in Vision and Ophthalmology May 3-7, 2009, Ft. Lauderdale, Florida

2008

“Effects of Indocyanine green on cultured retinal ganglion cells: An in vitro study” International society of ocular toxicology , Philadelphia, PA, 2008

“Effect of bevacizumab on viability of human corneal cell lines” International society of ocular toxicology, Philadelphia, PA, 2008

67 05/02/23

Page 68: 1.1.16 master CV

“In vitro study of proton beam radiation toxicity on retinal cells” International society of ocular toxicology, Philadelphia, PA, 2008

“An in vitro effect of UV-induced phototoxicity on retinal cells” International society of ocular toxicology, Philadelphia, PA, 2008

“Evaluation of Ultra wide angle ‘ora-ora’ high refractive index self-stabilizing Wide-angle Contact lens for Vitreous Surgery.”American Society of Retina Specialists October 11–15, 2008 Maui, Hawaii.

“Normative data for macular thickness by spectral-domain OCT (Spectralis).”American Society of Retina Specialists October 11–15, 2008 Maui, Hawaii.

“In vitro toxicity of bevacizumab (Avastin®) in retinal ganglion and choroidal endothelial cell”. American Society of Retina Specialists October 11–15, 2008 Maui, Hawaii.

“Evaluation of aqueous VEGF levels after intravitreal bevacizumab for retinal vein occlusion”. American Society of Retina Specialists October 11–15, 2008 Maui, Hawaii.

“Quality of Life Measured by the 25-Item NEI Visual Function Questionnaire Correlates Accurately With Severity of Diabetic Macular Edema” American Academy of Ophthalmology, Atlanta, 2008.

“ Inner Segment/Outer Segment Changes on Ultrahigh-Resolution Spectral OCT Accurately Predict Visual Acuity Recovery After macular hole repair” American Academy of Ophthalmology, Atlanta, 2008.

Macular thickness in normal subjects by spectral-domain OCT (Spectralis)” . American Academy of Ophthalmology, Atlanta, 2008.

Aqueous Vascular Endothelial Growth Factor Levels Accurately Correlate With Regression of Neovascularization After Avastin Administration in Exudative Macular Degeneration . American Academy of Ophthalmology, Atlanta, 2008.

“Assessment of Cytotoxicity of Bevacizumab on Choroidal Endothelial, Retinal Ganglion, and Retinal Pigment Epithelial Cells” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.Poster Presentation

“Use of Multiplex Technology for Analyzing Human Aqueous Samples for a Battery of Analytes” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.Poster Presentation

“Evaluation of Second Generation Modified Portable Digital Camera for Documentation of Retinal Pathology”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.Poster Presentation

“Evaluation of Bevacizumab Cytotoxicity on Human Corneal Cell Lines” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.Poster Presentation

“Perifoveal Retinal Function in Patients With Macular Drusen” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008.Poster Presentation

68 05/02/23

Page 69: 1.1.16 master CV

“Interleukin-11 Expression by Human Retinal and Corneal Cells: Regulation by IL-1, TNF-α, IFN-γ and TGF-β”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008Poster Presentation

“Evaluation of Vascular Endotheilal Growth Factor Levels After Intravitreal Bevacizumab in Retinal Disorders” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008Poster Presentation

”Improvement of Visual Acuity and Resolution of Macular Edema Associated With Chronic Disciform Scars After Intravitreal Bevacizumab”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008. Poster Presentation

“Comparative (Contact vs. Noncontact) Evaluation of Utility of Optiflex Assistant System in Wide Angle Panoramic Vitreoretinal Surgery”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2008. Poster Presentation

“Portable Digital Camera is as effective as traditional nonmydriatic fundus camera in screening for AMD”, American Academy of Ophthalmology, NewOrleans, 2008.Poster Presentation

“Birth weight alone is the most predictable and reliable criteria in screening for ROP” American Academy of Ophthalmology, NewOrleans, 2008.Poster Presentation

“Human Aqueous Vascular Endothelial Growth Factor levels accurately predict regression of Iris neovascularization after Avastin administration in neovascular glaucoma” American Academy of Ophthalmology, NewOrleans,2008.Poster Presentation

“Comparative analysis of optical coherence tomography and retinal angiography in eyes treated with intravitreal bevacizumab for neovascular AMD” Proceedings of American Society of Retina Specialists, San Diego, 2008.Poster Presentation

“Microperimetry findings in patients treated with intraviteal avastin for exudative age-related macular degeneration” Proceedings of American Society of Retina Specialists,2008Poster Presentation

“Evaluation of touch sensitive optiflex system as surgical assistant in vitreoretinal surgery” Proceedings of American Society of Retina Specialists, San Diego, 2008.Poster Presentation

“Evaluation of simultaneous placement of a foldable IOL (FIOL) in vitreoretinal surgery combined with phakoemulsification surgery” Proceedings of American Society of Retina Specialists, San Diego, 2008.Poster Presentation

2007

“Evaluation of Modified Portable Digital Camera as a Screening Tool in Retinal Disorders” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Poster Presentation

“Evaluation of Nerve growth factor levels (NGF) in Aqueous of Primary Open Angle Glaucoma” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Poster Presentation

69 05/02/23

Page 70: 1.1.16 master CV

“Role of Intracameral Avastin in Neovascularization of Iris Secondary to Retinal Diseases” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Poster Presentation

“TGF-β Upregulates Extracellular Matrix Protein Anosmin (KAL-1) Expression in Human Retinal Pigment Epithelial Cells” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Poster Presentation

“Evaluation of OptiFlex as Surgical Assistant in Wide-angle contact lens assisted Vitreoretinal Surgery” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Poster Presentation

“Evaluation of Modified Retinopathy of Prematurity (ROP) Using Birth-Weight (BW) as Sole Inclusion Criterion” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Poster Presentation

“Induction of Stem Cell Markers in Non-Stem Cell Lines With Growth Factor Stimulation” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007 Poster Presentation

“Ciliary Epithelium is an Extraretinal Source of Vascular Endothelial Growth Factor (VEGF) in Neovascular Glaucoma”Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007 Poster Presentation

“Microperimetry vs. Humphrey Visual Field in the Evaluation of Toxic Maculopathy” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007 Poster Presentation

“Intravitreal Bevacizumab for the Treatment of Central Retinal Vein Occlusion” Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2007. Poster Presentation

2006

Emerging Biological and Pharmacological Therapies for Ocular Diseases: Highlights of BCSC 2- Instruction Course, AAO, Las Vegas 2006.

“Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.”Paper AAO, Las Vegas 2006.

“Modified Portable Digital Camera as Effective as Traditional Nonmydriatic Fundus Camera in Screening of Diabetic Retinopathy” American Academy of Ophthalmology, Las Vegas, 2006. Poster Presentation

“Evaluation of Comparative Efficacy of Topical Tetravisc vs. Lidocaine Gel in Cataract Surgery”American Academy of Ophthalmology, Las Vegas, 2006. Poster Presentation

“Evaluation of portable digital camera for screening of diabetic retinopathy in Primary care and Satellite Clinics” American Society of Retina Specialists, Annual Meeting, Cannes, France 2006.Poster Presentation

70 05/02/23

Page 71: 1.1.16 master CV

“Retinopathy of Prematurity (ROP) Screening Guidelines Using Birth-weight (BW) of Less Than or Equal to 1250 grams as Sole Inclusion Criteria” American Society of Retina Specialists, Annual Meeting, Cannes, France 2006. Poster Presentation

“Correlation of Optical Coherence Tomography and Heidelberg Retinal Angiography in Patients Treated With Intravitreal Bevacizumab for Choroidal Neovascular Membranes” American Society of Retina Specialists, Annual Meeting, Cannes, France 2006.Poster Presentation

“Effect of intracameral bevacizumab on neovascularization of the iris”American Society of Retina Specialists, Annual Meeting, Cannes, France 2006. Poster Presentation

“Evaluation of toxic effects of Ultra-violetB induced Apoptosis in Retinal Ganglion Cells.” International Society of Ocular Toxicology, Germany, 2006. Poster Presentation

“Effects of Indocyanine Green on Cultured Rat Retinal Ganglion Cells in Vitro.” International Society of Ocular Toxicology, Germany, 2006. Poster Presentation

“Autoclavable Wide-Angle Multi-lens Contact Lens for Vitreoretinal evaluation”. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006. Poster Presentation

“ Evaluation of Fixation Patterns in Macular Diseases with Liquid Crystal Display Fundus Microperimetry”. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006 Poster Presentation

“Evaluation and Comparison of Vitreal Nerve Growth Levels in various Retinal diseases”. Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006 Poster Presentation

“Evaluation of Growth Factors in Human Neural Stem and Retinal Progenitor Cell Conditioned media”.Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006 Poster Presentation

“Influence of Ciliary Neurotrophic factor (CNTF) on Apoptotic Retinal Ganglion Cell Death Induced by Glutamate Excitoxicity”.Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2006 Poster Presentation

“Anti VEGF therapy for AMD” All India Ophthalmic Society, Bhopal, India, 2006. Podium Presentation

“MP-1 microperimetry in Retinal disorders” All India Ophthalmic Society, Bhopal, India, 2006. Podium Presentation

“Screening with birth weight < 1250 (g) identifies all high risk retinopathy of prematurity for early treatment and avoids unnecessary examinations” All India Ophthalmic Society, Bhopal, India, 2006. Podium Presentation.

2005

71 05/02/23

Page 72: 1.1.16 master CV

“Spontaneous medial wall fracture caused by nose blowing and persisting as proptosis”. SERI-ARVO combined meeting, Singapore, 2005. Poster Presentation

“Evaluation of Light Weight Autoclavable Self-Stabilizing Wide-Angle Contact Lens for Vitreous Surgery”. Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2005. Poster Presentation.

“Localization of Retinal Stem cells in Normal Human Eye”. Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2005. Poster Presentation

“Immunolocalization of Retinal Stem Cells With Multiple Markers in Human Proliferative Vitreoretinopathy”. Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2005. Poster Presentation

“Normal Values for Fundus Perimetry Using Liquid Crystal Display Microperimeter”. Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2005. Poster Presentation

“Evaluation of Modified Retinopathy of Prematurity(ROP) Screening Guidelines Using Birth-Weight(BW) as Sole Inclusion Criteria”. Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2005. Poster Presentation

. “Effects of Trypan Blue on Cell Viability and Gene Expression of Retinal Ganglion Cells”. Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2005 Poster Presentation

“Management of Vitreous Incarcerated in Sclerotomies in Phakic Eyes With a 25 Gauge Illuminated Curved Vitrector”. Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2005. Poster Presentation

“Sub-Solar Ultraviolet Radiation Decreases Cell Viability and Alters Gene Expression of Retinal Ganglion Cells”. Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2005. Poster Presentation

“Screening with birth weight < 1250 (g) identifies all high risk retinopathy of prematurity for early treatment and avoids unnecessary examinations” American Academy of Ophthalmology, Chicago, 2005. Podium Presentation

“25 g vs. 20 g: Ultrasound Biomicroscopic Evaluation of Vitreous Incarceration in Sclerotomies after Pars Plana Vitrectomy” American Academy of Ophthalmology, Chicago, 2005. Poster Presentation

“Evaluation of Concurrent Sutureless 25g Vitreoretinal Surgery & Bimanual Microincisional Phakoemulsification with Placement of Foldable IOLs” American Academy of Ophthalmology, Chicago, 2005. Poster Presentation

“Evaluation of Web-based Annotation of Ophthalmic Images for Multi-center Clinical Trials” . American Academy of Ophthalmology, Chicago, 2005. Poster Presentation

72 05/02/23

Page 73: 1.1.16 master CV

“Quality of Life measured by the 25-Item NEI Correlates accurately with severity of macular scotoma in age related macular generation.” American Academy of Ophthalmology, Chicago, 2005. Poster Presentation

“Anti VEGF therapy for AMD” Vitreoretinal Society of India, India2005. Podium Presentation

“Anti VEGF therapy for AMD” FOCUS Mumbai, India, 2005. Podium Presentation

“Anti VEGF therapy for Recalcitrant Macular Edema” FOCUS Mumbai, India, 2005. Podium Presentation

“25 gauge vitrectomy for anterior segment surgeon!” FOCUS Mumbai, India, 2005. Podium Presentation

Bombay Ophthalmic Association, Mumbai, India, 2005. “Anti VEGF therapy for Macular Edema in CRVO”. Podium Presentation

“Autoclavable Wide Angle Lens for Vitrectomy” The Renaissance Symposium, 2005 – Retina and Vitreous; 7th IAVRSC, Ahmedabad, India, 2005. Podium Presentation

“Ultrasound B Scan” Bombay Ophthalmic Association, – Vitreo Retina Diagnostics Mumbai, India, 2005. Podium Presentation

“Curved Illuminated 25 Gauge Vitrector in Uvea Practice!” Uveitis Society of India. Jalna, India. 2005. Podium Presentation

“A novel reusable instrument system for creating 25 gauge sclerotomies in sutureless pars plana Vitrectomy” American Society of Retina Specialists, Montreal, Canada, 2005. Poster Presentation

“Comparative Evaluation of toxic effects of ICG and Trypan Blue on survival of Retinal Ganglion Cells” American Society of Retina Specialists, Montreal, Canada, 2005. Poster Presentation

“Innovative surgical approach to anterior vitreoretinal pathology- instrumentation and its uses”American Society of Retina Specialists, Montreal, Canada, 2005. Poster Presentation

“Successful Management of Optic Disc Melanocytoma Associated Choroidal Neovascularization with Photodynamic Therapy (PDT)”American Society of Retina Specialists, Montreal, Canada, 2005. Poster Presentation

“ Birth weight of 1250 grams Identifies Infants with High Risk Retinopathy of Prematurity for Early Treatment ”American Society of Retina Specialists, Montreal, Canada, 2005. Poster Presentation

“Evaluation of Web-based Annotation of Ophthalmic Images for Multi-center Clinical Trials” American Society of Retina Specialists, Montreal, Canada, 2005. Poster Presentation

“Quality of Life in Diabetic Retinopathy as measured by the 25-Item NEI and TTO Utility Values” American Society of Retina Specialists, Montreal, Canada, 2005. Poster Presentation

73 05/02/23

Page 74: 1.1.16 master CV

2004

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2004. An In Vitro Study of the effect of varying pH on survival of Retinal Ganglion Cells. Accepted for Poster Presentation.

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2004. The Effect of Increased Pressure on In Vitro Survival of Transfected Rat Retinal Ganglion Cells. Accepted for Poster Presentation.

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2004. Evaluation of Newly Designed Aspheric Panoramic Wide-Field Lens for Gonioscopy. Accepted for Poster Presentation.

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2004. Evaluation of a Direct Image Fundus Lens for Indirect Ophthalmoloscopy. Accepted for Poster Presentation.

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2004. Indocyanine Green induces apoptosis in Retinal Ganglion Cells.Accepted for Poster Presentation.

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, FL, 2004. Correlation of Retinal Sensitivity to Visual Acuity Using Liquid Crystal Display Microperimetry. Accepted for Poster Presentation.

American society of retina specialists Annual Meeting, San Diego, 2004. “Evaluation of Screening Criteria for Retinopathy of Prematurity”. Podium Presentation

American society of retina specialists Annual Meeting, San Diego, 2004. “Evaluation of Concurrent Placement of Foldable IOLs in Vitreoretinal Surgery Combined with Phacoemulsification”. Poster Presentation

American society of retina specialists Annual Meeting, San Diego, 2004. “Evaluation of various retinal pathologies with Liquid Crystal Display Microperimeter”. Poster Presentation

American society of retina specialists Annual Meeting, San Diego, 2004. “Normal Values for Fundus Perimetry Using Liquid Crystal Display Microperimeter”. Poster Presentation

American society of retina specialists Annual Meeting, San Diego, 2004. “Direct Image Creating Aspheric Lens for Indirect Ophthalmoscopy”. Poster Presentation

International society of ocular pharmacology and toxicology Annual Meeting, Dallas, TX, 2004. “Indocyanine Green induces apoptosis in retinal ganglion cells”. Poster Presentation

International society of ocular pharmacology and toxicology Annual Meeting, Dallas, TX, 2004. “High hydrostatic pressure decreases survival of retinal ganglion cells in vitro”. Poster Presentation

74 05/02/23

Page 75: 1.1.16 master CV

International society of ocular pharmacology and toxicology Annual Meeting, Dallas, TX, 2004. “Ciliary Epithelium is an extraretinal source of Vascular Endothelial growth factor (VEGF)”. Poster Presentation

International society of ocular pharmacology and toxicology Annual Meeting, Dallas, TX, 2004. “The effect of pH on survival of retinal ganglion cells in vitro”. Poster Presentation

2003

All India Ophthalmological Society Annual Meeting, New Delhi, India, 2003. “Introduction & Evaluation of SVG Based Ophthalmic Image Annotation in Internet Based Multi-Center Clinical Trials”. Podium Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2003. “Intravitreal Concentration of Pigment-Epithelium Derived Growth Factor (PEDF) in Eyes with Proliferative Diabetic Retinopathy”. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2003. “Alpha-V beta-3 and Alpha V Beta-5 Integrin Identification on Endothelial Cells of Human Eyes with Choroidal Neovascular Membranes”. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2003. An In Vitro System for Studying the Effect of Ambient Hydrostatic Pressure on Growth, Morphology, and Biochemical Aspects of Ganglion Cells. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2003. “The Effect of Elevated Atmospheric Pressure on the Survival of Retinal Ganglion Cells using Flexcell Biopress System”. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2003. “Newly Designed Dual Purpose Autoclavable Wide-angle Lens for Vitreous Surgery”. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2003. “The Effect of Increased Hydrostatic Pressure on the Survival of Retinal Pigment Epithelial Cells”. Poster Presentation

Vitreous Society Annual Meeting, NewYork, NY, 2003. “Macular infarction in a young male with sickle cell disease”. Poster Presentation

Vitreous Society Annual Meeting, NewYork, NY, 2003. “The Use of Liquid Crystal Display Microperimetry to Detect Visual Impairment Following Photocoagulation in patients with Diabetic Macular Edema”. Poster Presentation

Vitreous Society Annual Meeting, NewYork, NY, 2003. “Autoclavable wide-angle two-piece lens for vitreous surgery”. Poster Presentation

75 05/02/23

Page 76: 1.1.16 master CV

Vitreous Society Annual Meeting, NewYork, NY, 2003. “Slitlamp Biomicroscopy Adapter for Simultaneous Photodocumentation during Clinical Assessment of the Fundus”. Poster Presentation

American Society of Cell Biology Annual Meeting, San Francisco, CA, 2003. The Effect of Elevated Atmospheric Pressure on the In Vitro Survival of Retinal Ganglion Cells. Poster Presentation

American Society of Cell Biology Annual Meeting, San Francisco, CA, 2003. Effect of Elevated Pressure on Retinal Pigment Epithelial Cell Viability: An In Vitro Study. Poster Presentation

American Academy of Ophthalmology Annual Meeting, Anaheim, CA 2003. Quality of Life in Diabetic Retinopathy as measured by the 25-Item NEI and TTO Utility Values. Poster Presentation

American Academy of Ophthalmology Annual Meeting, Anaheim, CA 2003. Successful Management of Cataract Surgery Associated Vitreous Loss with Sutureless Small Gauge Pars Plana Vitrectomy. Podium Presentation

2002

American Society of Cell Biology Annual Meeting, San Francisco, CA, 2002. “Apoptotic Cell Death of Retinal Ganglion Cells in Glaucoma”. Poster Presentation

American Society of Cell Biology Annual Meeting, San Francisco, CA, 2002. “The Role of Integrin Vb3 in Ocular Neovascular Disease”. Poster Presentation

American Society of Cell Biology Annual Meeting, San Francisco, CA, 2002. “Vitreous Nerve Growth Factor Levels in Vitreoretinal Pathologies”. Poster Presentation

Vitreous Soceity Annual Meeting, San Francisco, CA, 2002. “The Evaluation of a Self-Retaining Modified Levicky Infusion Cannula in Pars Plana Vitrectomy”. Poster Presentation

Vitreous Soceity Annual Meeting, San Francisco, CA, 2002. “No Patch Clear Shield Dressing vs. Conventional Eye Patch and Shield in Uncomplicated Vitreous Surgery”. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2002 . “Histopathologic and Ultrastructural Characterization of Anterior and Posterior Capsule in Kneist Dysplasia”. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2001. “Evaluation and Comparison of Vireal NGF levels in Human Proliferative Diabetic Retinopathy and Proliferative Vitreoretinopathy”. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2002. “Levels of Alpha-V beta-3 Integrin on Proliferating Endothelial Cells of CNV”.Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2002. “SVG Based Ophthalmic Image Annotation in Internet Based Multi-center Clinical Trials” . Poster Presentation

76 05/02/23

Page 77: 1.1.16 master CV

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2002. “Anti PDGF Antibody Effectively Prevents Mesenchymal Transformation of RPE in Human PVR” . Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2002 . “Expression of Gamma Interferon mRNA by Astrocytes”. Poster Presentation

American Academy of Ophthalmology, Ft. Lauderdale, Fl, 2002 .Quality of Life in Age-Related Macular Degeneration as Measured by the 25-Item NEI VFQ and the TTO Method. Poster Presentation

American Academy of Ophthalmology, Ft. Lauderdale, Fl, 2002 .Evaluation of Concurrent Placement of Foldable IOLs in Vitreoretinal Surgery Combined with Phacoemulsification Poster Presentation

2001

American Academy of Ophthalmology, New Orleans, 2001. “Neovascular Glaucoma:Parsplana Baerveldt Implant vs. ND:Yag Cyclophotocoagulation vs. Yag Endocyclophotocoagulation”. Poster presentation.

American Academy of Ophthalmology, New Orleans, 2001. Intravitreal Dexamethasone as well as Intravitreal Triamcinolone Reduces Postoperative Inflammation in Vireoretinal Surgery. Poster presentation.

American Academy of Ophthalmology, New Orleans, 2001. Optical Coherance Tomography Versus Pachymetry Measurements of Corneal Thickness in LASIK Candidates. Poster Presentation

American Academy of Ophthalmology, New Orleans, 2001 Evaluation of Risk Factors Associated with Cataract Formation After Vitreoretinal Surgery. Poster presentation.

American Academy of Ophthalmology, New Orleans, 2001. Endophthalmitis Following Gancyclovir Implant. Poster presentation.

Vitreous Society, Peurto Rico, 2001. Evaluation of Suction Assisted Self Retaining Low Weight One Piece Wide Angle Contact Lens for Vitreoretinal Surgery. Poster Presentation.

Vitreous Society, Peurto Rico, 2001.HRQL in Patients with Diabetic Retinopathy as Measured by the 25-Item NEI VFQ and Time Trade off Method. Poster presentation.

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2001. A Comparative Analysis of Corneal Thickness by Optical Coherence Tomography and Pachymetry . Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2001.Evaluation of Suction Assisted Self-retaining Contact Wide-angle Lens for Vitreoretinal Microsurgery. Poster Presentation

77 05/02/23

Page 78: 1.1.16 master CV

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2001 . Intravitreal Triamcinolone use in the control of Inflammation After Vitreoretinal Surgery . Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2001. Duncker Influence of Increased Hydrostatic Pressure on Expression of Matrix Metalloproteases by Trabecular Cells. Poster Presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, 2001.Amplification of Platelet-derived Growth Factor genes occurs in Retinal Pigment Epithelium in Human Proliferative Vitreoretinopathy. Poster Presentation

2000

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, April 30-May 5, 2000: “Insulin like growth factor-1 and its receptors are present in pterygia.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, April 30-May 5, 2000: “Intravitreal corticosteroid use in the control of inflammation after Vitreoretinal surgery.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, April 30-May 5, 2000: “Apoptosis of retinal pigment epithelial cells in human age related macular degeneration.” Poster presentation

1999

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “. Apoptosis of Photoreceptor cells in Fischer 344.” Poster presentation

American Academy of Ophthalmology, Annual Meeting, Orlando, FL, October 29-November 2, 1999: " Intravitreal Dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery." Poster presentation

American Academy of Ophthalmology, Annual Meeting, Orlando, FL, October 29-November 2, 1999: " ND:Yag Cyclophotocoagulation versus Parsplana Modified Baerveldt Implant in the Management of Neovascular Glaucoma." Platform presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “Growth factors present in Secondary Aqueous Humor increase expression of fibronectin in the trabecular meshwork system.” Poster presentation

78 05/02/23

Page 79: 1.1.16 master CV

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “TGF-Beta-2 modulates the mRNA expression protein production and secretion of fibronectin by trabecular cells.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “.Stromelysin expression in the trabecular meshwork of anterior segments perfused with growth factors present in secondary aqueous humor ”. Poster presentation.

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “Basic fibroblast growth factor and antiplatelet growth factor derived antibody synergistically inhibit retinal pigment epithelial cell induced collagen contraction.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “A comparision of snellen acuity estimates by visual evoked potentials by LKC Technology. Vs. Actual Snellen Acuity measurements.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “Enhanced visualization and access of peripheral retina in trans pars plana vitrectomy surgery with usage of a dual function curved light and laser probe.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “Rapid sterilization of wide field contact lens used in vitreoretinal surgery.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1999: “Anti insulin like growth factor antibody I and II have no inhibitory effect on retinal pigment epithelial cell induced collagen contraction.” Poster presentation

1998

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1998: “Comparison of retinal pigment epithelial cell contraction when incubated in vitreous aspirates from patients with proliferative vs. nonproliferative forms of retinopathies.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1998: “Evaluation of self retaining wide angle true field contact lens for vitreoretinal microsurgery.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1998: “ Effect of basic fibroblast growth factor on age related retinal degeneration in Fisher 344 rats: An ultrastructural study.” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1998: “Fibronectin mRNA and protein expression by trabecular cells in anterior segments perfused with transforming growth factor -bb2.” Poster presentation

79 05/02/23

Page 80: 1.1.16 master CV

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1998: “Anti-platelet derived growth factor antibody inhibits retinal pigment epithelial cell induced collagen contraction.” Platform presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 9-15, 1998: “ Detection of vascular endothelial growth factor mRNA and protein in the ciliary epithelium.” Poster presentation

1997

Second Annual Meeting of Collaborating for the Community, Richland Memorial Hospital and USC School of Medicine, Columbia, SC, May 14, 1997: "Aqueous humor in neovascular glaucoma patients contains a significantly increased level of vascular endothelial growth factor." Scientific Poster

Second Annual Meeting of Collaborating for the Community, Richland Memorial Hospital and USC School of Medicine, Columbia, SC, May 14, 1997: "Expression of TGF beta 3 mRNA and detection of the cytokine in human Tenon's capsule fibroblasts." Scientific Poster

Second Annual Meeting of Collaborating for the Community, Richland Memorial Hospital and USC School of Medicine, Columbia, SC, May 14, 1997: "Expression of mRNA's for gamma-interferon and transforming growth factor beta 1 in the retina and optic nerve of glaucomatous eyes." Scientific Poster.

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997: “Aqueous humor in neovascular glaucoma patients contains a significantly increased level of vascular endothelial growth factor”. Platform presentation (Jointly)

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997 “Correlation between levels of intravitreal vascular endothelial growth factor (VEGF) and various types of retinopathy” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997 “TGF beta 3 mRNA and detection of the cytokine in human Tenon's capsule fibroblasts” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997. “Barotoxic effects on morphology and viability of trabecular cells”. Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997 “A comparative analysis of glutaraldehyde disinfection for sterilization of wide -angle lens systems for microvitreoretinal surgery” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997 “Enhanced visualization of anterior retina in bans pars plana vitrectomy surgery using a curved light probe” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997 “The use of contact transscleral Nd:Yag cyclophotocoagulation in neovascular glaucoma” Poster presentation

80 05/02/23

Page 81: 1.1.16 master CV

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997 “Interobserver variations in optic nerve cupping quantitation using cup to disc ratios vs. measurement with a gridded lens system” Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, May 11-16, 1997 “Expression of mRNAs for gamma-interferon and transforming growth factor beta 1 in the retina and optic nerve of glaucomatous eyes” Poster presentation

Fourth Annual International Symposium on Retina and Vitreous Surgery, Hyderabad, India, August 30-31, 1997 “Tips and Tricks in Vitreoretinal Surgery” Platform presentation

Fourth Annual International Symposium on Retina and Vitreous Surgery, Hyderabad, India, August 30-31, 1997 “Recent advances in ocular anesthesia” Platform presentation

Fourth Annual International Symposium on Retina and Vitreous Surgery, Hyderabad, India, August 30-31, 1997 “Optics of wide angle viewing systems and their use in viteroretinal surgery” Platform presentation

1996

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, April 22-26, 1996: "Improved access to ora serrata using curved endolaser probe." Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, April 22-26, 1996: "An indirect lens system providing true-field erect images for retinal laser procedures." Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, April 22-26, 1996: "Upregulated expression of gamma-interferon and transforming growth factor - beta1 in the optic nerve of glaucomatous eyes." Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl, April 22-26, 1996: "Pressure dependent changes in trabecular meshwork cell morphology." Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl,. April 22-26, 1996: "Expression of PDGP-A and PDGF-B m RNAs by trabecular cells and lack of detectable level of PDGF-B in aqueous humor." Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Ft. Lauderdale, Fl,. April 22-26, 1996: "Differential expression of TGF-beta isoforms by trabecular cells and Tenon's fibroblasts: implications in glaucoma filtration surgery." Poster presentation

First Annual Meeting of Collaborating for the Community, Richland Memorial Hospital and USC School of Medicine, Columbia, SC, May 10, 1996: "Differential expression of TGF beta isoforms by trabecular cells and Tenon's fibroblasts: implications in glaucoma filtration surgery" Scientific Poster.

81 05/02/23

Page 82: 1.1.16 master CV

First Annual Meeting of Collaborating for the Community, Richland Memorial Hospital and USC School of Medicine, Columbia, SC, May 10, 1996: "Upregulated expression of gamma-interferon and transforming growth factor beta 1 in the optic nerve of glaucomatous eyes." Scientific Poster.

1995

Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, May 14-19, 1995: "Effects of bFGF and TGF-beta 1 on c-fos expression and TGF-beta 1 induction in trabecular cells. Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, May 14-19, 1995: "Age-related changes in trabecular cells: A model in vitro." Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, May 14-19, 1995: "Effects of TGF-Beta on mRNA alternative splicing and protein synthesis of fibronectin in trabecular cells of the eye." Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, May 14-19, 1995: " Contraction of collagen gels by trabecular cells" Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, May 14-19, 1995: "An in vitro system for studying pressure effects on growth, morphology, and biochemical aspects of trabecular meshwork cells" Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, May 14-19, 1995: "Increased tissue plasminogen activity in activated retinal pigmented epithelium and rationale for its use in management of submacular hemorrhage" Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, May 14-19, 1995: "A comparative study of IL-1 beta induced membranes in rabbit and human PVR membranes" Poster presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, May 14-19, 1995: "Wide-angle true feild lens system for vitreoretinal microsurgery" Poster presentation

Department of Ophthalmology, Catholic Medical Center, New York, NY, June 21, 1995: “Retinal peripheral degenerations: normal abnormal ” Platform presentation

Department of Ophthalmology, Roosevelt Medical center, New York, NY, September 30, 1995: “Optics of wide angle panoramic viewing systems” Platform presentation

American Academy of Ophthalmology, Annual Meeting, Atlanta, GA, October 29-November 2, 1995: "Laser applications in diabetic retinopathy” Platform presentation

1994

82 05/02/23

Page 83: 1.1.16 master CV

Department of Ophthalmology, Catholic Medical Center, New York, NY, June 19, 1994: “Recent advances in the management of Cytomegalovirus Retinitis” Platform presentation

Association for Research in Vision and Ophthalmology, Annual Meeting, Sarasota, FL, May 1-6, 1994: “ Assessment of blood retinal barrier integrity in alloxan diabetic rats using contrast enhanced MRI” Poster presentation

American Academy of Ophthalmology, Annual Meeting, San Francisco, CA, October 29-November 2, 1994: "Electrophysiological changes in Plaquenil Retinopathy." Poster presentation

83 05/02/23


Recommended